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Abstract (500/500 words) 
Background: Sexually transmitted infections (STIs) continue to represent a major public health 
challenge.  There is evidence that behavioural interventions to reduce risky sexual behaviours can 
reduce STI rates in patients attending sexual health (SH) services. However, it is not known if these 
interventions are effective when implemented at scale in SH settings in England.  
Objectives: The study had two main objectives: 1. develop and pilot a package of evidence-based 
sexual risk reduction interventions that can be delivered through SH services; 2. assess the feasibility 
of conducting a randomised controlled trial (RCT) to determine effectiveness against usual care.   
Design: The project was a multi-stage mixed methods study, with developmental and pilot RCT 
phases. Preparatory work included a systematic review; analysis of national surveillance data, and 
development of a triage algorithm; interviews and surveys with SH staff and patients to identify, 
select and adapt interventions. A pilot cluster RCT was planned for eight SH clinics; the intervention 
would be offered in four clinics, with qualitative and process evaluation to assess feasibility and 
acceptability. Four clinics acted as controls; in all clinics, participants would be consented to a 6-
week follow-up STI screen. 
Setting: SH clinics in England.  
Participants: Young people (aged 16-25 years old) and men who have sex with men.  
Intervention: A three-part intervention package: 1. triage tool to score patients as high or low risk of 
STI infection using routine data; 2. a study-designed webpage with tailored sexual health 
information for all patients, regardless of risk; 3. a brief one-to-one session based on motivational 
interviewing for high risk patients.     
Main outcome measures: The three outcomes were: acceptability of the intervention to patients and 
SH providers; feasibility of delivering the interventions within existing resources; and feasibility of 
obtaining follow-up data on STI diagnoses (primary outcome in a full trial).  
Results: We identified 33 relevant trials from the systematic review, including: videos, peer support, 
digital, and brief one-to-one sessions. Patients and SH providers showed preferences for one-to-one 
and digital interventions, and providers indicated these intervention types could feasibly be 
implemented in their settings. There were no appropriate digital interventions that could be adapted 
in time for the pilot; therefore, we created a placeholder for the purposes of the pilot. The 
intervention package was piloted in two SH settings, rather than the planned four. Several barriers 
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were found to intervention implementation, including a lack of trained staff time and clinic space. 
The intervention package was theoretically acceptable, but we observed poor engagement. We 
recruited patients from six clinics for the follow-up, rather than eight. The completion rate for 
follow-up was lower than anticipated (16% versus 46%).  
Limitations: Fewer clinics were included in the pilot than planned limiting the ability to make strong 
conclusions on RCT feasibility.  
Conclusion: We were unable to conclude whether a definitive RCT would be feasible due to 
challenges in implementation of a pilot, but have laid the groundwork for future research in the 
area. . 
Study registration: ISRCTN 16738765.  
Funding details: Funded by the NIHR Health Technology Assessment programme (12/191/05).   
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Plain English summary (298/300 words) 
Reducing sexually transmitted infections (STIs) is a public health priority. Those most likely to be 
diagnosed with an STI are men who have sex with men and young people (16-25 years old). 
Interventions aimed at changing sexual behaviours (e.g. increasing condom use), can reduce the 
chance of getting new STIs in patients attending sexual health clinics. However, it is not clear if these 
interventions will work in English sexual health clinics, or if they could be implemented within 
existing resources. We aimed to find out if effective interventions could be adapted to an English 
setting and tested in a randomised trial.  
We searched the scientific literature for potential interventions, and found 33 trials. Effective 
methods included: videos, digital web-based interventions, self-testing kits, and talking sessions (e.g. 
counselling). We asked patients and providers which interventions were acceptable and found 
preferences for digital and 1:1 talking interventions. Providers suggested these were feasible to 
deliver.  We used data routinely collected from patients (e.g. number of partners), to select patients 
at higher risk of having an STI, and developed a computerised risk score calculation, and direct the 
highest risk group to a 1:1 counselling intervention. There were no appropriate digital interventions 
available; we therefore created a stand-in webpage to signpost users to appropriate sexual health 
resources.  This was offered to all patients.    
The intervention package was piloted in two sexual health settings, rather than the planned four due 
to lack of clinic staff time and space.  We planned to follow-up a sub-set of patients from all 8 clinics 
6-weeks after their visit, to collect information on STI diagnoses. Patients were recruited from six 
clinics, but only 16% completed the survey and returned a sample.    
We were unable to definitively conclude whether a randomised trial is feasible due to challenges in 
implementation and recruitment.  
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Scientific summary (1,838/2,400 words) 
Background: 
Sexually transmitted infections (STIs) continue to represent a major public health challenge in the 
UK, with 417,584 diagnoses in 2016.  Although there have been reductions in the number of cases of 
gonorrhoea and genital warts, there was a 12% increase in syphilis diagnoses, and chlamydia 
incidence has remained stable. Despite having a national network of open-access clinics for the 
treatment of STIs, and improved diagnostics, infection rates remain high. STIs particularly affect sub-
groups of the population, with young people (<25 years) and men who have sex with men (MSM) 
having the highest rates of infection. A variety of factors contribute to the risk of STIs: lack of 
knowledge about STIs; low self-efficacy; poor condom use; peer norms; and a lack of sexual 
negotiation skills. This has led to the Department of Health’s Sexual Health Framework prioritising 
prevention and support for behaviour change, alongside access to sexual and reproductive health 
services, particularly for those most vulnerable to poor sexual health.  
Multiple behavioural interventions have been trialled, and in most cases shown to have a modest 
but consistently positive effect, but they have not been implemented systematically in a way that 
could have a population level impact in the UK. There is a lack of evidence about how they can be 
implemented, in which context, by whom, and for whom. A clearer understanding of the factors that 
influence implementation in particular settings is needed. As funding for healthcare is under 
pressure, providing substantial additional resources across a large number of services is unrealistic, 
and therefore implementation of new interventions needs to focus on identifying brief, pragmatic, 
labour non-intensive interventions that can be tailored to the level of risk of the individual attending 
any of a range of different SH services. Implementation should be achievable with reallocation of 
existing resources, not substantial new investment. 
 
Objectives: 
The overall aim of the project, developed in response to a commissioned call, was to determine the 
feasibility of a randomised controlled trial (RCT) of an individualised package of sexual risk reduction 
interventions, to be offered within routine clinical care pathways in SH clinics. This aim was 
addressed through ten objectives: 
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1. To review existing evidence relevant to the UK on the nature and efficacy of brief and self-
delivered sexual risk reduction interventions  
2. To identify a suite of interventions of known effectiveness that can be delivered and 
combined to meet individual users’ needs 
3. To develop a sexual risk assessment/triage tool to identify service users’ level of sexual risk 
and thus individualise packages of behavioural interventions to the user’s needs  
4. To describe current practice in UK SH clinics with respect to delivery of sexual risk reduction 
interventions and identify best practice  
5. To explore opportunities and challenges to the delivery of candidate risk reduction 
interventions in SH clinics  
6. Using stakeholder input, to select, adapt and develop a manual of the evidence-based suite 
of interventions that can be combined and delivered to meet individuals’ needs  
7. To determine the acceptability, feasibility and deliverability of the individualised 
intervention packages in different SH clinical settings 
8. To assess the feasibility of testing the effectiveness of this individualised package of 
behavioural interventions in a randomised controlled trial (RCT) against usual care 
9. To estimate the cost and resource implications of implementing the individualised 
intervention packages in different SH settings  
10. To refine a manual of the intervention packages and to outline a feasible trial design (if 
feasibility is supported)  
 
Methods: 
The project was a multi-stage mixed methods study, which included developmental work and a pilot 
cluster randomised control trial, and comprised six packages of work, using the methodological 
approach of intervention mapping.   
The developmental work included three main strands of work to inform the intervention package 
design: a systematic review of sexual risk reduction behavioural interventions focussing on UK 
relevant evidence; development of a sexual risk triage tool to identify individuals at increased risk of 
STI diagnosis; a mixed methods study to describe sexual risk reduction practices and preferences in 
sexual health clinics and to identify opportunities for intervention. Using the evidence generated 
17 
 
from these activities, we selected and adapted evidence-based intervention components to develop 
and manualise a 1:1 intervention. We sought feedback from patients and healthcare providers 
(HCPs) on the design and content of the intervention.    
We conducted a pilot cluster randomised trial to investigate the feasibility of implementing the 
intervention package, its acceptability, and the feasibility of obtaining outcome data necessary for a 
full RCT. The pilot was designed to include four intervention and four control clinics, including level-2 
and level-3 services. A sub-set of patients were recruited from intervention and control clinics, to be 
followed up 6-weeks later for a web-survey and STI screen. The STI screen was offered as either a 
postal self-sample kit, sent to patient’s home, or patients returned to the clinic for a screen. The 
screen included chlamydia and gonorrhoea tests. The web-survey collected information about their 
recent clinic visit, including any interventions received.  
In the intervention clinics, process data was collected from the electronic patient record system, or 
study data collection tools to monitor engagement with the intervention. Interviews and focus group 
discussions were conducted with patients and HCPs to gain feedback on the acceptability and 
feasibility of the intervention delivery.  
 
Results: 
Developmental work: we identified 33 RCTs in a systematic review, of which 24 provided evidence of 
some significant impact on sexual behaviours, reflected in increased testing for STIs, or reduced STI 
rates. Interventions included videos, digital online, peer-group delivered, talking interventions, such 
as counselling, or provision of self-sampling kits for STI testing. Feedback from both patients and 
providers indicated that talking interventions, such as brief motivational interviewing sessions, and 
digital interventions were considered acceptable to service users and desirable by HCPs. HCPs also 
indicated that these intervention approaches could feasibly be delivered within their clinical settings.  
We developed an intervention package, consisting of three components: 1. A triage tool to score 
patients as high or low risk of STI infection using routine data; 2. A digital intervention (webpage) for 
all patients, regardless of risk (low-intensity intervention); 3. A brief one-to-one consultation based 
on motivational interviewing for high risk patients (high-intensity). There were no appropriate online 
interventions that were available, or that could be adapted for the pilot; therefore, we created a 
placeholder for the purposes of the pilot.  
18 
 
Pilot intervention: We enrolled 8 pilot trial sites in 4 categories (level 2; small, medium and large 
level 3 GUM), and allocated these as 4 intervention and 4 control sites. Neither level-2 service (one 
intervention, one control) were able to implement the protocol. Among the remaining three 
intervention sites, the intervention package was implemented fully in one, partially in one and was 
not able to be piloted in the third. Principal barriers to site participation included: re-commissioning 
of services during the period of the pilot; lack of staff capacity or space; other changes such as 
implementation of a new EPR system, or re-location of the clinic. A search for replacement clinics for 
those unable to deliver was unsuccessful. 
The triage process was completed by 612 eligible patients in the intervention sites. The triage 
threshold was set to select 5% of young people and 15% of MSM as being at high-risk, based on the 
model development process. However when implemented, considerably more than this (19% young 
people, 29% MSM) were selected. Of those triaged as high risk, 18% attended the one-to-one 
session, and 0.4% of clinic attendees (both high and low-risk were eligible) were tracked as having 
visited the webpage.  
Patient and provider participants in the qualitative interviews and focus group discussions gave 
positive feedback about the one-to-one sessions, with health advisors feeling it was similar to, and 
reinforced their current roles, and patients who attended stating they found it acceptable. There 
were mixed views of the triage process, particularly from HCPs; there were difficulties in 
implementing the triage process within the clinic EPR systems in a reasonable timescale, so that 
alternative processes had to be used (self-completion tablet-computer questionnaires on arrival in 
the clinic). Participants felt that the principle of a web-based intervention was good, but neither 
HCPs nor patients had actively engaged with this part of the intervention package, which was limited 
by our inability to offer a fully functioning intervention.  
Pilot follow-up: We recruited 406 patients to test whether it was possible to collect follow-up data at 
6 weeks. This comprised a web-survey and STI screen (by self-sampling, and return by post). Of those 
enrolled, 273 (67%) were young people and 133 (33%) were MSM. 228 (56%) participants did not 
participate in either the web-survey or return a self-sample kit and 64 (16%) completed both. Young 
people were less likely to complete the web-survey (OR: 0.39, 95% CI: 0.25, 0.61), or complete an STI 
screen (OR: 0.45, 95% CI: 0.29, 0.72) than MSM. Amongst young people, women were more likely to 
participate than men, and there were significant differences in follow-up rates by clinic, even when 
the age, gender and ethnicity of the participant were taken into account. Among MSM, no 
demographic factors were significantly associated with response, although there were trends 
towards older and white MSM responding.   
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Conclusions:  
There are existing evidence-based interventions that could benefit patients attending UK sexual 
health services. We adapted and manualised a brief one-to-one intervention that was acceptable to 
staff and patients, although we had very limited opportunity to pilot it in clinics. However digital 
format interventions, while acceptable and more easily deliverable at scale, were not available to 
pilot. They required more adaptation than was possible within the remit of this project, and a 
commitment to longer term maintenance and updates. A mechanism to triage patients as part of 
routine care was developed, but before large scale testing it would require more engagement by 
software suppliers so that it could be incorporated into EPR systems. During piloting, we found some 
evidence to support the acceptability of the combined intervention package, but encountered 
multiple challenges in both the feasibility of implementation and conduct of a trial. Follow-up rates 
for the outcome measure were lower than anticipated. Therefore, we conclude that undertaking a 
cluster RCT of the proposed intervention package would be very difficult in the environment of 
current sexual health service provision in England. In addition to the challenge of limited resources 
and service re-organisation, there is a change in the model of care being commissioned, with a shift 
away from face-to-face consultation, to self-testing and online patient pathways. While there is 
agreement that there is a need for behavioural interventions, including one-to-one for the highest 
risk groups, the heterogeneity of services means that implementation of a large-scale national trial 
would be challenging. Digital interventions could be implemented in conjunction with new care 
pathways for STI testing but these have not been widely commissioned. Further developmental work 
is required to see how behavioural interventions can be incorporated into the new models of service 
delivery. Alternative evaluation designs are likely to be required to provide evidence of efficacy and 
cost-effectiveness at that point.  
Study registration:  
ISRCTN 16738765.  
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Chapter 1: Background, aim and overview 
1.1 Background 
Sexually Transmitted Infections 
In 2012, there were 448,422 new diagnoses of sexually transmitted infections (STIs) made in 
England.1 This declined to 417,584 diagnoses in 2016, with reductions driven mostly by gonorrhoea 
and genital warts. However a concurrent 12% increase in syphilis diagnoses was seen, and chlamydia 
incidence has remained stable.2 There has also been a considerable decline in the number of new 
HIV diagnoses between 2015 and 2016, with a 23% reduction in men who have sex with men (MSM) 
largely attributed to increased HIV testing and pre-exposure prophylaxis (PrEP).3, 4  
Despite improved diagnostics, widespread service provision for the treatment of curable STIs in 
England, and greater emphasis on partner notification, infection rates remain high. STI rates are 
particularly high in sub-groups of the population, with young adults (<25 years) and MSM having the 
highest rates of infection.1, 2 Many STIs in young people will go undiagnosed and for young women in 
particular, this may have consequences for their future fertility, and consequent costs for the health 
service. Individuals may be at risk for a variety of reasons such as lack of knowledge about STIs, low 
self-efficacy (lacking belief that one can successfully meet a goal or perform a particular task such as 
negotiating the using of condoms), poor condom use and/or sexual negotiation skills. Risk-taking 
may also be influenced by peer-group norms. Some groups of young people, often characterized by 
factors associated with the broader determinants of social and health inequalities e.g. education and 
literacy, are disproportionately affected by STIs.5  
This has led to the development of a Sexual Health Framework by the Department of Health, which 
prioritises prevention and support for behaviour change, alongside access to sexual and 
reproductive health services, particularly for those most vulnerable to poor sexual health.6 This is 
especially crucial in the context of increasing antibiotic resistance, for example in gonorrhoea,2 
where prevention of infection is as important as effective treatment, if we are to bring transmission 
rates down.     
Sexual Health Services 
Sexual health (SH) services are provided through a range of clinics in England, including GP practices, 
genitourinary medicine (GUM) and contraception clinics, young people’s services (including third 
sector providers such as Brook) and pharmacies. The types of care that these different providers’ can 
offer ranges. Level-3 services (e.g. GUM clinics) provide the full range of STI testing, treatment and 
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management for all patient groups, usually with contraceptive services, as integrated sexual health 
services. Level-2 services (e.g. some community sexual health services, Brook or enhanced GP 
services) provide more limited STI testing and management of uncomplicated or asymptomatic 
infections. Level-1 services offer limited STI screening for asymptomatic patients only.7  
Since 2013, the commissioning of NHS services for sexual health has changed, become more 
complex, and fragmented. Most services are now commissioned by local authorities, as part of their 
remit to provide public health services. NHS England remains responsible for HIV treatment and 
care, but also commissions some components of sexual health, such as national screening 
programmes. Clinical commissioning groups (CCGs) also have a role, through their responsibility for 
commissioning primary care services.8-10 Clinics that provide sexual and reproductive health services 
offer an opportunity to engage those at risk in sexual risk reduction interventions.11, 12 However, 
introducing complex triage and sexual risk reduction interventions into busy clinical settings on a 
large scale, essential if there is to be a population level impact, is challenging and will have resource 
implications. It is imperative to show that a complex intervention is effective and deliverable, as well 
as cost effective, in a sufficient proportion of the diverse range of services provided in England.   
Risk groups and behaviours 
Young people and MSM are at higher risk of STIs. MSM specifically are at risk of HIV infection, with 
more than one third of newly diagnosed HIV cases in Western Europe being amongst MSM.13 In 
addition to age and sexual orientation, several demographic, geographical and behavioural 
characteristics have been identified which are associated with an increased risk of STIs. This 
potentially allows for targeted provision of prevention services to sub-groups at highest risk of STI 
acquisition.  
Amongst young people, factors associated with an increased risk of a STI diagnosis include: multiple 
partners, previous STI diagnosis and reported lack of condom use. In England specifically, the relative 
level of deprivation and the geographical region where someone lives are also associated with STI 
risk.2, 14, 15 Similar patterns are seen amongst MSM, with associations with multiple partners and 
geographical variations observed.16, 17 There are also differences in STI diagnoses according to 
ethnicity, with gonorrhoea rates being considerably higher amongst black ethnic minorities.18 In 
addition, the use of drugs during sex (‘chemsex’), is a pronounced risk factor amongst MSM groups, 
although also seen as a risk in heterosexuals.16, 19, 20 Information about these factors are often 
routinely collected within SH services as part of taking a clinical history, and could therefore be used 
as part of triage processes. 
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Risk reduction interventions 
Behaviour change interventions seek to promote changes in behaviour patterns associated with STI 
acquisition. The white paper ‘Healthy Lives, Healthy People’ emphasises a commitment to behaviour 
change approaches as a solution to reducing preventable illness and death.21 Research has shown 
that behaviour change interventions can help people adopt health-promoting behaviour patterns, 
including safer sex practices.22, 23 However, intervention effectiveness varies in relation to 
intervention type and target audience.24, 25  Attendance at a SH clinic provides an opportunity for 
intervention delivery at a potentially ‘teachable moment’, when people are primed to think about 
their sexual behaviour and the consequences for their health.26  
Sexual risk reduction interventions are complex interventions, which at the same time need to be 
integrated into routine service provision alongside STI testing and treatment, repeat testing and 
partner notification. These interventions can take a number of forms, and have different objectives, 
such as increasing knowledge of STI’s; changing cognitive antecedents, such as attitudes and/or 
beliefs (including normative beliefs); or increasing self-efficacy.27 The mode of delivery can vary 
widely. The US Centers for Disease Control and Prevention Community Guide concluded that 
community-based individual, group, and community-level interventions can be effective in reducing 
the risk for STIs in MSM.27 Digital approaches, such as ‘apps’ or online interactive interventions have 
also be shown to be effective and offer novel delivery which can be done outside of the clinic 
environment.28 Other intervention formats, such as waiting-room videos can be provided to all clinic 
attendees, although they may need adapting to different clinic settings; they have been shown to 
reduce incident STIs.29 However there is also evidence that tailoring interventions to individuals’ 
preferences and needs leads to greater uptake, and makes them more likely to be effective.30 
As clinic resources are limited, the use of triage or risk assessment can ensure that more resource-
intensive interventions are targeted at those who need them most, or for whom the intervention 
has been designed, and is more likely to be effective. As electronic patient record (EPR) systems 
become more widely used within clinical settings, using the coded data collected as part of routine 
care to inform a triage algorithm, could provide a mechanism to target different risk groups with 
appropriately tailored risk-reduction support.   
Evidence-gap 
Currently, multiple interventions have been trialled but there is a lack of clarity about which 
intervention would best be implemented in which context, by whom, and for whom. Therefore, a 
clear understanding of the factors that influence implementation in particular contexts is needed. In 
addition, such interventions, while tested individually and in most cases showing a modest but 
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consistent positive effect, have not been implemented systematically in a way that could have a 
population level impact in the UK. An additional challenge is that any implementation can only be 
achieved if it can be delivered at minimal overall cost. As funding for healthcare services, particularly 
those commissioned by local authorities is under pressure, any demand for additional resources 
across a large number of services is unrealistic. In this context, research is required to identify brief, 
pragmatic, labour non-intensive interventions that can be tailored to the level of risk of the 
individual attending any of a range of different SH services. The characteristics of those in the higher 
risk groups will differ by clinic setting, gender, sexual orientation and other factors which will need 
to be incorporated into the intervention model. The HTA call which led to the work described in this 
report was intended the address a first, important step by determining whether it would be feasible 
to conduct a definitive trial of effectiveness of brief behavioural interventions in sexual health 
services, incorporating the development of triage process to ensure that the interventions were 
most efficiently delivered to those most likely to benefit, and whether such a strategy meets is 
acceptable on cost-effectiveness criteria.   
 
1.2 Aim  
The overall aim of the project was to determine the feasibility of a randomised controlled trial (RCT) 
of an individualised package of sexual risk reduction interventions offered within routine clinical care 
pathways in SH clinics. This addresses two key aims: 
1. To develop and pilot a package of evidence-based sexual risk reduction interventions for 
those at most risk, that can be implemented in SH services. The suite of interventions will be 
matched to service users’ needs and developed alongside a triage method for identifying 
target groups.   
2. To assess the feasibility of testing the effectiveness of this individualised package of 
behavioural interventions in an RCT against usual care.   
 
1.3 Objectives 
The aims were addressed through ten specific objectives: 
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1. To review existing evidence relevant to the UK on the nature and efficacy of brief and self-
delivered sexual risk reduction interventions  
2. To identify a suite of interventions of known effectiveness that can be delivered and 
combined to meet individual users’ needs 
3. To develop a sexual risk assessment/triage tool to identify service users’ level of sexual risk 
and thus individualise packages of behavioural interventions to the user’s needs  
4. To describe current practice in UK SH clinics with respect to delivery of sexual risk reduction 
interventions and identify best practice  
5. To explore opportunities and challenges to the delivery of candidate risk reduction 
interventions in SH clinics  
6. Using stakeholder input, to select, adapt and develop a manual of the evidence-based suite 
of interventions that can be combined and delivered to meet individuals’ needs  
7. To determine the acceptability, feasibility and deliverability of the individualised 
intervention packages in different SH clinical settings 
8. To assess the feasibility of testing the effectiveness of this individualised package of 
behavioural interventions in a randomised controlled trial (RCT) against usual care 
9. To estimate the cost and resource implications of implementing the individualised 
intervention packages in different SH settings  
10. To refine a manual of the intervention packages and to outline a feasible trial design (if 
feasibility is supported)  
 
1.4 Project Overview 
The project was a multi-stage mixed method study design that incorporated: a systematic review; 
secondary analysis of national surveillance data; interviews and surveys with clinic staff; semi-
structured interviews, a discrete choice experiment and focus groups with clinic attendees; 
monitoring of intervention offering, uptake, and completion, and follow-up questionnaires; and 
capturing the clinical resources used.  In order to achieve this, the study was organised into 6 
overlapping work packages (WP), summarised below (Figure 1):  
Work Package 1:  A systematic review of sexual risk reduction behavioural interventions focussing on 
UK relevant evidence (Objective 1 & 2).  
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Work Package 2: Development of a sexual risk assessment/triage tool to identify individuals at 
increased risk in SH settings (Objective 3). 
Work Package 3: A mixed methods study to describe sexual risk reduction practices and preferences 
in SH clinics in the UK and to identify opportunities for intervention (Objectives 4 & 5).  
Work Package 4: The selection and adaptation of a suite of evidence based interventions suitable for 
delivery in SH settings and acceptable to patients and staff (Objective 6). 
Work Package 5: A pilot study of the feasibility of implementing interventions, to assess their 
acceptability, practicality, and cost of implementation; to comment on the feasibility of a future 
randomised control trial (Objectives 7-9).  
Work Package 6:  The refinement of the triage tool and manuals of the interventions to ensure that 
the triage tool can be incorporated into routine care (or derived from routinely collected data) and 
to ensure the fidelity of the interventions; an outline of the trial design for a full evaluation 
(Objective 10). 
The project focussed on understanding factors that influence implementation of interventions in 
complex SH clinic settings, from both patient and provider perspectives. We used co-creation 
approaches to intervention identification and adaptation with health advisors, clinicians and service 
users as an essential part of ensuring that the intervention would be acceptable and deliverable.  We 
followed the Medical Research Council (MRC) revised guidance on developing and evaluating 
complex interventions,31, 32 taking the results of the systematic review and selecting and developing 
the most promising package of interventions to reduce sexual risk. The National Institute for Health 
and Care Excellence (NICE) and the Department of Health, recommend user input when designing 
services as it leads to services that are more responsive to the needs of users as services are less 
likely to be designed inappropriately and more likely to be used.  
The methodological steps to delivering the objectives set out above were informed by the 
Intervention Mapping (IM) approach to intervention design.33  The IM approach is iterative and can 
be described as 6 steps (see Box 1). As described, the views of stakeholders, including service users 
and staff who deliver interventions, are captured and are vital to the successful design and 
implementation of interventions that are acceptable, practically feasible and sustainable over time.34 
Co-creation of interventions with stakeholders is integral to the IM approach.33 Although in part 
already defined by the project brief, the project included consideration of the needs of the 
population, and identified specified behaviour change outcomes corresponding to those needs. 
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Regulatory processes underpinning specified behaviour changes were identified from relevant 
research and matching change techniques selected.  
 
Figure 1: Work Package Overview 
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In the case of the interventions, it was anticipated that as these were to be selected from those for 
which efficacy evidence already existed, that we would be able to select practical intervention-
components designed to change defined behaviour regulation processes that work in-situ.  
This IM process facilitates identification of primary and secondary outcome measures, specified as 
needs and target behaviour changes, thus anticipating the evaluation design. Prototype 
interventions should be tested and adapted to ensure fidelity of delivery in context, prior to 
finalising an intervention manual.  
The IM process combines an ecological approach with participation of all stakeholders, a focus on 
specification of the underlying mechanism (in a clear logic model), and a research-based approach to 
ensuring fidelity of implementation. A key part of this process is to identify change techniques (e.g. 
Abraham & Michie, 2008 (124); Abraham 2011 (125); Michie & Johnston, 2012 (126)), modes of 
delivery and delivery competencies that maximise intervention effectiveness in real-world contexts 
(110).  All of this underpinned the approach taken to deliver the project. 
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1.4.1 Project Management 
Structured oversight of the project was conducted by a Project Steering Committee (PSC), with an 
independent chair, and was convened according to guidelines from the NIHR HTA Programme. This 
committee also served the function of the Data Monitoring Committee.  
The Project Management Group (PMG), chaired by the CI oversaw the work of all work packages.  It 
played the role of agreeing the details of project set-up, design, initiation and supervision of the 
study.  Each work package had a WP working group responsible for day to day management of the 
work, and this reported to the PMG monthly. 
 
1.4.2 Patient Public Involvement 
We embedded patient and public involvement (PPI) into the research programme at key points, 
including at the proposal development stage. It was essential that the developed intervention 
packages were endorsed by service users, therefore PPI and service user input throughout the 
proposal was sought for the translation of the research outcomes into improvements in current 
service provision. We set up a PPI group specifically for this project and liaised with them throughout 
the project. The PPI group (including our target groups of young people and MSM) helped in writing 
and approved the patient information sheets for this study. 
 
Box 1:  Intervention Mapping: six iterative steps applied to the Santé Project  
1. Needs assessment (partially pre-determined by commissioned brief, and part by WP1 and 
WP3) 
2. Mapping of intervention objectives (i.e. main outcomes) onto psychological, behavioural 
and environmental determinants or change processes (WP4) 
3. Selecting techniques and strategies to modify the determinants of behaviour based on an 
understanding of change processes (WP4) 
4. Selection and construction of intervention components and materials (WP4) 
5. Planning for intervention adoption, implementation and sustainability (WP5) 
6. Planning evaluation including process and outcome evaluation methods and instruments 
(partially by WP5) 
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1.4.3 Ethics 
Ethical approval for the study was granted by Westminster National Research Ethics Committee (ref: 
15/LO/0690) for work conducted in work packages 3 and 4, and the Chelsea National Research Ethics 
Committee (ref: 16/LO/0673) for work conducted in work package 5. The use of data in WP2 was 
approved by Public Health England’s Associate Caldecott Guardian. The anonymised data was 
collected as part of a pilot of enhanced routine STI surveillance, and the use of it was not considered 
to require ethical review. All service user participants provided written informed consent for 
interviews, focus group discussions and surveys. Healthcare providers provided written informed 
consent for focus group discussions, verbal consent for interviews and implied consent for web-
surveys. Process data from clinics was anonymised, and posters informing service users that the 
clinic was currently part of a study were displayed informing them that they could opt-out of their 
process data being used in analysis.  
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Chapter 2: Work Package 1 – Systematic Literature Review 
2.1 Background 
A 2010 meta-analysis of sexual risk reduction interventions suggested that behavioural interventions 
are effective, with moderate effect sizes, and should be implemented widely to reduce the 
population burden of STIs including HIV.30 However, this review focussed solely on USA-based 
intervention studies within STI clinics. An earlier UK review of behavioural interventions in GUM 
clinics, included 14 trials, but 12 were conducted in the USA.35  
Potential interventions could include those delivered in the clinic setting, such as brief 1:1 
motivational interviews, or beyond the clinic visit, such as interactive digital interventions. A recent 
review of interactive digital interventions has confirmed that they can be effective in improving 
knowledge about sexual health and suggest that they influence sexual behaviour positively; however 
evidence of an effect on STI rates was lacking.36  Other systematic reviews of interventions have 
been limited to particular groups, such as: adolescents,37-41 HIV-positive individuals,42 older adults,43 
MSM44 or have focussed only on condom promotion,45 or HIV risk.46  
There was a need to update these systematic reviews to include brief interventions that could be 
delivered in the wider range of sexual health services available in the UK (e.g. GUM, CASH and Brook 
services), focussing on the highest risk groups of MSM and YP. This chapter has been published 
previously. 47 
 
2.2 Aim 
The aim of this review was to identify evidence-based waiting-room-delivered, self-delivered and 
brief-healthcare provider-delivered interventions that evaluated effectiveness against reducing risky 
sexual behaviour or incidence of STIs in both young people and MSM. 
 
2.3 Methods 
A review protocol was developed and set out the methods used in the review (PROSPERO 
registration number: CRD42014014375). The review was conducted in 2015.  
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2.3.1 Search strategy 
The search strategy was developed in MEDLINE (OVID) and adapted for use in other databases. The 
search used a RCT filter to identify methodologically relevant studies. Search terms were identified 
by consulting literature, and an iterative search process was used to ensure an appropriate balance 
of sensitivity and specificity. MeSH terms used in the original MEDLINE search were translated for 
use in other databases as necessary.  
The following databases were searched: MEDLINE (OVID); PsycINFO (OVID); EMBASE (OVID); CINAHL 
(EBSCO); CENTRAL; DARE (via Cochrane); HTA (via Cochrane). All searches were conducted in 
October 2014. Further searching was carried out by hand of references of retrieved studies and 
relevant systematic reviews. The database search results were exported and managed using to 
Endnote (X5) and de-duplicated using the software and manual checking. A full search strategy is 
presented in Appendix 1.  
 
2.3.2 Study selection 
We considered only individual and cluster RCTs. Relevant studies were identified in two stages using 
predefined eligibility criteria. Titles and abstracts were examined independently by two researchers 
and screened for possible inclusion. Disagreements were resolved by discussion. Full texts of the 
identified studies were obtained. Two researchers examined these independently for inclusion or 
exclusion. Gwet’s AC1 statistic was calculated to assess inter-rater reliability 48 and disagreements 
were resolved by discussion. A third reviewer was available if necessary.  
 
2.3.3 Inclusion criteria 
Population: Young people aged 16-25 years or MSM groups 
Study design: RCTs of brief interventions for reducing sexual risk that could be implemented in 
sexual health clinics in the UK were considered. Within this definition, interventions were divided 
into those that involved one 30-minute (or less) session, and those that involved between two and 
six 30-minute sessions. The analysis was restricted to RCTs to increase the likelihood that evidence 
of effects would be robust.  
Intervention: Interventions in the following settings were included: social networking sites; primary 
care; emergency care settings; community treatment settings e.g. GUMs and sexual health clinics; 
32 
 
educational settings (including schools and colleges). Waiting room tasks, self-delivered, clinician 
delivered and digital interventions were included. 
Outcome: biological (e.g. STI incidence), sexual behaviours (e.g. condom use or number of sexual 
partners), testing (e.g. home-based, appointment booking and clinic visits). Outcomes were 
measured at a minimum of 60 days follow-up. [Note: we included studies that did not show 
statistically significant effects on primary or secondary outcomes].  
Setting: The UK and other high-income settings.  
 
2.3.4 Exclusion criteria 
Population: Studies focused exclusively on victims of sexual or domestic abuse or violence, those in 
prison or psychiatric facilities or nursing homes or individuals / communities with no fixed address. 
Study design: studies without a randomised control group; animal models; narrative reviews, 
editorials, opinions; non-English language papers; and, reports published as meeting abstracts only, 
or where insufficient methodological details are reported to allow critical appraisal of study quality. 
Systematic literature reviews were not included in the review, but their reference lists were 
searched for relevant RCTs. Studies published prior to 2000 were excluded. 
Intervention: All non-tailored interventions (e.g. social marketing campaigns providing free access to 
condoms); interventions for adherence to medical treatment (e.g. adherence to ARVs); Interventions 
for couples and family/parent-centred interventions.  
Outcome: psychological changes only evaluated, such as attitude change, or a follow-up of less than 
60 days. 
Setting: Low or middle-income settings. 
 
2.3.5 Critical appraisal 
The methodological quality of each paper was assessed using the Cochrane ‘risk of bias’ tool 49. The 
tool includes six key criteria against which potential risk of bias is judged: adequacy of allocation 
sequence generation; adequacy of allocation concealment; blinding of participants, personnel or 
outcome assessors; completeness of outcome data; selectivity of outcome reporting, and other 
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biases.  Quality was assessed by one reviewer, and checked by a second. Any discrepancies were 
discussed and resolved and reviewed by a third reviewer.   
2.3.6 Data extraction 
Data on the study design, setting, population, intervention, outcomes and results were collected 
using a standardised data extraction form. Data were extracted by one reviewer and 50% checked 
for accuracy by the second reviewer.  
 
2.3.7 Analysis  
Findings of each RCT were summarised alongside a narrative synthesis. The summaries qualitatively 
examined the range of results and potential associations with effect size.  Additional potential 
moderators or mediators that we examined included characteristics of the interventions (e.g. degree 
of tailoring), intervention components (e.g. condom use skills training), and population (sex, sexual 
orientation and co-existing conditions). Intervention components were categorised into ten 
categories based on Albarracin et al.25 – summarised in Box 2. The ten intervention component 
categories were: normative arguments (NormA), attitudinal arguments (AttA), behavioural skills 
arguments (BSA), information (info), threat-inducing arguments (TIA), condom use skills training 
(CUST), interpersonal skills training (IST), self-management skills training (SMT), condom provision 
(CP) and HIV/STI counselling and testing (HIV/STI testing). Components were independently coded 
for each intervention description by one reviewer and 50% were independently coded by a second 
reviewer. Gwet’s AC1 statistic was calculated to assess inter-rater reliability.48  
 
2.4 Results 
The search yielded 17,916 unique publications (Figure 2). Titles and abstracts of all publications were 
screened by two independent reviewers. Inter-reviewer agreement, assessed with Gwet’s AC1 
statistic48 was nearly perfect (99% agreement; AC1 = 0.99) for study screening and selection. 84 
articles were identified for full text screening and 33 studies were included in the review. Data were 
extracted and rated on all the intervention strategies by one reviewer and a second reviewer 
extracted 50% of the data independently; inter-rater reliability was excellent (80.6% percent 
agreement; AC1=0.86). 
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2.4.1 Study Descriptions 
Of the 33 studies included, 23 were focused on young people and 10 on MSM groups. The majority 
of studies were based in the USA, including all 10 of the MSM and 16 of the YP studies; other YP 
studies were from the UK (n=3), Australia (n=2) and one each from the Netherlands and Denmark. A 
summary of the studies is presented in Table 1.   
Many interventions were culturally tailored to a target group, usually based on age, gender, sexual 
orientation and ethnicity and the types of interventions evaluated were very heterogeneous. The 
majority of interventions were aimed at reducing high-risk sexual behaviours (e.g. condomless sex or 
multiple partners) and maximising protective behaviours. Many interventions provided basic 
information about STIs and commonly included risk assessment, hands-on skills training in condom 
use, problem solving, decision making, goal setting, and communication around safe sex. Five studies 
also included additional testing components.50-54 Intervention delivery used print, mail, computer, or 
video-based formats and included face-to-face counselling with varying levels of intensity, from 1 
short session up to 2 hours contact time.  
The most commonly reported outcome was condom use or unprotected sex, alongside other self-
reported behavioural outcomes (16/23 YP and 9/10 MSM studies).  Twelve studies reported on at 
least one STI outcome (9/23 YP and 3/10 MSM studies), with chlamydia and gonorrhoea being the 
most frequent.52-62 STIs diagnosed at recruitment, or baseline, were treated therefore bacterial 
infections at follow-up were considered new infections. For studies that included viral infection 
outcomes, only infections after baseline assessment were counted in the results. Most of the studies 
collected their own samples at follow-up, and many supplemented this with medical record reviews.  
Overall 24 of the 33 RCTs reported some effectiveness against either the primary or secondary 
outcomes. We retained non-effective studies in the review to allow a comparison of those strategies 
which did not work. A reduction in STI incidence was reported in half of the young people studies 
which evaluated this (4/8 studies), and 8 of the 16 to report on behavioural outcomes found a 
beneficial effect. Of the three trials which reported STI outcomes in MSM, none showed any 
effect,52, 61, 62 but the majority of those reporting on behavioural outcomes reported beneficial 
results for at least one measure.  
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Figure 2: PRISMA flowchart of included studies in the systematic review 
2.4.2 Young people 
The trials were generally considered to be of fair to good quality, with some exceptions. Two studies 
were judged to be at risk of selection bias due to poor randomisation procedures,63, 64 two reported 
inadequate allocation concealment procedures,60, 64 two had a high risk of reporting bias53, 63 and  
two were high risk of attrition bias due to incomplete outcome data.59, 63  
Several of the RCTs specifically targeted  women, with 10 of the 23 studies not including men, and 
only a single trial limited to sexually active young men.50 Four RCTs recruited from STI clinics52, 55, 58, 65 
with two of these trials reporting reductions in STIs55, 58 and two were based within schools.  
Four out of five video interventions designed for young people (with or without counselling) were 
found to be beneficial, either for reducing STIs,57 reducing risky sexual behaviour 54, 57, 60 or increasing 
STI test uptake.66 Of the three video-based interventions that reduced risky sexual behaviour, all 
employed behavioural skills arguments and interpersonal skills training strategies.54, 57, 60 Three of 
the seven brief one-to-one counselling interventions were found to be beneficial, either for 
increasing STI test uptake67 or reducing STIs,55, 58 with both of these studies including HIV/STI testing 
as part of the intervention package. Four digital interventions, out of the six included, were 
successful in either reducing risky sexual behaviour through behavioural skills arguments or 
normative arguments strategies,63, 68, 69 or increasing STI test uptake.70 The three home testing 
interventions were found to be beneficial, either for increasing STI test uptake50, 56 or reducing STIs.59 
Of the two interventions that used printed materials, one reduced risky sexual behaviour,71 
specifically unprotected sex. However, several of the studies reported no impact on either primary 
or secondary outcomes and may reported effects only in secondary outcomes or were 
underpowered to present sub-analyses.  
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Box 2: Intervention strategies 
Definitions of intervention strategies used in this systematic review based on Albarracin’s 
categorisation:25 
 Normative Arguments (NormA): normative arguments about the support of condom use by 
friends, family members or partners; “other people are doing it; other people will approve of 
you doing this” 
 Attitudinal Arguments (AttA): such as the discussions of the positive implications of using 
condoms for the health of the partners and for the romantic relationship; the pros and cons; 
the consequences of this behaviour will be good or bad 
 Behavioural skills arguments (BSA): (what to do when partners do not want to use a 
condom; when recipient’s or their partners are sexually excited, and when alcohol or drugs 
are involved) Verbal description e.g. instruction about how to put on a condom 
 Any kind of information (Info): factual information (i.e. mechanisms of HIV, HIV transmission, 
and HIV prevention) 
 Threat-inducing arguments (TIA):  Such as discussions about the recipients personal risk of 
contracting HIV or other sexually transmitted infections (STI’s)’  Fear based arguments based 
on  
o Perceived susceptibility to a STI: “you are the type of person who will get this”  
o Perceived severity of STI: “it will harm you / you will die” 
 Condom use skills training (CUST): e.g. practice with unwrapping and applying condoms 
 Interpersonal skills training (IST): e.g. role playing of interpersonal conflict over condom use 
and initiation of discussions about protection 
 Self-management skills training (SMT): self-monitor goals e.g. practice in decision making 
while intoxicated, avoidance of risky situations 
 STI/HIV counselling and testing (STI); involves the administration of a seropositivity test as 
well as the type of counselling in place 
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2.4.3 MSM 
Overall included studies were considered to be of fair to good quality. One trial was deemed at risk 
of selection bias due to poor randomisation procedures,62 and one study was at high risk of both 
attrition bias and detection bias due to poor blinding of outcome assessment and incomplete 
outcome data.72  
Four of ten trials were limited to younger MSM, two of the studies specifically included Latino or 
African American men only, one addressed substance-using MSM73 and one included only HIV-
positive MSM.62 Five out of six digital interventions designed for MSM were beneficial, either for 
reducing risky sexual behaviour 51, 62, 74, 75 or increasing STI test uptake.76 There was no evidence that 
any of the digital interventions reduced STI incidence. Of the four digital interventions found to 
reduce risky sexual behaviour in MSM, all employed normative arguments and behavioural skills 
arguments,51, 62, 74, 75 alongside self-management training51, 74, 75  and information provision.51, 74 Three 
of the four one-to-one counselling interventions were beneficial, either for reducing risky sexual 
behaviour 52, 73  or increasing STI test uptake;72 all these included HIV/STI testing.  
One study investigating a 25-minute pre-HIV test session within a clinic setting found a significant  
increase in the overall incidence of STIs in MSM, with higher rates amongst those who received the 
intervention versus control (aRR: 1.41; 95% CI: 1.05, 1.90).52  
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Table 1: Summary of Included Studies of Interventions 
Young People 
Study Participants Intervention Outcomes 
Study Setting Number Population Mode of Delivery 
Intensity 
 
Duration 
(days) 
Intervention 
Strategies* 
Outcomes Effectiveness 
Follow-
up (mths) 
Shrier 
(2001)60 
 
 
USA 
Hospital and  
adolescent 
clinic 
Total=123 
Intervention=60 
Control=63 
Women, < 24 
yrs 
Video, tailored 
1:1 counselling, 
condoms & 
information 
4 sessions 
(approx. 
37 mins) 
180 NormA, AttA, 
Info, BSA, TIA, 
CUST, IST, 
SMT, STI 
Condom use 
Attitudes 
Knowledge 
↑ condom attitude 
score (7.9 vs. 8.3) 
↓ non-main partner 
(25 vs. 10%)  
1, 3, 6, 12 
Scholes 
(2003)71 
USA  
Managed care 
settings 
Total=1210 
Intervention=596 
Control =614 
Women, 18-24 
yrs 
Self-help 
magazine & 
condoms;  
tailored feedback 
newsletter & 
condoms 
2 tailored 
rounds 
 
180 CP, Info, CUST Condom use ↑ condom use any 
partner (aOR: 1.86, 
CI: 1.32, 2.65), 
primary partner 
(aOR: 1.97, CI: 1.37, 
2.86) 
3, 6 
Booth 
(2014)77  
UK  
School-based 
Total=253 
Intervention=145 
Control=108 
 
Men and 
women, 
16-24 yrs 
Short video + 
posters, followed 
by talks and 
repeated video  
1 session 
(approx. 
15 mins)  
1 NORMA, AttA, 
Info, Cust 
Test uptake ↑attitude to testing 
(aOR: 1.53, CI: 1.06, 
2.22)  
N/A 
Cook 
(2007)56 
USA 
Community-
based setting 
Total=403 
Intervention=211 
Control=209 
Women, 15-24 
yrs.  
 
Home testing kit 
 
Kits at 6, 
12 and 18 
months 
540 3 Info Test uptake 
STI  
↑ testing (RR: 1.38, 
CI: 1.23, 1.55) 
12, 24 
Apoola 
(2011)67 
UK  
Community 
substance 
misuse service  
Total=54 
Intervention=27 
Control=27 
Men and 
women, <20 yrs 
Oral swab HIV, 
Hep B and C  test 
1 session 4 2 STI Test uptake ↑ testing (100% vs. 
18.5% HIV testing) 
N/A 
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Bolu 
(2004)55 
USA  
Public STI 
clinics 
Total=4328 
Intervention=1447  
Control=1443 
Men and 
women, <25yrs 
Tailored brief 1:1 
counselling + HIV 
test counselling 
2 sessions 
(2x20 min)  
7-10 STI STI ↓STI incidence in 
<20yrs (OR: 0.53, CI: 
0.32, 0.86) 
12 
Crawford 
(2014)65 
UK 
STI clinics 
Total=212 
(No. in groups not 
presented) 
Men and 
women, 19-
25yrs 
Leaflet & tailored 
1:1 by phone or 
face to face   
1 session 
(up to 30 
mins) 
1  Info Alcohol 
Condom use 
No effect 6 
Bull 
(2012)68 
USA 
Online 
Total=1578 
Intervention=942 
Control=636  
Men and 
women, 16-25 
yrs 
Social media 
(Facebook) page 
8-week 
content 
cycle 
180 NormA. Info, 
BSA 
Condom use ↑ condom use (68% 
vs. 56% control, at 
2mths) 
2, 6 
 
Calderon 
(2011)66 
USA 
Urban 
Emergency 
Department  
Total=200  
Intervention=100 
Control=100 
Men and 
women, 15-21 
yrs, HIV –ve 
HIV pre-test 
video  
 
1 session 
(4 mins) 
1 STI Knowledge 
Testing 
↑HIV knowledge 
score (79% vs. 66%) 
↑HIV testing (51% vs 
22% in control) 
N/A 
Chacko 
(2010)53 
USA  
Urban 
reproductive 
health clinic 
Total=376 
Intervention=192 
Control=184 
Women, 16 - 
22.5 yrs 
Tailored 1:1 
motivational 
interviewing 
3 sessions 
(2x30-50 
min; 1x15 
min) 
180 NormA, AttA,  Testing  
STI 
No effect  6, 12 
 
Downs 
(2004)57 
USA  
Urban health 
centres 
Total=300 
(No. in groups not 
presented) 
Women, 14-18 
yrs 
Video 4 sessions 
(1x30 min; 
3x15 min) 
180 Atta, Info, 
BSA, IST, 
NormA 
STI 
Condom use 
Knowledge 
↓STI (OR of STI in 
control: 2.79, p-
value: 0.05) 
↑ abstinence 
1,3,6 
Gottlieb 
(2004)58 
USA 
STI clinics 
Total=1766 
(No. in groups not 
presented) 
Men and 
women, 14-
40yrs 
Brief 1:1 general 
risk reduction 
counselling 
2 sessions 
(20mins 
each) 
NR STI STI ↓Chlamydia incident 
infections 
3,6,9,12 
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Grimley 
(2005)78 
USA  
Hospital and 
adolescent 
clinic 
 Total=275 
Intervention=137 
Control=138 
Women, 14-
23yrs 
Tailored 1:1 
session  
3 sessions 
(15 mins 
each)  
90 NormA, AttA, 
Info, BSA, 
SMT 
Douching 
cessation 
↓in douching (OR of 
stopping: 3.49, CI: 
1.66, 7.32) 
6,12 
Kang 
(2012)70 
Australia 
Online 
Total=704 
Intervention=211 
Control=493 
Men and 
women, 16-25 
yrs 
Personalised 
emails 
 
Variable 180 Info 16 Testing 
Condom use 
↑ Chlamydia testing 
(53% vs 31%)  
6 
Klein 
(2011)63 
USA  
Online 
Total=178 
Intervention=91 
Control=87 
Women, 14-19 
yrs 
Tailored internet-
based session 
2 sessions 
(1hr each) 
1 NormA, Info, 
BSA, CUST, IST 
Condom use 
Knowledge 
↑ condom use (51% 
vs. 71%, pre-post) 
↑ knowledge in both 
groups 
3 
Mevissen 
(2011)69 
Netherlands  
Online 
Total=218 
Non-tailored =81 
Tailored=67 
Control=70 
Men and 
women, 18-25 
yrs 
Tailored internet-
based session 
1 session 1 NormA, AttA, 
Info, BSA, TIA 
Condom use 
Testing 
Perceptions 
↑ condom use (0.88 
vs. 0.43 mean) 
3 
Non-tailored 
internet-based 
session 
1 session 1 NormA. AttA, 
BSA, TIA  Info 
Condom use 
Testing 
Perceptions 
↑ condom use (0.62 
vs. 0.43 mean) 
3 
Metsch 
(2013)52 
USA 
STI clinics 
Total=1258 
Intervention=638 
Control=620 
Men and 
women, < 25yrs 
Tailored 1:1  
counselling + HIV 
testing 
1 session 
(20-40 
mins) 
1 STI, CP, Info STI 
Condom use 
Sexual risk 
↓ no. of partners 
(IRR: 0.76, CI: 0.69, 
0.84) 
6 
Norton 
(2012)79 
USA  
University of 
Connecticut 
Total=198 
HIV group=37 
STI group=42 
Pregnancy 
group=37 
Men and 
women, >18yrs 
Multi-media DVD 
on HIV 
1 session  
(60 mins) 
1 NormA, Info, 
BSA 
Condom use 
Sexual risk 
No effect vs. control 1,2 
Multi-media DVD 
on STIs or 
pregnancy 
1 session  
(60 mins) 
1 NormA, Info, 
BSA 
Condom use 
Sexual risk 
↑ condom use (OR: 
0.19 vs. HIV) 
1,2 
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↓inconsistent 
condom use (OR: 
0.42 vs. HIV) 
Ostergaard 
(2000)59 
Denmark  
School-based 
Total=5487 
Intervention=2603 
Control=2884 
Women, 15-
19yrs 
 
Chlamydia home 
test kit 
1 test 365 Info, STI  STI ↓ Chlamydia 
prevalence (2.9% vs. 
6.6%) 
12 
Proude 
(2004)64 
Australia  
Family 
practice 
Total=312 
Intervention=156 
Control=156 
Men and 
women, 18–25 
yrs 
Brief advice 
about safe sex & 
condoms 
1 session 1  Info, BSA, CP Sexual risk 
Perception 
No effect 3 
Roye 
(2007)54 
  
 USA  
Planned 
Parenthood 
sites 
Total=400 
Video=88 
Counselling=81 
Combined=84 
Control=84 
Black and Latina 
women, 15-21 
yrs 
Video & brief 1:1 
counselling 
1 session 
(40 mins) 
1 BSA, TIA, IST Condom use ↑ condom use 3,12 
Scholes 
(2007)50 
USA 
Group Health 
Cooperative 
Total=8820 
Intervention=2940 
Control=2940 
Men, 21-25 yrs 
 
Home testing kit 
(letter & test 
request card)  
1 session  NR Info, STI 23 Test uptake ↑ testing (RR: 5.6, 
CI: 3.6, 8.7) 
4 
Home testing kit 
(letter & 
sampling kit) 
1 session NR Info , STI 23 Test uptake ↑ testing (RR: 11.1, 
CI: 7.3, 16.9) 
4 
Suffoletto 
(2013)80 
USA 
Emergency 
department 
Total=52 
Intervention=23 
Control=29 
Women, 18-25 
yrs. Hazardous 
drinking & risky 
sex  
Tailored weekly 
risk reduction 
text messages  
 
Weekly for 
3 months 
90 AttA, Info, , 
TIA, SMT 
Condom use ↑ condom use (20% 
to 53% pre-post 
intervention) 
3 
MSM Studies 
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Study Setting Participants Population Mode of Delivery 
Intensity 
(mins) 
Duration 
(days) 
Intervention 
Strategies* 
Outcomes Significant findings 
Follow-
up (mths) 
Carpenter 
(2010)74 
USA 
Online 
Total=199 
Intervention=99 
Control=100 
MSM, 18-30 yrs Online training 
modules 
7 tutorials 
(approx. 2 
hrs each) 
7 AttA, Info, 
BSA, SMT, 
NormA 
Condom use ↓ risky sex in both 
study arms 
3 
Coffin 
(2014)73 
USA  
Community 
Total=326 
Intervention=162 
Control=164 
MSM, ≥ 18 yrs; 
Substance-use 
Personalized 
cognitive 
counselling + HIV 
test 
1 session 
(30-50 
mins) + 
booster 
1 STI, SMT Sexual risks 
Substance 
use 
↓ unprotected 
receptive anal sex 
(RR = 0.57, CI: 0.33, 
1.01) 
3,6 
Hirshfield 
(2012)81 
USA 
Online 
Total=3092 
Video=1874 
Webpage=609 
Control=609 
 
 
MSM, 18-81 yrs Internet-based  
video and HIV 
prevention 
information 
Videos 9 
and 5 mins  
1 BSA, SMT Test uptake 
Condom use 
↓ unprotected anal 
sex (OR = 0.61, CI: 
0.48, 0.77) 
2  
 
 
Webpage 1 Info Test uptake 
Condom use 
↓ unprotected anal 
sex (OR = 0.42, CI: 
0.27, 0.66) 
2  
Metcalf 
(2005)61 
USA 
Public STI 
clinics  
Total=138 
Intervention=70 
Control=68 
MSM, 15-39 yrs 
. 
Brief 1:1 
counselling 
2 sessions 
+ booster 
(20 mins) 
180  STI, SMT STI  
Sexual risk 
No effect 3,6,9,12 
Metsch 
(2013)52 
USA 
STI clinics  
Total =1074 
Intervention=529 
Control=545 
MSM, ≥ 18 yrs Tailored 1:1  
counselling + HIV 
testing 
1 session 
(20-40 
mins) 
1 STI, CP, Info STI 
Condom use 
Sexual risk 
↑ STI incidence in 
intervention group 
(aRR: 1.41, CI: 1.05, 
1.90) 
↓ unprotected sex 
(IRR: 0.71, CI: 0.61, 
0.83) 
6 
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Milam 
(2014)62 
USA 
University 
clinical sites 
Total=179 
Intervention=90 
Control=89  
HIV-infected 
MSM, ˃18 yrs 
 
Internet-based 
tailored 
messaging 
Monthly 
messages 
360 NormA, BSA STI 
Condom use 
↓ unprotected sex 
in both study arms 
Monthly 
(1 -12 
months) 
Mustanski 
(2013)51 
USA 
Online 
Total=102 
Intervention= 50 
Control=52 
HIV-negative 
MSM, 18-24 yrs 
‘KUI!’ 3 online  
modules  
2 hrs 90 NormA, AttA, 
Info, BSA, 
SMT 
Condom use 
HIV attitude 
↓ unprotected anal 
sex at 3 months (RR: 
0.56) 
1.5, 3 
Outlaw 
(2010)72 
USA 
Community 
services 
Total=188 
Intervention=96; 
Control=92 
African 
American MSM, 
18-26 yrrs 
Community 
motivational 
interviewing + 
HIV testing  
30 
minutes 
7 -10  STI, CP Test uptake ↑ HIV testing (49% 
vs. 20%) 
N/A 
Rosser 
(2010)75 
USA 
Online 
Total=650 
Intervention=337 
Control=313 
MISM, ˃18 yrs 
 
‘Sexpulse’ 
webpage 
 
Completed  
7 days 
after 
enrolment 
1 NormA, BSA, 
SMT 
Condom use ↓ unprotected anal 
sex at 3 months 
(aRR: 0.84, CI: 0.70, 
1.01) 
3,6,9,12 
Young 
(2013)76 
USA 
Online 
Total=112 
Intervention=57 
Control=55 
African 
American and 
Latino MSM, 
˃18 yrs 
Social media 
(Facebook) page 
and home-testing 
Kit offered  
every 4 
weeks  
90 STI, Info Test uptake 
Condom use 
↑ HIV testing (44% 
vs. 20%) 
3 
Notes: CG = control group; NR = not reported; OR = odds ration; STI = sexually transmitted infection; MISM = men who use the internet to seek sex with men; RR = relative risk 
* NormA (Normative Arguments); AttA  (Attitudinal Arguments); Info (Any kind of Information); BSA (Behavioural Skills Arguments); TIA (Threat-inducing Arguments);  CUST (Condom Use 
Skills Training);  IST (Interpersonal Skills Training); SMT Self-Management Training;  STI (STI/HIV Counselling and Testing) 
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2.5 Discussion 
We found 33 RCTs that met our inclusion criteria of evaluating a brief behavioural intervention for 
improving sexual health outcomes amongst young people and MSM. A number of interventions 
trialled were effective at improving testing, reducing self-reported risk behaviours (such as 
condomless sex) and decreasing STI diagnoses (Table 2). However, the effect sizes seen were generally 
small, the types of interventions and outcomes evaluated highlight that there is still a lack of evidence 
for certain approaches to improving sexual health behaviours, and one study demonstrated a negative 
intervention impact.  
Table 2: Summary of Intervention Effectiveness 
Intervention 
Young People (n=23) MSM (n=10) 
No. of 
trials 
Effective 
trials 
Improved 
outcome 
No. of 
trials 
Effective 
trials 
Improved 
outcome 
Digital 
6 3 RSB 
Test  
6 4 
1 
RSB 
Test 
One-to-one 
counselling 
7 2 STI 
Test 
4 2 
1 
RSB 
Test 
Video 
5 3  
1  
1 
RSB 
STI  
Test 
      
Printed 
materials 
2 1 RSB       
Home test kit 
3 1  
2 
STI 
Test 
      
RSB = risky sexual behaviour; Test = STI test uptake; STI = STI incidence 
 
2.5.1 Reducing sexual risk behaviours 
The majority of trials in both young people and MSM populations involved either digital interventions 
or one-to-one counselling. Digital interventions were found to be effective for reducing risky sexual 
behaviour in half of the trials for young people, and in two thirds of MSM studies. The successful 
digital interventions in both young people and MSM employed normative arguments and behavioural 
skills arguments.51, 62, 63, 68, 69, 74, 75 In addition, successful digital interventions in both high risk 
populations employed information in five trials51, 63, 68, 69, 74 and self-management skills training in three 
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trials.51, 74, 75 Successful interventions provided most or all of the following: arguments about the 
support of condom use by friends, family members or partners; information about STIs, such as 
prevalence, transmission, and details on how to reduce the risk for transmission; help in identifying 
personal risk for STIs; training in common behaviour change processes, such as problem solving, 
decision making, and goal setting; and training in communication surrounding condom use and safe 
sex.  
Two of four trials of one-to-one counselling showed improvement in risky sexual behaviour for MSM, 
while none of the seven trials of one-to-one counselling in young people were found this to be 
effective for this outcome. Although the sample of studies is too small to draw statistical inferences 
this could indicate a difference between the two groups regarding effectiveness of these interventions 
on risky sexual health behaviour, with MSM appearing to respond better to both one–to-one 
counselling and digital interventions than young people. However, the difference in effectiveness may 
be related to the nature of the intervention strategies employed. While both normative arguments 
and behavioural skills training were successfully employed in digital interventions for both MSM and 
young people to reduce risky sexual behaviour, the successful digital interventions for MSM also used 
information and self-management skills training (in addition to normative arguments and behavioural 
skills arguments), and this may have accounted for their success. 
Video interventions were effective for reducing risky sexual behaviour in three out of the five RCTs, 
and those that were successful contained behavioural skills training and interpersonal skills training, 
and two used threat-inducing arguments.54, 57, 60 One intervention involving printed materials was 
successful in reducing sexual behaviour in young people, using condom provision, information and 
condom use skills training.71  
However, both the video and printed material interventions were only conducted in young people, 
with no RCTs involving either conventional (non-online) videos or printed materials targeting MSM. 
This presents a potential opportunity for developing interventions involving video and printed 
materials tailored to a MSM population to reduce risky sexual behaviour. However, it should be noted 
that one MSM trial used a video format within an online digital intervention, and this was not found to 
be effective for any of the outcomes of interest in our review.  
 
2.5.2 Reducing STI incidence 
None of the MSM interventions reported success in reducing STI diagnoses. Both of the one-to-one 
interventions that reduced incidence of STIs in young people consisted of a brief counselling session 
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plus a HIV/STI test,55, 58 while one-to-one counselling did not reduce STIs in any of the four trials 
conducted with MSM.   
One out of five trials of video interventions aimed at young people showed an improvement in STIs, 
employing attitudinal arguments, information, behavioural skills training and interpersonal skills 
training.57 One out of three trials of home test kits showed an improvement in STIs in young people, 
delivering information alongside the test kit.59 Again, neither of these intervention formats were 
trialled in MSM populations.   
 
 
2.5.3 Increasing STI testing  
For digital interventions, one MSM and one young person’s trial increased STI test uptake.70, 76 
Successful interventions provided information including information about testing, one being 
personalised advice through email. Similar findings were observed for one-to-one counselling, with 
only one trial for young people and one trial for MSM being found to be effective for increasing STI 
test uptake, which both included oral swab tests.67, 72 In video interventions developed for young 
people, one of five trials was effective for increasing STI test uptake; the successful video was 
specifically designed to replace one-to-one counselling before an HIV test.66 
More promising however were interventions involving home test kits. Two of the three trials using this 
methodology effectively increased testing, and both included information and instructions on using 
the test kit.50, 56 It is notable that no RCTs involving home test kits were found for MSM, suggesting a 
potential opportunity for developing such interventions tailored to a MSM population. Table 3 
summarises the successful strategies used within RCTs that showed evidence for improved outcomes, 
and strategies for which there was weaker evidence (potential strategies). 
Table 3: Summary of Features Associated with Programme Effectiveness 
Outcome Intervention 
Successful strategies Potential strategies 
Young people MSM Young people MSM 
Reduce risky 
sexual 
behaviour 
Counselling 
 HIV/STI 
testing 
  
Digital  NormA, BSA NormA, BSA  SMT, Info 
Video BSA, IST  TIA, AttA, info  
Home test kit     
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Printed materials   CP, info, CUST  
Reduce STI 
incidence 
Counselling HIV/STI testing    
Digital     
Video 
Atta, Info, BSA, 
IST 
   
Home test kit    HIV/STI testing  
Printed materials     
Increase STI 
test uptake 
Counselling 
HIV/STI testing HIV/STI 
testing 
  
Digital Info Info   
Video HIV/STI testing    
Home test kit Info    
Printed materials     
NormA: Normative Arguments; AttA: Attitudinal Arguments; Info: Any kind of Information; BSA: Behavioural Skills 
Arguments; TIA: Threat-inducing Arguments; CUST: Condom Use Skills Training; IST: Interpersonal Skills Training; 
SMT: Self-Management Training; HIV/STI testing: STI/HIV Counselling and Testing. 
 
 
2.5.4 Recommendations for intervention development 
Existing evidence suggests that digital interventions for both MSM and young people should contain 
normative arguments, behavioural skills training and information in order to maximise impact on risky 
sexual behaviour and STI test uptake. In addition, self-management skills training may be usefully 
employed to reduce risky sexual behaviour. One-to-one counselling interventions for both MSM and 
young people should contain HIV/STI testing as part of the intervention, with trials to date showing 
this can increase STI testing, reduce STIs and reduce risky sexual behaviour. However, these 
interventions have not been widely evaluated in different geographical and demographic populations, 
so some caution is needed in assuming that these benefits will be realised in this population.  
There was more evidence for diverse intervention formats amongst young people, and video-based 
interventions also containing behavioural skills training, interpersonal skills training, attitudinal 
arguments, information and HIV/STI testing could improve risky sexual behaviour, STIs and STI test 
uptake. Additionally, threat-inducing arguments, attitudinal arguments and information may be 
usefully employed to reduce risky sexual behaviour. Home testing kits should contain information in 
order to improve STI test uptake, and the act of testing may be usefully employed to reduce STIs.  
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Given the lack of RCTs identified in this systematic review for conventional (non-online) video 
interventions, home test kits and printed materials for the MSM population, opportunities exist for 
developing such interventions. We would cautiously recommend using the strategy components 
described above in any new intervention design for MSM, while accepting the need for further 
adaptation and piloting. 
 
2.5.5 Challenges for intervention adaptation 
Many of the successful interventions were tailored to gender or ethnicity groups, with half of the 
young people studies targeting Latina or African American women. Therefore, taking these 
interventions out of this cultural and demographic context may change both their efficacy and 
acceptability. This is particularly a challenge for the young heterosexual male group, as very few 
interventions were designed specifically for this group. Interventions such as Roye et al.54 were 
designed with input from the specific patient group it was targeting (i.e. young African American 
women), which makes it less likely to be appropriate as an ‘off the peg’ intervention for use in the UK. 
So while several interventions may be desirable or acceptable in principle, we anticipate that 
considerable adaptation may be needed.   
Metsch et al. (2013)52 found an increase in STI incidence amongst MSM in the 1:1 pre-HIV testing 
intervention group (12.5% control vs. 18.7% intervention). Conflicting efficacy within intervention 
formats or between sub-groups, such as MSM or young people, could lead to negative results when 
adapted to a different context or setting.  
 
2.5.6 Strengths and limitations 
A key strength of this review is that it began with a broad search for RCTs of behavioural interventions 
in both young people and MSM. However, despite the extensiveness of the search, with over 17,000 
articles screened, young heterosexual males were found to be under-represented in the literature 
with only one RCT focused exclusively on this group.50 This could represent a publication bias, or be a 
lack of research into this particular risk group. Several of the RCTs did not assess STI outcomes, but 
reported risk behaviours as the primary outcome. The outcomes are self-reported and could suffer 
from social desirability bias, and therefore should be interpreted with caution. In addition, several of 
the studies reported on multiple secondary outcomes, and lacked power to assess these and did not 
account for multiple hypothesis testing.82 This may have resulted in some of the weak statistical 
associations observed. However, it also poses the potential for interventions presented for adaptation 
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and scale-up to have modest effects. We included studies in the review which showed no effect, 
allowing us to examine whether there was consistent evidence for an intervention format or strategy 
being successful or not.       
The diverse range of settings in which the RCTs were performed could have influenced our 
conclusions. The quality and availability of resources, such as counselling, which are routinely offered 
could affect the efficacy of the trials; when usual care is extremely minimal, a relatively brief 
intervention might improve on it enough to show a benefit. While other settings, where routine care is 
more comprehensive, may show a smaller effect or no effect at all. This limits the generalisations we 
can make, particularly for the MSM studies which were all conducted in the USA.  
Many of the RCTs identified in this review use specific gender and ethnic samples, and the diversity of 
these groups must also be taken into account when considering generalizability of the review findings. 
For example, one study was restricted to HIV-positive MSM, who may react different to intervention 
approaches than HIV-negative MSM.62 We found very few studies conducted in the UK, and only one 
within a UK sexual health setting.  
Length of follow-up may have resulted in the apparent lack of impact seen on some sexual behavioural 
outcomes. It was notable that some interventions showed short-term improvement in outcomes, 
which was not seen later in the follow-up period.54, 68, 75 This is confirmed by other evidence that 
suggests that the effect associated with an intervention may diminish with time after intervention 
delivery.83, 84 Therefore, our assessment may have excluded potentially effective intervention 
approaches, but which lacked longer term impacts. Such approaches might be effective in the longer 
term if repeatable.  
 
2.6 Conclusion 
A number of interventions have the potential to be adapted for use in routine sexual health settings 
within the UK were identified. Intervention formats, such as videos, self-testing kits, one-to-one 
counselling sessions, and various forms of digital interventions (e.g. social media and emails) could all 
be appropriate candidates, and showed limited but significant effectiveness in increasing testing, 
reducing risk behaviours, and reducing STIs. Despite the diversity of the interventions, there were 
common themes within the successful interventions, such as using behavioural skills arguments that 
can be used to guide intervention adaptation.  
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Chapter 3: Work Package 2 - Triage Tool Development 
3.1 Background 
The use of data driven triage tools, developed using predictive statistical models, is relatively common 
in both primary and secondary clinical care.85 They are used to target individual care, based on key risk 
characteristics found at the population level, such as the Framingham risk score which has been widely 
used to support treatment decisions for cardiovascular disease.86 In sexual health, triage is common-
place.87, 88 Clinics often stratify patients according to symptoms, behavioural risks and demographics to 
receive different services, such as ‘quick checks’ or safe-guarding.89, 90 These triage processes tend to 
be a dichotomous decision based on pre-defined criteria, which may not necessarily take into account 
risk behaviours or identify patients most in need of interventions.91  
Since 2009, SH clinics in England have provided data to a mandated surveillance system for sexual 
health episodes, the Genito-Urinary Medicine Clinic Activity Dataset (GUMCAD).92, 93 This dataset 
contains 12 variables that include demographics and any tests and diagnoses related to that episode 
of care. This has allowed spatial trends in STIs to be monitored over time; however it lacks information 
on risk behaviours, which would allow for more detailed risk stratification.  
In order to facilitate a more in-depth understanding of STI epidemiology in England, Public Health 
England (PHE) enhanced the GUMCAD dataset to include numbers of partners, drug and alcohol use, 
prior GUM clinic visits and partner notifications in GUMCADv3.94, 95 These variables are all 
recommended to be recorded as part of a patient consultation by BASHH, and are therefore intended 
to be feasible for collection in routine care.96 The GUMCADv3 reporting system was piloted in two 
phases, with revisions made in phase 2 based on clinic feedback and data quality issues from phase 1.   
A population-level data-driven approach to triage, based on the risk of a STI diagnosis, has not yet 
been applied to the UK setting. In order to test a model of delivery of a behavioural intervention that 
is tailored to the risk profile and characteristics of the target population we therefore developed a 
data-driven triage tool that could be integrated into service systems and processes.    
 
3.2 Aim 
To develop a triage tool, based on clinical data routinely collected within SH clinics in England, to 
stratify patients according to their risk of STI diagnosis and thereby direct service users to tailored 
behavioural interventions individualised to their needs. Separate models were to be developed for the 
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MSM and young people groups, due to the different risk types and relative importance of behavioural 
and demographic data.   
 
3.3 Method 
We conducted secondary data analysis of the nationally mandated GUMCADv2 data from 2013-2015 
and the second phase of the GUMCADv3 pilot, conducted in 2015-2016. Analysis of the Phase 1 
GUMCADv3 pilot is not presented as this version of the surveillance system was superseded by the 
Phase 2 version.   
 
3.3.1 Datasets 
Surveillance (GUMCADv2): This is a national mandatory reporting dataset for England, which all level-2 
and level-3 SH services are required to submit their sexual health patient episodes to PHE. It covers an 
estimated 600 services and reports STI diagnoses and sexual health services provided. The dataset 
contains 12 variables (Table 4): demographics, attendance information and any episode activity and 
diagnoses. Data from the reporting periods Q1 2013 – Q3 2016 were used. This dataset is referred to 
as ‘v2’ throughout.   
Enhanced surveillance (GUMCADv3 Pilot 2): This dataset was generated by PHE during a pilot 
conducted from July 2015 –June 2016 in five SH clinics: Bedford (Brook), Bristol (GUM), Croydon 
(GUM), Barnet (GUM) and Southend (GUM). This dataset contains the same 12 variables from v2 and 
an additional 18 questions on recent sexual behaviours, drug and alcohol use, and previous diagnoses 
and attendance (Table 4). This dataset will be referred to as ‘v3p2’ throughout.    
Table 4: GUMCAD variables available for triage tool analysis 
Surveillance 
Question Format 
Gender Categorical 
Age at attendance (derived from date of birth) Continuous 
Self-defined ethnicity Categorical 
Country of birth Categorical 
Deprivation index (derived from Lower layer super output area of residence) Continuous 
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Self-identified sexual orientation Categorical 
SHHAPT or READ codes of the diagnoses and/or service received Categorical 
Enhanced Surveillance 
Question Format 
Number of partners in the last 3 months? Categorical 
How many were new partners? (heterosexual and WSW only) Categorical 
Did you/your partner use a condom the last time you had penetrative (vaginal or 
anal) sex? (heterosexual only) 
Categorical 
Have you had anal (receptive or insertive) sex with a known HIV positive partner 
in the last 3 months? (MSM only) 
Categorical 
Have you had any condomless anal sex (receptive or insertive) in the last 3 
months? (MSM only) 
Categorical 
Have you had any receptive condomless anal intercourse in the last 3 months? 
(MSM only) 
Categorical 
Was alcohol use assessed? Categorical 
Was alcohol use documented as problematic? Categorical 
Have you used recreational drugs in the last 3 months? Categorical 
Did you take: amphetamine/speed; benzodiazepines; cannabis; cocaine; crack; 
crystal meth; E/MDMA; GBH/GBL; heroin; ketamine; legal highs; m-cat; 
methadone; poppers; solvents/glue; other 
Binary (yes) 
Did you inject any recreational drug in the last 3 months? Categorical 
Did you share equipment with anyone when injecting drugs? Categorical 
Were you under the influence of recreational drugs (before or during sex) the last 
time you had sexual intercourse? 
Categorical 
Have you ever attended another GUM service? Categorical 
Have you been diagnosed with an STI in the last year? Categorical 
Did you have: chlamydia; gonorrhoea; herpes; LGV; non-specific genital; syphilis; 
warts; other  
Binary (yes) 
When did you last have an HIV test? Categorical 
Het = heterosexual; msm = men who have sex with men; wsw = women who have sex with women 
 
 
3.3.2 Definitions 
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Young person: Any attendance amongst all women, and men who have no report of sex with men and 
self-reported as heterosexual, aged 16-25 years old.  
MSM: Any attendance amongst men who have any report of sex with men, or self-report as bisexual 
or homosexual, of any age.  
Attendance: Any first attendance within an episode of care   
Outcome: any new diagnosis of HIV, syphilis, gonorrhoea, chlamydia, hepatitis, LGV, trichomonas or 
herpes. Recurrent herpes and warts infections and non-specific genital infections were excluded.  
 
3.3.3 Data Management 
The v2 data undergoes routine data cleaning processes by PHE; details of this process are available on 
request from PHE (‘GUMCADv2 Specifications Manual_v3_23_09_2014’). The v3 data was cleaned for 
inconsistencies between demographic and reported sexual behaviours (e.g. female heterosexual 
reported as having female sex partners), drugs reports (e.g. no reported drug use and sharing injecting 
equipment) and previous sexual health attendances and diagnoses. During the cleaning, any positive 
answer to a risk behaviour was prioritised during cleaning, for example a patient reported ‘no’ to drug 
use in the prior 3-months but reports yes to using cannabis in subsequent questions. In this case, ‘any 
drug use’ would be changed to ‘yes’, and cannabis use unchanged. For discrepancies between gender, 
sexual orientation and types of partners, gender and partner type were prioritised. For example, male, 
heterosexual, reporting male partners would be classified as MSM within the model. Cases with 
multiple pieces of conflicting data were excluded.   
The core v2 variables were still reported through the routine v2 system for the pilot clinics; the v3 pilot 
data was submitted separately to PHE. The clinic code, patient ID and attendance date were used to 
merge the two datasets. Checks for discrepancies in demographic information between v2 and v3 
datasets were conducted, and resolved on a case by case basis – and cases with inconclusive cleaning 
were excluded from analysis. Comparing demographic variables between patients from the v3p2 who 
merged with a v2 record was done to test for possible biases in the sub-set of patients available for 
analysis. All cleaning, merging and data management was done using Stata version 13.97  
 
 
3.3.4 Selection of candidate predictors 
57 
 
The predictor variables investigated were those available in the dataset. The behavioural and risk 
variables included in the v3p2 dataset were based on those recommended for sexual history taking by 
BASHH in 2013 and are well supported in the literature as being indicators of STI risk.96  The variables 
were split into demographic and behavioural variables. Demographics variables included: age, 
deprivation, prior GUM visits, prior STI diagnosis (including specific infections), ethnicity, country of 
birth, sexual orientation, and gender and HIV status. Behavioural variables included: number of sexual 
partners, new partners, condom use, problematic alcohol use and drug use, and unprotected anal 
intercourse (UAI) and sex with known HIV positive partners in MSM. Depending on the number of 
observations and degrees of freedom in the models, variables were re-categorized between models.   
All these variables were considered in the model development; however, exclusions due to missing 
data and low prevalence (e.g. 5%) were done following initial description. Variables with missing data 
may introduce bias if the data is not missing at random (e.g. if patients are less likely to disclose risky 
behaviours, or differences in reporting quality between clinics), and if they are not frequently available 
then including them in a triage tool might be impractical.98 There are several approaches to dealing 
with missing data. For variables with limited missing data (<25%),  which are assumed to be missing at 
random, multiple imputation is recommended as it preserves sample size.99 However, including 
missing data as a distinct category may be a more pragmatic approach as complete data collection 
within a routine clinical setting may not be realistic, and missing data is unlikely to be missing 
completely at random. This was our primary analysis approach.  
To protect against over-fitting, a general rule is to have 10 outcome events (i.e. STI diagnoses) per 
degree of freedom in the development model (i.e. predictor variable).100 Lower-priority or highly 
correlated candidate predictors were removed to reduce degrees of freedom where possible and 
needed.100   
 
3.3.5 Developing the prediction model 
The primary outcome was the binary composite variable of STI diagnosis. Multi-variable logistic 
regression was used to develop the triage tool. The primary models were developed in the v3p2 
dataset, one for MSM and one for young people.  
We used a full model approach, with all pre-defined variables included regardless of statistical 
association in univariate analysis.98, 101 We conducted a sensitivity analysis using a forward stepwise 
approach to explore whether a more parsimonious model could be used. All variables were binary or 
categorical, except age and deprivation score (derived from the patient’s postcode). Continuous 
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variables were investigated for non-linear relationships with the outcome, and categorised if 
appropriate. Data reduction within the categorical variables (e.g. ethnicity) was done based on data 
patterns and substantive knowledge.  
The regression coefficients were used to calculate an individual’s probability of STI diagnosis, using the 
following equations (Box 3 presents a worked example): 
EQ1: Log odds of STI            = model intercept + (variable value x coefficient) +…. 
EQ2: Patient’s Odds of STI = e(patient’s log odds value) 
EQ3:  Probability of STI        = [Odds / (1 + Odds)] x 100 
 
3.3.6 Model performance  
Model performance was evaluated using several statistical tests. The Hosmer-Lemeshow goodness of 
fit test was done to measure model calibration,102 despite its limitations.103 Model discrimination was 
tested using the c-statistic (area under the receiver operating characteristic curve (AUROC)).98, 104  The 
c-statistic and the pseudo R2 were the main parameters for determining if the model was effective at 
predicting the outcome of interest. A c-statistic of >0.7 is generally considered reasonable model 
discrimination for a clinical tool, and >0.8 as strong discrimination; 0.5 indicates that the model is no 
better than chance at predicting the outcome.105 The Bayesian Information Criteria (BIC) was used to 
determine the most parsimonious model in sensitivity analyses, with lower values favouring model 
selection.  
We compared different probability thresholds with the patient’s true outcome, to give sensitivity, 
specificity, positive predictive values (PPV) and negative predictive values (NPV). External validation, 
where the regression equation is tested in a district dataset is recommended as an independent 
assessment of the model performance to assess the extent of over-fitting and the resulting optimism 
of its performance.106 External validation was not conducted due to the limited sample size of the v3p2 
pilot; however it was discussed that external validation could done as part of the WP5 (Chapter 6) pilot 
implementation.    
 
3.3.7 Sensitivity analyses 
We conducted sensitivity analyses in order to test assumptions about our primary modelling 
approach. We assessed a model which only included demographic data to determine how much added 
value the additional behavioural information provides; this also allowed us to investigate whether 
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demographics at the national level had different relationship directions and magnitude of effect to the 
smaller v3p2 dataset.  Missing data, which was included as a distinct category in the primary model, 
was compared to imputed models to gives us more information on pragmatic implementation. Taking 
a categorised missing approach was done to reflect the real-world nature of routine data, and as we 
made the assumption that data was not missing at random and therefore may contain predictive value 
in itself. Finally, a full model, where all a priori defined variables were included was compared to a 
forward stepwise regression to approach.  
 
3.4 Results 
3.4.1 Data description 
 
 
During the pilot period from July 2015 to June 2016, a total of 28,514 episodes of care were reported. 
Table 5 describes the key demographic variables, between those with and without enhanced 
behavioural data. The patients recorded in the v3p2 dataset were similar in terms of ethnicity, age and 
gender to those with basic surveillance only for the same time period. There was considerably higher 
levels of missing sexual orientation in the enhanced dataset (16% vs. 7%), and lower levels of 
homosexual or bisexual patients (6% vs. 13%). This likely reflects the pilot sites not including any of the 
larger MSM clinics, such as Dean Street or Brighton.  
Following cleaning of the merged dataset, there were 9,530 non-MSM young people recorded in the 
v3p2 pilot, of which 1,005 had an STI diagnosis (10.6%). This is very similar to the STI diagnosis rate 
seen in the national surveillance dataset during the same time period (10.8%). There were 1,448 MSM 
records in the v3p2 dataset, with 318 STI diagnoses (22.0%). This was higher than the nationally 
reported rate of 14.9%. This allows up to 100 and 32 degrees of freedom in the young person and 
MSM models to avoid over-fitting. 
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Table 5: Description of demographic variables in the GUMCAD surveillance and enhanced surveillance 
datasets 
Variables 
 
Enhanced surveillance (N, %) 
N = 23,107 
Surveillance only (N, %) 
N = 5,407 
Gender 
Male 9,419 (41%) 2252 (42%) 
Female 
Missing 
13,613 
3 
(59%) 
(0%) 
3155 (58%) 
Sexual 
Orientation 
Heterosexual 17,761 (77%) 4,314 (80%) 
Bisexual 1.034 (4%) 493 (9%) 
Homosexual 540 (2%) 202 (4%) 
Missing 3,772 (16%) 398 (7%) 
Ethnicity 
White  16,197 (70%) 3,544 (66%) 
Asian 1,124 (5%) 282 (5%) 
Black 3,732 (16%) 967 (18%) 
Mixed 1,374 (6%) 374 (7%) 
Other 233 (1%) 49 (1%) 
Missing 447 (2%) 191 (4%) 
Age 
<25 years 8,990 (39%) 1,781 (33%) 
25-34 years 8,665 (38%) 1,964 (36%) 
35-44 years 3,293 (14%) 898 (17%) 
45-64 years 2,007 (9%) 696 (13%) 
>=65 years 151 (1%) 68 (1%) 
 
 
Young people and MSM differed from the general surveillance population, and from each other (Table 
6). There were more young women than men, compared to the general clinic population (69% versus 
59% female). The MSM group were generally older than the overall clinic population, and more likely 
to be of White ethnicity (70% versus 82%).  The number of partners reported by young people 
generally reflected the general population, but MSM reported a higher proportion of multiple 
partners, with 15% reporting five or more partners in the previous 3-months compared to 3% of the 
general pilot clinic population. They also had a lower level of missing data for this variable. MSM had 
double the rate of drug use reported compared to young people (14% versus 7%) and considerably 
lower rates of missing data for this variable (31% versus 52%). This supports the assumption that data 
was unlikely to be missing at random, with either MSM being more likely to disclose drug use, or 
providers being more likely to ask about drug use with MSM patients.  
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Table 6: Description of GUMCAD enhanced surveillance data 
Variables 
Total (N, %) 
N = 23,103 
Young people (N, %) 
N = 9,530 
MSM (N, %) 
N = 1,448 
Demographic Variables 
Gender 
Male 9,491 (41%) 2,983 (31%) 1,448 (100%) 
Female 13,612 (59%) 6,547 (69%) - 
Age 
<20 years 2,938 (13%) 2,628 (18%) 77 (5%) 
20 – 24 years 6,052 (26%) 6,902 (82%) 297 (21%) 
25 – 34 years 8,664 (38%) - 562 (39%) 
35 – 44 years 3,291 (14%) - 262 (18%) 
45 – 64 years 2,007 (9%) - 213 (15%) 
>= 65 years 151 (1%) - 37 (3%) 
*Sexual 
Orientation 
Heterosexual 17,758 (77%) 7,809 (82%) 51 (4%) 
Bisexual 540 (2%) 120 (1%) 299 (21%) 
Homosexual 1,034 (4%) 27 (0%) 963 (67%) 
Missing 3,771 (16%) 1,574 (17%) 135 (9%) 
Continent of 
birth 
UK 15,682 (68%) 6,813 (71%) 1,049 (72%) 
Europe 2,095 (9%) 643 (7%) 153 (11%) 
Africa 1,134 (5%) 309 (3%) 40 (3%) 
Americas 821 (4%) 217 (2%) 43 (3%) 
Asia 289 (1%) 51 (1%) 19 (1%) 
Other 618 (3%) 190 (2%) 54 (4%) 
Missing 2,464 (11%) 1,307 (14%) 90 (6%) 
Ethnicity 
White British 13,639 (59%) 6,072 (64%) 1,003 (69%) 
Other White 2,554 (11%) 785 (8%) 185 (13%) 
South Asian 661 (3%) 201 (2%) 33 (2%) 
Other Asian 463 (2%) 165 (2%) 36 (2%) 
Black Caribbean 1,353 (6%) 448 (5%) 28 (2%) 
Other Black 2,379 (10%) 991 (10%) 54 (4%) 
White & Black mixed 826 (4%) 418 (4%) 31 (2%) 
Other Mixed 548 (2%) 249 (3%) 38 (3%) 
Any Other 233 (1%) 79 (1%) 17 (1%) 
Missing 447 (2%) 122 (1%) 23 (2%) 
Deprivation 
quintiles 
Lowest 4,731 (20%) 1,744 (18%) 294 (20%) 
2nd quintile 6,019 (26%) 2,364 (25%) 354 (24%) 
3rd quintile 4,257 (18%) 1,768 (19%) 259 (18%) 
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4th quintile 4,291 (19%) 1,937 (20%) 273 (19%) 
Highest 2,917 (13%) 1,363 (14%) 213 (15%) 
Missing 888 (4%) 354 (4%) 55 (4%) 
**Previous STI 
diagnosis 
No 21,526 (93%) 8,795 (92%) 1,329 (92%) 
Yes 1,577 (7%) 735 (8%) 119 (8%) 
Behavioural Variables 
Number of 
partners+ 
None 1,068 (5%) 365 (4%) 73 (5%) 
1 partner 10,893 (47%) 4,336 (46%) 410 (28%) 
2-4 partners 4,037 (17%) 1,660 (17%) 506 (35%) 
>= 5 partners 649 (3%) 206 (2%) 215 (15%) 
Missing 6,456 (28%) 2,963 (31%) 244 (17%) 
New partners+ 
No   2,658 (28%) - 
Yes   2,663 (28%) - 
Missing   4,209 (44%) - 
Condom use 
last sex 
No   3,881 (41%) - 
Yes   2,014 (21%) - 
Missing   3,635 (38%) - 
Anal sex with 
known HIV 
+ve+ 
No   -  786 (54%) 
Yes   -  124 (9%) 
Missing   -  538 (37%) 
Condomless 
anal sex+ 
No   -  419 (29%) 
Yes   -  535 (37%) 
Missing   -  494 (34%) 
Receptive 
condomless 
anal sex+ 
No   -  138 (10%) 
Yes   -  350 (24%) 
Missing   -  960 (66%) 
Problematic 
alcohol use 
No 4,558 (20%) 1,890 (20%) 192 (13%) 
Yes 203 (1%) 102 (1%) 22 (2%) 
Missing 18,342 (79%) 7,538 (79%) 1,234 (85%) 
Drug use+  
No 10,212 (44%) 3,860 (41%) 795 (55%) 
Yes 1,537 (7%) 686 (7%) 199 (14%) 
Missing 11,354 (49%) 4,984 (52%) 454 (31%) 
*These relate to females only in the young people, and in the MSM, self-reported heterosexuals who reported same sex 
male partners were included in the MSM group; **within the previous 12 months; + within the previous 3 months. 
 
3.4.2 Young person model 
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Variable selection 
Deprivation was included as quintiles, based on the UK indices of multiple deprivation derived from 
the patient’s postcode. Age was included in the model as a categorical variable; plotting the 
relationship between age and STI diagnosis showed the association was not linear. We described the 
number of prior STI diagnoses reported, both longitudinally and from patient report. Within this 
cohort of young people, there were very few non-chlamydia prior diagnoses and therefore we 
included prior chlamydia infection only in the model. Ethnicity and continent of birth contain a large 
number of categories, 15 and 9 respectively, adding 23 degrees of freedom to the model. Many of the 
categories contained <5% of the patient population; therefore, these variable categories were 
collapsed to ensure more balanced categories for modelling. Drug use and problematic alcohol use 
were excluded due to high levels of missing data, and sexual orientation excluded for having too little 
heterogeneity.  
Table 7 describes the variables and categories that were included in the primary analysis.  
Table 7: Variables and their definitions in the primary young person’s model 
Demographic  
Gender Male (reference), Female 
Ethnicity 
White (reference), White other, S. Asian, Asian other, Black Caribbean, 
Black other, White and black mixed, Mixed other, Other, Missing 
Continent of birth  UK (reference), Europe, Africa, Americas, Asia, Other, Missing 
Prior Chlamydia diagnosis No (reference), Yes – within the last year 
Age 16-17 (reference), 18-19, 20-21, 22-23, 24-25 years 
Deprivation score Quintiles – least deprived (reference) 
Behavioural  
Number of partners None (reference), One, Two – Four, Five or more, Missing 
New partners No (reference), Yes, Missing 
Condom use No (reference), Yes, Missing 
 
Primary model 
The primary model categorized missing data, retaining all records in the model (Table 8). The model 
included 34 degrees of freedom, and therefore met the required 10 outcomes per degree of freedom. 
Amongst YP, females were less likely to have an STI diagnosis (OR: 0.71, 95% CI: 0.62, 0.83), and being 
older was associated with lower odds of STI diagnosis. Being of black or mixed white and black 
ethnicity had higher odds of STI diagnosis, compared to being white British.  
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Table 8: Full multivariable logistic regression model for STI diagnosis in the current visit in YP 
Variable Odds ratio Coefficient p-value 95% confidence interval 
Gender 
 
Male 
Female 
1.00 
0.71 
 
-0.34 
 
0.000 
 
0.62 
 
0.83 
Ethnicity 
White British 1.00     
White, other 1.33 0.28 0.099 0.95 1.86 
South Asian 0.73 -0.32 0.308 0.39 1.35 
Asian, other 0.94 -0.06 0.854 0.49 1.80 
Black Caribbean 2.65 0.98 0.000 2.01 3.50 
Black, other 1.57 0.45 0.000 1.25 1.97 
White & black mixed 1.85 0.61 0.000 1.39 2.45 
Mixed, other 0.88 -0.13 0.596 0.55 1.41 
Other 0.69 -0.37 0.409 0.29 1.66 
 Missing 0.85 -0.16 0.661 0.42 1.73 
Continent of 
birth 
UK 1.00     
Europe 1.03 0.03 0.881 0.72 1.47 
Africa 0.66 -0.42 0.046 0.44 0.99 
Americas 0.77 -0.26 0.234 0.50 1.18 
Asia 0.42 -0.86 0.262 0.09 1.90 
Other 0.89 -0.12 0.695 0.48 1.62 
 Missing 0.78 -0.24 0.033 0.62 0.98 
Age 
 
16-17 years 1.00     
18-19 years 0.77 -0.26 0.050 0.59 1.00 
20-21 years 0.81 -0.21 0.107 0.63 1.05 
22-23 years 0.70 -0.36 0.006 0.54 0.90 
24-25 years 0.62 -0.48 0.000 0.48 0.80 
Deprivation 
 
Quintile 1 (highest) 1.00     
Quintile 2 (high) 0.91 -0.10 0.325 0.74 1.10 
Quintile 3 (medium) 1.00 -0.004 0.973 0.80 1.24 
Quintile 4 (low) 0.84 -0.18 0.126 0.67 1.05 
Quintile 5 (lowest) 0.80 -0.23 0.090 0.61 1.04 
Missing 1.14 0.13 0.464 0.80 1.61 
Previous 
Chlamydia 
No 
Yes 
1.00 
3.66 
 
1.30 
 
0.000 
 
2.88 
 
4.65 
Number of 
partners 
0 partners 1.00     
1 partner 2.16 0.77 0.011 1.19 3.91 
2-4 partners 2.51 0.92 0.003 1.36 4.64 
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>= 5 partners 2.58 0.95 0.008 1.28 5.22 
Missing 1.49 0.40 0.149 0.87 2.57 
New partners 
No 
Yes 
Missing 
1.00 
1.45 
1.89 
 
0.37 
0.64 
 
0.000 
0.000 
 
1.19 
1.38 
 
1.77 
2.60 
Condom use 
No  
Yes 
Missing 
1.00 
0.50 
0.35 
 
-0.69 
-1.04 
 
0.000 
0.000 
 
0.41 
0.25 
 
0.62 
0.50 
 
Behavioural risks included: prior chlamydia diagnosis (OR: 3.66, 9% CI: 2.88, 4.65), multiple partners in 
the prior 3-months; and having a new partner. Condom use at last sex was protective (OR: 0.50, 95% 
CI: 0.41, 0.62).  
The model had reasonable performance, with a pseudo R2 of 7.8% and c-statistic of 0.703. The 
Hosmer-Lemeshow test showed good model fit (p-value = 0.1602). The models predicted probabilities 
range from 1 – 75%, with a mean of 12%. Using a risk cut-off of 15%, you would refer 19% of patients, 
with a sensitivity of 42% and specificity of 84% (Table 9, Figure 3).  
Table 9: Sensitivity, specificity, PPV and NPV values for different risk prediction thresholds in the young 
person’s model 
Prediction 
threshold 
STI 
(n=1005) 
No STI 
(N=8525) 
Sensitivity Specificity PPV NPV 
Correctly 
classified 
% 
referred 
>5% 905 6411 90.0% 24.8% 12.4% 95.5% 31.7% 76.8% 
>10% 673 3118 67.0% 63.4% 17.8% 94.2% 63.8% 39.8% 
>12% 581 2304 57.8% 73.0% 20.1% 93.6% 71.4% 30.3% 
>15% 425 1385 42.3% 83.8% 23.5% 92.5% 79.4% 19.0% 
>18% 309 861 30.8% 89.9% 26.4% 91.7% 83.7% 12.3% 
>20% 252 605 25.1% 92.9% 29.4% 91.3% 85.8% 9.0% 
>30% 112 192 11.1% 97.8% 36.8% 90.3% 88.6% 3.2% 
 
Figure 3: Model performance graphs for the primary Young Persons model 
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Sensitivity analyses 
A model fitted using a forward stepwise approach, using a p-value threshold of 0.2, did not exclude 
any of the variables and therefore had the same model performance.   
A model was fitted using multiple imputation. The following variables underwent 10 imputation 
rounds using chained equations: continent of birth, ethnicity deprivation, and number of partners, 
new partners and condom use. The model had a pseudo R2 of 6.6% and c-statistic of 0.688; the 
predicted risks ranged from 1 – 68%. Overall this showed worse discrimination than the model which 
included categorised missing values.  
A model including demographic data only, and fitted using the v2 dataset (1,045,373 observations), 
showed considerably poorer model performance, with a pseudo R2 of 1.4% and c-statistic of 0.590. 
The range of predicted risk of STI diagnosis was limited, ranging from 2 – 24%, reflecting poor 
discrimination. A typical high risk individual based on demographics alone would be an 18-19 year old, 
Black Caribbean male, born in Europe and living in an area of high deprivation (predicted risk – 23%).  
 
3.4.3 MSM Model 
Variable Selection 
Similarly to the young person’s model, age and deprivation were included as categorical variables and 
ethnicity and country of birth were reduced to fewer categories due to the lack of heterogeneity 
within the sample. Within this cohort of MSM, there was a range of prior STI diagnoses reported, 
including HIV, syphilis, chlamydia and gonorrhoea. Many of these contained too few records to be 
included as individual predictors; therefore a single binary variable indicating STI in the prior 12-
months was used. Problematic alcohol use excluded for having too much missing data.  
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Table 10 summarises the variables in all the models from this point forward.  
 
Table 10: Variables and their definitions in the primary MSM model 
Demographic  
Ethnicity 
White (reference), White other, S. Asian, Asian other, 
Black Caribbean, Black other, White and black mixed, 
mixed other, Other, Missing 
Continent of birth  
UK (reference), Europe, Africa, Americas, Asia, Other, 
Missing 
STI diagnosis No (reference), Yes – within the last year 
Age <20 (reference), 20-24, 25-34, 35-44, 45-64, >=65 years 
Deprivation score Quintiles – least deprived (reference) 
Behavioural  
Number of partners None (reference), One, Two – Four, Five or more, Missing 
Condomless anal sex No (reference), Yes, Missing 
Known HIV positive partner No (reference), Yes, Missing 
Any drug use in the prior 3-months No (reference), Yes, Missing 
  
 
Primary Analysis  
The model was fitted, using categorised missing values, with 36 degrees of freedom, and may 
therefore be over fitted (Table 11). In the MSM model, the only significant demographic predictors of 
STI diagnosis were being of South Asian ethnicity (OR: 2.53, 95% CI: 1.05, 6.10), or being born in 
Europe (OR: 2.46, 95% CI: 1.26, 4.78). Significant behavioural risks included having had condomless 
anal sex in the previous 3 months (OR: 1.95, 9% CI: 1.39, 2.73), and any drug use prior 3 months (OR: 
1.89, 95% CI: 1.31, 2.74). 
The model had reasonable performance, with a pseudo R2 of 7.0% and c-statistic of 0.676. The 
Hosmer-Lemeshow test showed good model fit (p-value = 0.224). The models predicted probabilities 
range from 3 – 71%, with a mean of 16%. Using a risk score threshold of 30% would result in 1 in 5 
patients being classified as high risk of STI diagnosis, with a sensitivity of 38.7% and specificity of 84.8% 
(Table 12, Figure 4). 
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Table 11: Full multivariable logistic regression model for STI diagnosis in the current visit in MSM 
Variable Odds ratio Coefficient p-value 95% confidence interval 
Ethnicity 
White British 1.00     
White, other 0.67 -0.40 0.236 0.35 1.30 
South Asian 2.53 0.93 0.039 1.05 6.10 
Asian, other 1.43 0.36 0.518 0.48 4.21 
Black Caribbean 0.57 -0.56 0.307 0.20 1.67 
Black, other 0.98 -0.02 0.957 0.47 2.03 
White & black mixed 0.76 -0.28 0.569 0.29 1.97 
Mixed, other 1.19 0.17 0.676 0.53 2.70 
Other 1.05 0.04 0.947 0.28 3.90 
 Missing 1.99 0.69 0.159 0.76 5.20 
Continent of 
birth 
UK 1.00     
Europe 2.46 0.90 0.008 1.26 4.78 
Africa 1.00 0.002 0.995 0.42 2.42 
Americas 1.43 0.36 0.417 0.60 3.40 
Asia 1.23 0.21 0.737 0.37 4.16 
Other 0.88 -0.13 0.796 0.33 2.32 
 Missing 0.65 -0.43 0.185 0.35 1.23 
Age 
 
<20 years 1.00     
20-24 years 0.75 -0.28 0.364 0.41 1.39 
25-34 years 0.79 -0.24 0.409 0.44 1.39 
35-44 years 0.63 -0.47 0.141 0.34 1.17 
45-64 years 0.55 -0.59 0.076 0.29 1.06 
>=65 years 0.41 -0.89 0.117 0.13 1.25 
Deprivation 
Quintile 1 (highest) 1.00     
Quintile 2 (high) 0.93 -0.07 0.708 0.63 1.36 
Quintile 3 (medium) 0.87 -0.14 0.504 0.57 1.32 
Quintile 4 (low) 1.08 0.08 0.716 0.72 1.63 
Quintile 5 (lowest) 0.66 -0.41 0.094 0.41 1.07 
Missing 1.15 0.14 0.709 0.56 2.35 
Previous STI 
No 
Yes 
1.00 
1.40 
 
0.33 
 
0.150 
 
0.89 
 
2.20 
Number of 
partners 
0 partners 1.00     
1 partner 1.24 0.21 0.604 0.55 2.76 
2-4 partners 1.30 0.26 0.524 0.58 2.93 
>= 5 partners 1.70 0.53 0.219 0.73 3.97 
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Missing 1.01 0.01 0.976 0.44 2.36 
Unprotected 
anal 
intercourse 
No 
Yes 
Missing 
1.00 
1.95 
0.89 
 
0.67 
-0.12 
 
0.000 
0.758 
 
1.39 
0.43 
 
2.73 
1.86 
Known HIV 
positive partner 
No  
Yes 
Missing 
1.00 
1.52 
1.15 
 
0.42 
0.14 
 
0.065 
0.681 
 
0.98 
0.59 
 
2.37 
2.22 
Drug use in 
prior 3-months 
No 
Yes 
Missing 
1.00 
1.89 
1.29 
 
0.64 
0.25 
 
0.001 
0.210 
 
1.31 
0.87 
 
2.74 
1.91 
 
Table 12: Sensitivity, specificity, PPV and NPV values for different risk prediction thresholds in the 
MSM model 
Prediction 
threshold 
STI No STI Sensitivity Specificity PPV NPV 
Correctly 
classified 
% 
referred 
>10% 308 1018 96.9% 9.9% 23.2% 91.8% 29.0% 91.6% 
>15% 262 714 82.4% 36.8% 26.8% 88.1% 46.8% 67.4% 
>18% 227 531 71.4% 53.0% 30.0% 86.8% 57.0% 52.3% 
>20% 209 452 65.7% 60.0% 31.6% 86.2% 61.3% 45.6% 
>25% 157 294 49.4% 74.0% 34.8% 83.9% 68.6% 31.1% 
>30% 123 172 38.7% 84.8% 41.7% 83.1% 74.7% 20.4% 
>35% 86 111 27.0% 90.2% 43.7% 81.5% 76.3% 13.6% 
 
Figure 4: Model performance graphs for the primary MSM model 
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Box 3: Worked example of the triage tool 
The model regression equation is used to calculate the patient log odds, using the following equations: 
Patient’s log odds of STI diagnosis  = constant + (var1 x coefficient1) + … + (vari x coefficienti) 
Patient’s Odds of STI diagnosis   = e(patient’s log odds value) 
Probability of STI diagnosis   = [Odds / (1 + Odds)] x 100 
Taking the young person models:  
Log odds of STI diagnosis = -2.34 + (south Asian x -0.32) + (other Asian x -0.06) + (black Caribbean x 
0.98) + (other black x 0.45) + (other white x 0.28) + (mixed white & black x 0.61) + (mixed other x 
-0.13) + (other ethnicity x -0.37) + (missing ethnicity x -0.16) + (born Africa x -0.42) + (born Asia x 
-0.86) + (born Europe x 0.03) + (born Americas x -0.26)+ (born other x -0.12) + (born missing x -
0.24) + (age 18-19yrs  x -0.26) + (age 20-21yrs x -0.21) + (age 22-23yrs x -0.36) + (age 24-25yrs x 
-0.48) + (deprivation 2nd x -0.10) + (deprivation 3rd x -0.004) + (deprivation 4th x -0.18) + 
(deprivation 5th x -0.22) + (missing deprivation x 0.13) + (prior chlamydia x 1.30) +  ( 1 partners x 
0.77) + (2-4 partners x 0.92) + (>= 5 partners x 0.95) + (missing partners x 0.40) + (new partner x 
0.37) + (new partner missing x 0.64) +  (condom use x -0.69) + (missing condom use x -1.04) 
 
Taking the example of a black Caribbean, 19 year female, who lives in an area in the second quintile of 
deprivation. She was diagnosed with chlamydia in the previous 12 months, has had 2 partners in the 
previous 3-months, of which one was new. She used a condom at last sex. In this case, the regression 
equation for this patient would look like: 
Log odds of STI diagnosis = -2.34 +  (black Caribbean x 0.98) + (born UK x 0) + (age 18-19yrs  x -
0.26) + (deprivation 2nd x -0.10) + (prior chlamydia x 1.30) + (2-4 
partners x 0.92) + (new partner x 0.37) +  (condom use x 0)  
Log odds of STI diagnosis  = 0.87 
Patient’s Odds of STI diagnosis  = e(0.87) 
Patient’s Odds of STI diagnosis  = 2.39 
Probability of STI diagnosis          = [2.39 / (3.39)] x 100 
Probability of STI diagnosis          = 70.5% 
This is therefore an example of a very high risk patient, with the model predicting a 70.5% likelihood of 
them being diagnosed with an STI.  
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Sensitivity Analyses 
Using a forward stepwise approach to the model, with a p-value threshold of 0.2, excluded age, 
deprivation quintile, number of partners and ethnicity.  This model was favoured according to the BIC 
statistic, but had a poorer discrimination (c-statistic = 0.658) and model fit (pseudo R2 = 5.8%); BIC 
tends to favour parsimonious models which include fewer explanatory variables.  
A model was fitted using multiple imputation, which underwent 10 imputation rounds using chained 
equations of continent of birth, ethnicity, deprivation, and number of partners, sex with a known HIV 
positive partner, condomless anal sex and drug use in the prior 3 months. The model had a pseudo R2 
of 6.8% and c-statistic of 0.676; the predicted risks ranged from 4 - 71%. This model showed very 
similar performance and discrimination to the mode which included categorised missing data, and 
similar direction and magnitude of relationships with the outcome.  
A model including demographic data only with the v2 dataset (245,863 observations), showed very 
poor model performance, with a pseudo R2 of 0.5% and c-statistic of 0.553. The range of predicted risk 
of STI diagnosis was limited, ranging from 7 – 23%, reflecting poor discrimination. A typical low risk 
individual based on demographics alone would be a >65-year-old South Asian living in an area of low 
deprivation, who was born in Asia (predicted risk: 7%). This is contradictory to the v3p2 model, in 
which being South Asian was one of the main risks for STI diagnosis.  
3.5 Discussion 
We developed two triage tools, for young people and MSM groups, based on routinely collected 
demographic and limited behavioural data as part of a pilot implementation of GUMCADv3. Overall, 
both models showed borderline reasonable, but not good, performance with the young person’s 
model (c-statistic = 0.706) having slightly improved performance than the MSM model (c-statistic = 
0.676). A c-statistic of >0.7 is generally considered the threshold for a diagnostic to be clinically 
reasonable. The inclusion of STI history and behavioural data was crucial to model performance, with 
models based on demographic showing very poor performance (c-statistic = 0.590 and 0.553 for young 
people and MSM respectively).  
 
3.5.1 Young People 
The young person’s model identified several significant predictors of STI diagnosis, as well as 
protective factors, such as being female, being older than 17 years and reporting condom use at last 
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sex. This agrees with previously published literature which has also found older age and condom use 
to be associated with lower risk of STI diagnosis in other settings.107-109 Similarly, multiple partners and 
prior diagnoses are established risks for STIs amongst young people.15, 108, 110 The finding that young 
people of black ethnicities (Including Black Caribbean) and mixed white and black ethnicity are at 
higher risk of STI diagnosis agrees with previous findings from the UK.111, 112 Amongst young people, 
possible explanations for this association may be around different levels of sexual health knowledge, 
and therefore behaviours, amongst younger and black ethnic minorities.113  
Applying the young person’s model as a triage tool within a clinical setting requires a threshold to be 
set, with patients having a score above the threshold categorised as ‘high risk of STI diagnosis’ and 
those below the threshold as ‘low risk of STI diagnosis’. The risk predictiveness curve (Figure 3) shows 
that most young people were relatively low risk, with predicted risk rising sharply from 20 – 75% in 
only 10% of the population. Using a predicted risk threshold of >20%, where the slope of the curve 
rises steeply, results in a sensitivity of 25% and specificity of 93%. Applying a lower threshold of >15% 
improves the sensitivity to 42% and reduced the specificity to 84%; however this would double the 
number of patients classified as ‘high risk of STI diagnosis’ (9% versus 19%). While this lower threshold 
increases sensitivity, the feasibility of delivering a brief intervention to one in five young people may 
not be possible.  
 
3.5.2 MSM 
The MSM model only identified four significant predictors of STI diagnosis: being of South Asian 
ethnicity (OR: 2.53), being born in mainland Europe (OR: 2.46), having had condomless anal sex in the 
previous 3-months (OR: 1.95) and drug use in the prior 3-months (OR: 1.89). The use of drugs has been 
reported as a risk for STI diagnosis by multiple studies, so this finding would be expected.16, 20, 114 
However, the lack of association seen between number of partners and STI diagnosis contradicts 
multiple studies which have found it to be a significant risk, as we found in young people.16, 17, 115 In 
fact, when we used a forward stepwise modelling approach, number of partners was not retained in 
the model, along with age, deprivation and ethnicity. Compared to other reports of risks for different 
STIs in the UK, the finding that being of South Asian ethnicity is a significant risk was unexpected;116 
this may be the result of small numbers of observations (n=33), a handful of cases in this group could 
result in a significant relationship.   
The risk predictiveness curve for the MSM model (Figure 4) showed a more consistent increase in risk 
of STI diagnosis across the population, suggesting that more patients are higher risk amongst MSM 
than young people where it is concentrated in a small proportion of the population. Amongst MSM, 
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half the patients have a predicted risk of an STI >20%, which explains the models poorer ability to 
discriminate than the young person’s model. Using a predicted risk threshold of >30% would result in 
20% of the MSM clinic population being classified as ‘high risk of STI diagnosis’, with a sensitivity of 
39% and specificity of 89%. A threshold of >20% would give a better balance of sensitivity and 
specificity (66% and 60%, respectively), but results in 46% of patients being ‘high risk of STI diagnosis’.  
 
3.5.3 Implementation challenges 
A key challenge of implementing risk scores for triaging in real-world clinical settings is the need to 
balance sensitivity and specificity, and available resources. The aim of this pilot study was to 
demonstrate feasibility of triaging patients into different behavioural risk reduction interventions, 
crucially, within existing clinical resources.  Therefore, the decision about what threshold to use when 
operationalising the triage is likely to be driven more by the proportion of patients classified as high 
risk, rather than optimising either the sensitivity (identifying more true positives) or specificity 
(identifying fewer false positives). Based on this being the priority, a risk threshold of 20% for young 
people and 30% for MSM may be the best balance between resources, sensitivity and specificity.  
A potential challenge for this approach, assuming high risk patients would all be referred to an 
intervention which requires a level of clinic resources, would arise if clinic populations differ 
dramatically in terms of their demographics and sexual behaviours. A clinic which see mostly lower 
risk patients, for example young people who are mostly female of white or Asian ethnicity and aged 
>18 years, would likely classify less than the expected 9% high risk patients. In comparison, a clinic 
with more young black men attending would likely classify more than 9% as high risk, resulting in an 
unequal burden on resources.  
 
3.5.4 Strengths and limitations 
In general, the young people and MSM populations were representative of the wider clinic 
populations from the five pilot sites in terms of continent of birth, deprivation and ethnicity. MSM 
patients tended to have lower levels of missing data than young people and general populations; 
therefore it is likely that the two populations used in the model development reflect the wider 
population of these clinics. However, these clinics may not be representative of national GUM clinic 
attendance. For MSM specifically, the STI rate in this sub-sample was higher than the nationally 
reported rate for the same time period (22% versus 15%), but conversely does not include any of the 
higher risk London clinics with large MSM populations.18 The pilot clinics were all located in the south 
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of England, and therefore the demographic profile of patients within models are unlikely to be 
generalizable nationally.    
A limitation of the v3p2 dataset is the level of missing data within the behavioural variables. While the 
behavioural variables are recommended as part of the BASHH guidelines and are intended to be 
feasible for collection in routine care,96 in practice this may not be the case. As the level of missing 
data differs between young people and MSM, it suggests that these questions were not asked to 
patients randomly, but rather that clinical staff selected who they asked and recorded data for based 
on personal characteristics. For example, a young woman attending a GUM clinic for contraception 
may be less likely to have their recent sexual behaviour recorded than those attending for an STI 
screen. We found that MSM were much more likely to have (49% vs. 31%) drug use recorded than the 
general population, potentially reflecting awareness of chemsex being more common risk behaviour in 
MSM. As it is reasonable to assume the missingness is not random and there are several mechanisms 
which could lead to this missingness, our primary models would not have accounted for this. 
Improving data completeness for the limited behavioural data, across the whole clinic population, 
would likely improve model performance and discrimination. This would also allow for additional 
variables to be included in the triage tool, such as problematic alcohol use.     
We did not conduct any internal validation of either model, therefore we cannot comment of how well 
the model would generalise to a different dataset. The young person’s model met the rule of thumb to 
prevent over-fitting that there should be 10 outcome events per degree of freedom in the model, with 
1005 outcomes and 34 degrees of freedom. The MSM model however was fit with 36 degrees of 
freedom for 318 outcomes; therefore it is likely to be over-fitted, despite having poorer performance. 
External validation was planned during the pilot feasibility trial implementation, providing a more 
robust method of model validation than internal validation.106    
 
3.6 Conclusion 
Triaging patients into high or low risk groups, based on routinely collected data within sexual health 
clinics showed reasonable discriminatory ability; however at a minimum, basic behavioural data is 
needed to improve the discrimination of these models. The ability to include additional, or more 
complete, behavioural data would likely improve performance further. The models were developed 
using the only dataset available at this time, from a pilot that included a small sample of clinics, which 
were not representative all of all clinics in the UK (e.g. larger London clinics with a high proportion of 
high-risk patients were not able to be included). While the work demonstrated that developing such a 
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tool was possible to a minimal threshold of clinical utility, further refinement and external validation is 
needed to improve the performance of the tool and assess the real-world applicability of this 
approach.  
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Chapter 4: Work Package 3 – Current opportunities, barriers, and preferences for behavioural 
interventions 
4.1 Background 
Attendance at a sexual health clinic provides an opportunity to deliver interventions at a potentially 
‘teachable moment’. In-line with this, NICE recommends that high risk groups, including young 
people and MSM, should undergo risk assessment at sexual health services. Those considered at 
high risk are recommended to receive a brief structured one-to-one risk reduction intervention.117 
There is currently a lack of evidence from the UK as to how patients are being triaged in clinics, what 
criteria are being used to determine risk, and what interventions are being offered. Considering the 
range of potential evidence-based interventions identified in WP1,47 understanding what is currently 
offered as standard of care across diverse services is important.  
Taking account of the views of stake holders, including service users and staff who deliver 
interventions is vital to the design and implementation of interventions that are acceptable, 
practically feasible and sustainable over time.34 Co-creation of interventions with stakeholders is 
important to the Intervention Mapping (IM) approach to intervention development and adaptation. 
118 This iterative process combines an ecological approach with participation of all stakeholders, a 
focus on specification of the underlying mechanisms (in a clear logic model) and a research-based 
approach to ensuring fidelity of implementation. A key part of this process is to refine modes of 
delivery and delivery competencies that maximise intervention effectiveness in real-world 
contexts.119 Understanding service user and provider preferences for different intervention 
approaches, and the motivation for these preferences forms part of the IM process. This part of the 
project therefore used qualitative and quantitative methods to obtain evidence to inform the IM 
process. 
 
4.2 Aim 
To describe current practice in sexual health clinics with respect to triage and delivery of sexual risk 
reduction interventions, and to explore opportunities and challenges to the delivery of candidate 
risk reduction interventions. 
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4.3 Method 
We conducted a mixed-methods study with healthcare providers and service users, using four 
phases of data collection.   
 
4.3.1 Key informant provider interviews   
Key informant interviews were conducted with a range of service providers to explore the current 
use of triage methods and behavioural interventions in SH services in England. We explored 
respondents’ views on the opportunities and challenges to the delivery of sexual risk reduction 
interventions within existing resources in SH services.  
Participant selection: We purposively recruited a range of health care providers, to include: service 
leads, health advisors, doctors and nurses. Providers were targeted to reflect different types of 
clinics, sizes, geographic locations and client mixes. Selection of clinics was done through individual 
contacts and through random selection from the list of clinics provided by PHE, which was done in 
Stata. In total, we aimed to conduct 30 interviews.  
Recruitment: Interviews were pre-booked, following an invitation sent by email. Participants were 
contacted up to three times by email, before they were considered as not interested in taking part.  
Data collection: The interviews were conducted by telephone. Interviews lasted approximately 30 
minutes in total, and consent was taken verbally at the start. The interviews were audio-recorded 
and transcribed by a professional service.  
Analysis: Analysis used the framework approach, a deductive approach, which allows for a more 
structured approach to data analysis based on pre-determined aims and objectives as well as 
accommodating emerging themes. Content analysis was conducted independently by two 
researchers and themes were agreed through discussion until consensus was reached.  Both pre-
determined concepts used for developing the topic guides and emergent themes arising from the 
data informed the process of identifying the key thematic categories to be used in data coding.120, 121  
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4.3.2 Web-based service provider survey  
A brief web-survey was conducted with sexual health service providers to determine current triage 
and intervention strategies in use across England, and the resources that are available for these. The 
content of the web-survey was informed by findings from the analysis of the key informant provider 
interviews, and therefore the survey was conducted sequentially to the interviews.  
Study population:  All sexual health services that report to the PHE GUMCADv2 reporting system 
were eligible to participate. This includes level-1, 2, and 3 services within England. An estimated 570 
services were reporting to PHE at the time of the survey, and a list of clinic contacts was provided by 
PHE. A supplementary list of clinic contacts was provided by Tom Nadarzynski (BSMS, PhD student), 
and used to update contact information.   
Data collection: Providers were contacted by email, which contained study information and the link 
to the web-survey. Up to five email reminders were sent, over a 6-month period (December 2015 – 
June 2016), with three generic and two personalised emails sent. The link to the survey was also 
distributed in the delegate packs at the British Association for Sexual Health and HIV (BASHH) 2016 
annual conference. The survey was developed in Opinio which is hosted within UCL servers, and was 
designed to take 10 minutes. The survey was piloted by two independent clinicians who work in 
level-3 services to check for understanding and language. No personally identifiable information was 
collected.    
Analysis: The survey was analysed using descriptive statistics, adjusted for clinic type, and location. 
All analysis was done using Stata 13.  
 
4.3.3 Semi-structured interviews with patients  
Interviews with service users were conducted to gain an understanding of patient perceptions of risk 
and their attitudes towards different risk reduction interventions, to inform acceptable and desirable 
interventions.   
Participant selection: We purposively sampled young men and women, and MSM who were 
attending NHS sexual health services. The recruitment framework categorised MSM by age and 
young people by age and gender, with equal recruitment across two clinic sites. A total sample of 15 
heterosexual young people and 20 MSM were targeted (total = 35).  
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Recruitment: Participants were recruited from two sexual health clinics: Claude Nicol, Brighton and 
Mortimer Market Centre, London. Participants were approached in the clinic waiting room and given 
a study information sheet to read before deciding to take part. Participants were offered a £20 high-
street voucher as a thank you for taking part. Interviews were either scheduled to take place on the 
day of recruitment, or scheduled for a future time.  
Data collection: Interviews were conducted by researchers in person within the clinical setting. 
Interviews were designed to last 30 minutes, and were piloted with members of the PPI group to 
check for understanding and sensitivity. Written consent was taken prior to the interview starting, 
and the interviews were audio-recorded and then transcribed using a professional service.  
Analysis: We used the same analysis methodology as described for the healthcare provider 
interviews.  
 
4.3.4 Patient discrete choice experiment  
We conducted a cross-sectional discrete choice experiment (DCE), to assess patient preferences for 
risk reduction interventions.  DCEs are based on the premise that services can be described in terms 
of their ‘attributes’ and ‘levels’ (or characteristics) and that an individual’s preference, and therefore 
choice, of service is based on a combination of these characteristics. Information from WP1 and both 
provider and patient interviews were used to define the key issues of importance (attributes and 
attribute levels) that may influence patients’ preference.  
Study population and sample size: We recruited young people and MSM who were attending a NHS 
sexual health clinic, aiming for a representative sample of attenders within these groups. DCEs are 
not amenable to conventional power calculations in advance of developing the instrument. 
However, other studies using DCE methods to assess preferences for healthcare have typically 
included 200 participants.122 As we planned sub-analyses in young people and MSM, we aimed to 
recruit 350 participants.  
Recruitment: Patients were recruited from three sexual health clinics: Claude Nicol, Brighton; 
Mortimer Market Centre (MMC), and Archway, London. Participants were approached in the clinic 
waiting room and given a study information sheet to read before deciding to take part.  
Instrument design: The questionnaire used a ‘labelled’ rather than generic design.  Four modes of 
brief behavioural intervention were included in the final design: ‘talking’ to someone (meaning 
talking therapies such as counselling and motivational interviewing), an ‘email or text containing 
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health advice’, an ‘online session by yourself’ or an ‘online group session’ plus a fifth ‘opt out option’ 
(Error! Reference source not found.13). The attributes included: type of contact, type of activity 
involved in each session, length and number of sessions, and the person who mediates the sessions. 
Note however that each attribute was not necessarily applicable to each intervention, e.g. a person 
is not needed to mediate an email / text based intervention. The number of sessions (1 to 6) and 
their length (15 minutes to an hour) were deliberately short to reflect the brief nature of the 
interventions shortlisted.  
Table 13: DCE attributes and levels 
Attribute 
Options 
Email or text 
containing 
health advice 
Online session by 
yourself 
Online group 
session 
Talking with at 
least one person 
Opt out 
Type of 
contact 
Emails or texts 
from a NHS 
service 
containing health 
information 
Interactive online 
information 
including videos 
and quizzes 
A Facebook 
Group Chat or 
Twitter (or 
similar online 
social media) 
1:1 phone 
conversation, 1:1 
face-to-face 
meeting in clinic, 
group face-to-face 
meeting in clinic 
N/a 
Type of 
session 
Reading emails / 
texts 
Typing questions 
and responses 
Read / watch 
online and ticking 
boxes via a 
webpage or app 
Talking N/a 
Length of 
each session 
N/a 
Up to 15, 30 or 
60 mins 
Up to 15, 30 or 
60 mins 
Up to 15, 30 or 
60 mins 
N/a 
Number of 
sessions 
N/a 1, 2-3 or 4-6 1, 2-3 or 4-6 1, 2-3 or 4-6 N/a 
Person who 
mediates 
the session 
N/a N/a 
A health 
counsellor, nurse 
or peer 
A health 
counsellor, nurse 
or peer 
N/a 
 
The pilot questionnaire was generated using an orthogonal approach and set to 12 choice tasks 
given 12 degrees of freedom in the design using the Ngene V1 software (http://www.choice-
metrics.com/). It was completed by 24 clinic attendees. The pilot design required participants to 
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make two choices per DCE question. The first included an ‘opt out’ option; this was omitted in the 
second (referred to as a ‘forced choice’ question). This two stage approach was included to evaluate 
concerns that a large number of participants would ‘opt out’. However, the forced choice question 
was removed from the final design, as only a minority of responses indicated a preference not to 
participate. The final instrument was produced using a d-efficient approach using priors from the 
pilot. Participants were asked to complete all 12 DCE questions. Eight versions of the questionnaire 
were produced in which the ordering of the DCE options and questions were changed. 
Data collection: The paper questionnaire was given to patients once they signed a consent form, and 
asked to complete it while in the waiting room. The questionnaire was designed to take 10 minutes. 
Participants were asked to provide limited demographic and risk behaviour information, including: 
age, gender, ethnicity and sexual orientation. The questionnaire was piloted with patients in one 
clinic to check for understanding. Data was entered into an Access database. 
Data analysis: Analysis used conditional logistic (CLOGIT) and latent class models (LCMs). CLOGIT 
models were the basic form of analysis but since the results are presented for the ‘average’ 
respondent, they do not address issues of heterogeneity. LCMs address heterogeneity by assuming 
the population of interest consists of a number of pre-specified latent classes with a probability each 
individual belongs to each class. Likely ‘membership’ of each class is estimated as a function of pre-
specified covariates: born in the UK (yes / no), having tested for a STI within the past year (yes / no), 
previously diagnosed STI (yes / no), and risk group (heterosexual 16-20 yrs, heterosexual 16-25, 
MSM 16-25, MSM 26-50 and MSM 51+). The number of classes was determined by selecting the 
number of classes in the model with the lowest BIC and examination of the standard errors on the 
coefficients. 
All results are presented as odds ratios and 95% confidence intervals (CI’s) based on robust standard 
errors given each participant provided multiple responses. All attribute levels were dummy-coded (1 
for group membership, 0 otherwise) except when estimating the alternative specific constants 
(ASCs). The ASCs represent the extent to which people preferred one of the intervention options or 
opting out when all other factors are disregarded. That is, they indicate the strength of preference 
for each individual label. For the ASCs, effects coding was used (1 for group membership, -1 
otherwise) to avoid confounding with the base levels on the main attributes. ‘Email or texts’ was 
used as the reference option in all analyses. Statistical analyses were performed using Stata 14 and 
NLOGIT 5, the scenario evaluation was undertaken using Excel.  
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4.4 Results 
4.4.1 Key informant provider interviews   
A total of 40 healthcare providers were individually contacted by email, and 26 telephone interviews 
were subsequently completed. Those interviewed included a mix of clinical leads, nurse practitioners 
and health advisors, from level 2 and 3 services inside and outside of London (Table 14). 
Table 14: Healthcare provider participants in key-informant interviews 
 Number Job title Location 
Level-2 8 
Nurse = 5 
Doctor = 3 
London = 3 
Non-London = 5 
Level-3 18 
Health advisor = 7 
Nurse = 1 
Doctor = 10 
London = 9 
Non-London = 9 
 
 
Current Services 
Most staff reported a mixture of appointment and walk-in services, with variety between clinics on 
how patient pathways are set up. Level-2 services, many of which are nurse-led, have set clinic times 
for specific procedures (e.g. coil fitting) which ca require involvement of different specialities and are 
therefore appointment based. Self-check-in and booking was mentioned by two GUM clinics: 
“Before they see the doctor or the nurse, there will be a, sort of, kiosk that will ask them pertinent 
questions in a way just to save time.  So the majority of the history taking, if you like, will be done on 
the, sort of, electronically by patients” (Doctor, level-3).  
Several clinic staff reported having specific services and pathways for young people and MSM 
groups. The age cut-off for ‘young’ varied from 16 to 19 years and under, and the change in the 
pathways included additional questions, assessments for vulnerability and speaking to a health 
advisor. “An MSM who’s in his 20s or 30s, whatever, with symptomatic, so we have a policy of do-
not-turn-away, we need to see that person and treat them” (Nurse, level-3). Other services were 
offered by participating clinics, with little standardisation in how the services were set-up; these 
included: contraceptive clinics, drug and alcohol services, psychological services and condition 
specific (e.g. warts) services. Referrals to external services also varied between clinics, including: 
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GUM services (by level-2 clinics), sexual assault or domestic abuse, drug and alcohol services, 
charities (such as London Friend or THT) and other clinical specialties (e.g. psycho-sexual).  
A variety of triage methods and their purposes were described by staff from different clinics. 
Examples of how triage rules varied included: “MSM with greater than X number of partners” 
(Doctor, level-3) or “Somebody who is displaying a sexual behaviour where there is multiple partner 
change” (Doctor, level-3). Not all clinics had set rules, with triage lacking standardisation. “Well we 
have guidelines. We have sort of GUM guidelines, departmental guidelines, but it's down to the 
individual doctor or nurse, seeing the patient, to decide whether someone should see the health 
adviser” (Doctor, level-3). One participant reported having an electronic triaging system, similar to 
the proposed approach in this project. “The system, the way it’s devised, does flag up to say this 
patient needs to see a health advisor because of risk A and B and it lists it down for you, what the 
clinician in the room has ticked” (HA, level-3). 
Clinic staff reported offering a range of sexual health promotion and risk reduction interventions, 
some more formally than others. Many of these activities were not specifically funded, but were 
done within existing resources: “So we just get paid as a level two sexual health screen regardless of 
whether we offer an intervention or not” (Nurse, level-2). Informal interventions included condom 
distribution and general health promotion messages, which were reported as being done by all clinic 
staff: “I mean, I think, really, sexual health promotion is just sort of integral to every kind of 
consultations so, in a way, some degree of sexual health promotion should be happening in every 
consultation” (Doctor, level-3). Various national campaigns were being delivered by clinics, such as 
the C-card initiative 123, and the Sex Positive campaign by Brook 124. More formal risk reduction 
interventions focussed on one-to-one sessions and outreach or educational services. One-to-one 
sessions in level-3 services were generally performed by HAs or counsellors, rather than all clinical 
staff: “So to a certain extent, the majority of staff have had some training in motivational 
interviewing […] if someone starts to need more intensive motivational interviewing interventions, 
they’re referred to the health advisors” (Doctor, level-3). The one-to-one intervention method 
mentioned most often was motivational interviewing. Brook specifically reported a longer 6-week 
educational programme about self-esteem and sexual health.  
Proposed Triage 
The proposed Santé approach was generally seen as something which was done already and this 
resulted in some respondents not being sure of the utility: “we already have, well, it’s not a tool, but 
we have a means to ask people, so if anything was going to be developed that had a chance of being 
used it would have not to increase the length of time” (Doctor, level-3). However, this led others to 
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state it could be acceptable: “I think that would work because we do triage forms which give us a 
little bit of a clue” (HA, level-3). Potential barriers to the proposed triage included: increasing the 
time needed with patients, how well the score would perform, training required in using it, how the 
patient referral would work, and issues in adapting EPR systems. On the other hand there were 
several opportunities highlighted, such as the perceived benefits of standardisation and accurate 
prediction, ease of having an EPR-based system, and potential patient acceptability.  
Proposed Interventions 
We presented the following intervention types to the HCPs, and asked for both the opportunities 
and barriers to potentially implementing them in their setting: videos in the waiting room, group 
sessions, online resources including mobile phone ‘apps’, single and multiple one-to-one sessions.  
HCPs gave mixed opinions on videos, with the practical ease of implementing them and having a 
potentially receptive and captive audience given as opportunities: “It’s an easy way for people to 
kind of… people aren’t doing very much, so it's quite a good time to kind of drill it in” (HA, Level 3). 
However, there were concerns with the lack of targeting and appropriateness for diverse waiting 
rooms:  “we have a very heterogeneous waiting room for the walk-in clinic, you know. The challenge, 
I guess, would be how you target that, or do you have a number of different ones for different risk 
groups” (Doctor, Level 3). 
Patient group sessions as an intervention format was, on the whole, not well received (e.g. “I think 
that’s a non-starter” – HA, level-3). The barriers to using group sessions focussed on resource issues, 
with a lack of appropriately trained staff, staff time, lack of clinic space and general disruption to the 
clinic running smoothly. HCPs also anticipated low patient acceptance: “personally, if I was a patient, 
I’d run out screaming if somebody tried to get me to do some group-work when I’m sitting in a clinic 
that I might feel slightly uncomfortable about, anyway” (Nurse, Level 3). Positive aspects to group 
sessions were highlighted, although were mostly assigned to specific risk groups and support group 
models. Another was being opportunistic and engaging with patients while they are at the clinic: 
“Catch them while they’re waiting you know, they haven't got anywhere to go” (Nurse, level-2). One 
HCP reported offering a group intervention and another that they had done so in the past. 
Some clinic staff reported having online resources and apps which they refer patients to; specific 
examples included dedicated online education tools for psychosocial issues. There was generally a 
positive attitude to using digital interventions, across staff and clinic types. The main barriers 
concerned patient motivation and uptake and a current lack of tools to refer patients to: “There’s so 
much else to distract them on the internet, but unless it’s something they enjoy doing, the learning is 
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not going to happen unless it’s couched in a very user-friendly, quick, vehicle” (Doctor, Level 3). 
Opportunities for digital interventions included their accessibility, perceived patient preference and 
minimal staff delivery time required: “We have quite an IT-savvy patient group, I would say, so 
something like that might appeal” (HA, Level-3) and “Yeah, well, they love apps.  I mean we suggest 
apps.  I’m quite an elderly nurse now but even I know to suggest apps” (Nurse, Level-2). 
Brief one-to-one sessions of MI were mentioned as something offered by all the GUM and the Brook 
clinics we engaged with. However, it was also an intervention that providers highlighted had a lot of 
challenges. One participant identified a lack of evidence as a challenge; this was more frequently 
raised than for other intervention types. The current needs associated with one-to-one sessions 
focussed on costs and staff resourcing: “So I think the clinical time, availability of time in the clinic is 
probably the biggest challenge” (Doctor, level-3). Patient motivation was also viewed as a barrier, 
whether the patient would be open to the intervention: “With behavioural interventions, if people 
are referring into that service, if you’ve got to work out whether the patient is really ready for this 
intervention, because if the patient is not ready for it, it’s just no point doing it” (HA, level-3). The 
main opportunity that was raised for one-to-one sessions was the flexibility that these offer, and the 
ability to tailor sessions to individual risks and needs. Many of the HCPs expressed that they felt the 
brief sessions were effective, even if this is hard to demonstrate: “Yes I know that's probably not the 
most cost efficient. But I think that’s probably the most effective method of risk reduction, because it 
is tailored to the actual patient's needs and you have time to explore what their risk is” (HA, level-3). 
Similar opportunities and barriers were raised around a series of one-to-one sessions, with HCPs 
highlighting the constraints of time and resources available in clinic to deliver these: “Yes, that’s a 
great idea, but we’ve never had capacity to do that” (HA, level-3). There was a perception that this 
was a good intervention format, and that it could be effective, provided patients were motivated: 
“But if it's something that perhaps is reserved for people who are seen as particularly high risk, and 
particularly amenable to this sort of intervention, then it would have a place” (Doctor, level-3). 
Implementation Challenges: 
Financial and staffing constraints were raised frequently as barriers to the delivery of current 
services, as well as being an anticipated barrier for delivering novel triage pathways or interventions. 
One approach currently taken to limited budgets was self-sampling: “All this quick checking and self-
assessment has started as a result of changes in funding and competition in sexual health services 
[…] that’s where that’s all heading” (HA, level-3). There was a perception that commissioners 
focused on treatment rather than prevention for STIs and that evidence was needed for a service to 
be commissioned: “Commissioners, I think, will not fund anything that hasn’t been shown to be 
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effective. And so I think you’ll have to demonstrate in some way that it is effective and not just that 
it’s acceptable” (Doctor, level-3). Continuity of care was deemed both important and lacking by 
HCPs, with issues associated with how services are commissioned: “one of the problems that we 
face, generally, is that drug and alcohol services generally tend to be borough-based, and all the 
patients we see come from everywhere” (Doctor, level-3). Additional services or improvements 
which were desired by HCPs included outreach for homeless people or sex workers, improved drug 
services, community education, and PEP follow-up pathways.  
 
4.4.2 Provider web-survey 
We received 100 responses, representing 145 clinical services. Of the responses, 82 (82%) were 
complete.  The majority of responses were from Level-3 services (80%), and three were from Level-1 
services. Respondents included: clinical leads (41%); doctors (37%); health advisors (8%); and nurses 
(8%). Respondents had been working within their service on average 10 years (range: 0 – 31 years). 
The overall response rate was 25%, with a higher response rate among level-3 services (31%).  
Current services 
Two respondents reported not offering any health promotion or risk reduction intervention services, 
both of which were level-3 services. Table 15 describes the services currently being offered by sexual 
health services in England:  
Table 15: Summary of interventions currently delivered by sexual health providers 
 Level 3 (n = 80) Level 1 and 2 (n = 20) 
Leaflets 65 (81%) 15 (75%) 
Educational videos 3 (4%) 1 (5%) 
Online learning materials 8 (10%) 5 (25%) 
Mobile ‘app’ 2 (3%) 0 (0%) 
Brief 1:1 sessions 56 (70%) 11 (55%) 
Multiple sessions of MI 38 (48%) 2 (10%) 
Group sessions 7 (9%) 5 (25%) 
 
The least common health promotion activities offered were videos and apps, while leaflets and brief 
one-to-one sessions were relatively common in both level-2 and 3 services at the time of the survey 
in 2015/16. Five respondents reported previously showing educational videos; reasons for stopping 
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included:  lack of funding (n=3), no observed impact (n=1) and the materials no longer being 
available (n=1). Lack of funding was cited as the reason for one clinic ceasing to offer an app, and 
another for ceasing an online intervention. Clinics which previously offered ‘talking interventions’ 
(1:1, multiple sessions of MI and group sessions), HCPs cited a lack of trained staff time as the main 
reasons for stopping.  
Triage 
The majority of clinic staff (77%) reported triaging on the basis of sexual health risk; this was less 
common in level-2 services (68% vs. 84%). No respondents reported the triage decision being an 
automated (or algorithm-based) decision, with either a nurse, doctor or HA making the decision, 
along with patient input.  Comments in the free text about an automated system were mixed, with 
many reporting it is “not necessary”, while others stated it would be useful, for example: “a good 
thing as long as not too long and time consuming”.  Healthcare providers were asked what three 
factors they considered most important for assessing patient risk of STIs. Sexual orientation, number 
of recent partners and the types of sexual activity reported (e.g. condomless sex) were the most 
commonly selected factors, and this was consistent between level-2 and 3 services. These are all 
variables included in the GUMCADv3 tool. 
Overall 14 responses stated that the SH service did not have any EPR system (level-2 = 2 (13%), level-
3 = 12 (18%)). Of those with EPR systems, 45 (55%) reported having it amended, of which a quarter 
stated that it was very difficult to do and 9% were not able to amend their system despite trying.  
 
 
 
 
Intervention barriers and opportunities 
Of interventions not currently offered by clinics, the most desired by level-3 services were online 
learning materials (67%), or mobile apps (64%). Group sessions were the least popular, with only 
18% of level 1 and 2 and 23% of level-3 clinics expressing any desire to offer them (Table 16).  
Table 16: Number of clinics reporting a desire to deliver, or not deliver, different intervention types 
 Level 3 Level 1 and 2 
 Desired Not Desired Desired Not Desired 
Educational videos 30 (46%) 11 (17%) 5 (33%) 3 (20%) 
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Online learning materials  40 (67%) 6 (10%)  8 (73%) 1 (9%) 
Mobile ‘app’  41 (64%)  3 (5%) 8 (50%) 0 (0%) 
Brief 1:1 sessions 5 (33%) 2 (13%) 3 (60%) 1 (20%) 
Multiple sessions of MI 13 (42%) 2 (6%) 3 (21%) 2 (14%) 
Group sessions 14 (23%)  29 (48%) 2 (18%) 3 (27%) 
*Note: the percentages are calculated based on the number of clinics not already providing this service 
 
For those interventions that clinic staff expressed an interest in delivering, the main barriers and 
motivations are presented in Table 17. Most of the barriers were related to funding and staff time 
for delivery, while the motivations were around potential effectiveness and uptake (rather than 
practical reasons). This suggests that if digital or video based interventions were developed for 
clinics, they would be able (and want) to deliver these.  
Table 17: The main barriers and motivations for intervention formats in Level 1, 2 and 3 clinics 
Intervention Barriers Motivations 
Educational videos Lack of funding for development (37%) Captive patient audience (37%)  
Online learning materials Lack of funding for development (61%) Minimal staff time (33%) 
Mobile ‘app’ Lack of funding for development (65%) Potential patient uptake (47%) 
Brief 1:1 sessions Time constraints (50%) Widely appropriate for patients (38%) 
Multiple sessions of MI Lack of funding for staff (50%) Perceived effectiveness (50%) 
Group sessions Lack of trained staff time (38%) Encourages peer learning (50%) 
*Note: percentages are calculated based on the number of clinics who expressed an interest in delivering this 
intervention format 
 
Trial feasibility 
Respondents were asked if they would be interested in taking part in a cluster Randomised 
controlled trial (RCT) of brief behavioural interventions, and whether being randomised at the clinic 
level would be acceptable. Nearly half the clinics (48%) expressed an interest in trial participation, 
but only 40% reported being comfortable with randomisation. There was no statistical difference 
between level-2 and level-3 clinics (38% vs 41%, respectively).   
 
4.4.3 Semi-structured interviews with patients 
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We recruited 35 service users, 15 young heterosexuals and 20 MSM. A description of the 
participants is presented in Table 18.   
Table 18: Description of participants in service user semi-structured interviews 
 Number Gender Age group Ethnicity 
Young people 15 
Male = 7 
Female = 8 
16-20 years = 8 
21-25 years = 7 
White British =10 
White other = 3 
Black African = 1 
Asian British = 1 
MSM 20 n/a 
16-25 years = 7 
26-50 years = 6 
>=51 years = 7 
White British = 11 
White other = 2 
Black British = 2 
Black other = 1 
Chinese = 1 
Missing = 3 
 
The service users we recruited were visiting the clinics for a range of reasons, including routine 
checks, results and treatment (including as part of partner notification), or because they had 
symptoms. The reasons were similar between MSM and young people with regular attenders in both 
groups. Some reported being motivated to attend because they were anxious, especially with 
symptoms or a recent ‘risky’ event.  
Risk perception 
We asked participants about their self-perception of sexual risk, as a way to introduce the concept of 
our proposed triage approach, and to gain an insight into potential barriers to triage. Trust, or lack of 
trust of a sexual partner, was frequently associated with service user’s perceptions of their sexual 
risk, driving sexual risk behaviour decisions such as using condoms; this was common between 
young people and MSM. The concept of causal and regular partners was much more common 
amongst MSM, and the types of sexual behaviours practiced within these partnerships were 
different e.g. not using a condom was something only done in a relationship. Young people 
discussed different levels of trust between people they knew being trusted compared to someone 
met, for example, via the dating app Tinder.  
Use of condoms, a major aspect of risk perception in young people, was reported as being 
influenced by peers. Young women specifically discussed an inability to negotiate the use of 
90 
 
condoms, or we described by young men as not negotiating condoms: “it would be a big rarity if a 
girl basically asked me to put on a condom” (Male, 21-25 years). There was a perception that peers 
were not using condoms and that normalized the behaviour; concern about pregnancy was more of 
a motivation for their use than STI risk. In MSM on the other hand, condom use was seen as a matter 
of preference. Condom use was also circumstantial, and non-use was often seen as one-off events:  
“I like to class myself as someone who is safe with sex but I am not perfect” (MSM, 16-25 years). 
Other behaviours which shaped how people felt about their personal risk included drug and alcohol 
use, general prevalence of STIs in the population and overseas partners. 
Risk was seen as dynamic by both groups, and was related to relationship status, age or maturity and 
either a personal scare or that of someone they know. Commonly being in a relationship was viewed 
as lower risk and that risk decreased with age: “I’d like to think that the older people do get the more 
kind of cautious and aware of STIs they are” (Female, 16-20 years). More specifically to young 
people, university was seen as a distinct time where more risks are taken, but that this was self-
limited during this period. In MSM, self-esteem was specifically mentioned as affecting risk 
behaviours: “if your self-esteem is quite low, its quite possible to engage in un-safer practice than if 
your self-esteem is quite high” (MSM, 26-50 years).  
Proposed triage 
We asked participants about being offered services based on standardised risk assessment, and 
service users had mixed views. Positive aspects of triaging included the process of having a score 
acting as an intervention in itself as it may raise awareness about risks that service users had not 
considered previously: “it’s something that people might not like, but you, kind of have to know, it’s 
better to know” (Female, 21-25 years). Trust towards the healthcare professional also meant that 
they would listen as they were seen as knowing best, although this would rely on the triage being 
well-explained (no ‘technical jargon’) and trusted: “you’re a registered healthcare professional, so I 
trust your reasoning” (Female, 16-20 years). It was acknowledged that while triage might act as a 
‘shock factor’, service users may not be supportive of it at the time but could ‘reflect’ afterwards. 
This may not lead to behaviour change however: “I wouldn’t consider changing my behaviour 
actually, I would just see it as, yes, a warning” (MSM, 16-25 years).  
Concerns raised with triage included anxiety associated with a classification of ‘high risk’. 
Alternatively telling them something they already knew was considered redundant: “either way I'm 
going to get tested, so I don’t know why they tell people really” (Female, 21-25 years). Amongst 
MSM specifically there was concern that it could feel like being pigeonholed simply based on being 
MSM within a certain demographic: “with gay culture being so sleazy you just sort of expect to be 
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high risk all the time” (MS< 16-25 years). Onward referral based on triage raised concerns that 
services should be available to everyone, with the denial of services or rigidity of referrals criteria 
not liked. However, many noted that the offer of supportive services was positive and service 
streamlining made sense.  
Proposed interventions 
Similar to the HCP interviews, we asked participants for their thoughts on different intervention 
formats and any preferences between them: waiting room videos, group sessions, online and apps, 
one-to-one sessions. Service users raised multiple concerns about videos in the waiting room, 
suggesting that they would make people feel awkward in mixed waiting rooms or increase their 
anxiety. One commented, "having had sex with 20 different people last night, they don’t need a 
video saying don’t be promiscuous" (MSM, 16-25 years). Opportunities however focussed on the 
notion that education is good, and a sexual health setting is the correct setting for sexual health 
education: "Why not?" Information is a good thing. It’s a sexual clinic, so that’s why people are there, 
to talk about sex” (MSM, 26-50 years). Recommendations about content included text information 
or statistics being desirable and short advert or campaign type clips would be acceptable, but 
content should not be graphic.  
Group sessions were not viewed favourably, with many participants stating they would not take part 
despite seeing the role they could play. Privacy and confidentiality was the primary concern with this 
intervention format, as they did not want to talk about sexual health in a group despite considering 
themselves open: “you share funny stories with your friends, and I do talk about sex quite a lot with 
my friends, but not about this part” (Female, 21-25 years). Amongst MSM this was particularly seen 
as an issue if someone is shy or isolated: “they cannot talk at home, they cannot talk at school, and 
they cannot talk in church and they cannot talk to their own best friends, so they are not going to 
start talking here” (MSM, 26-50 years). These concerns were associated with the group or others 
situations not being appropriate to their circumstances, and that there would be judgement about 
lifestyle. In MSM, there was also the possibility of bumping into someone known, and HIV status 
affecting how someone might participate. On the other hand, the ability to learn from others 
experiences was seen as valuable.  
Generally having some form of digitally based intervention (e.g. website, social media or app) was 
positively viewed, although respondents felt differently about the various formats. While concerns 
about apps were expressed across participants, this was more distinct in young people; phones were 
described as shared; with friends and family often looking at them or them being out ‘on the table’: 
“people use my phone, so they would know my business” (Female, 16-20 years). Apps were 
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considered somewhat redundant if there was a website available: “most information I can find it 
online, I don’t need an app just for that […] it’s not like you need to check it every day” (MSM, 16-25 
years). In favour of apps however was convenience and immediacy, especially if it could do more 
than just provide information (e.g. appointments or remote clinical consultation), or gave wider 
health information. Social media was less popular with concerns over Facebook or Twitter not being 
anonymous and therefore lacking privacy: “I wouldn’t share my, as much personal information as if I 
come here and I talk to someone” (Female, 21-25 years). However, there were some MSM who said 
they had followed online pages about sexual health, and seen adverts about sexual health 
promotion advertised through Facebook. More specifically, MSM targeted apps or websites such as 
Grindr were suggested as good places to have sexual health information. Online formats were 
viewed as convenient, could be accessed as and when needed, however there was a concern that 
they needed to be a reliable source to ensure anonymity.  
One-to-one ‘chatting’ interventions were well received and most participants indicated it was their 
favoured option. Being face-to-face and the element of human interaction was important (“the thing 
about, you know, chatting to a human is, they're receptive”, Male, 16-20 years), and the ability to ask 
questions in a tailored session. The need for the session and what people expected to get out of it 
was related to their trust in the healthcare provider, both for the referral and what they would share 
in the session. Negative aspects of this intervention were the possibility of being embarrassed, not 
seeing it as needed and being inconvenient. Most participants said that between 15 to 30 minutes 
would be a good duration. Having sessions by phone had mixed reactions, with many saying they 
preferred face-to-face and privacy from a clinic, while others saw value in the convenience: “You get 
to speak to a real person, you can do it from the comfort of your own home” (Female, 21-25 years).  
 
4.4.4 Patient discrete choice experiment  
A total of 368 eligible patients completed the questionnaire, and 90% (331/368) completed all 
12 DCE questions, resulting in 21,495 DCE observations overall. Of respondents, 43% were MSM and 
50% were young people; compared to GUMCADv2 data from the clinics during recruitment, the 
sample was broadly demographically representative although there were slightly higher young MSM 
(16-25 years) and lower MSM aged 26-50. 52% of the sample was recruited from Brighton, 62% were 
born in the UK and 59% were male; 6 respondents identified as transgender. 46% of respondents 
have had a previous STI diagnosis, with 22% having three or more STI tests in the last 12-months, 
and 22% having had no tests.   
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Twenty percent of respondents (71/368) chose one particular intervention consistently (Table 19). 
However, there was minimal evidence to suggest that a particular attribute level dominated 
participants choices, only a small proportion of respondents always chose the option with the 
shortest duration (up to 15 minutes, <1%), the fewest number of session (one, <1%), sessions 
organised by nurses (<1%) or by other health care professionals (<1%). These findings suggest that 
respondents were ‘trading’ between different intervention options, which is an important requisite 
of DCE studies to be useful. 
Table 19: Dominant responses from 368 participants 
Choice N (%) 
Talking 28 (7.6) 
Online 1:1 1 (0.3) 
Online group 2 (0.5) 
Email or text 34 (9.2) 
Opt out 6 (1.6) 
 
Conditional (fixed-effects) logistic regression (CLOGIT) analysis 
‘Talking’ was chosen as the most preferred intervention option on 40% of occasions. The next most 
frequently chosen option (27% of responses) was the ‘email / text’ based design. The opt-out option 
was preferred on <10% of occasions (Table 20). 
The CLOGIT model explained more of the variation in the data than a model with no independent 
variables (likelihood ratio chi-square test, p<0.0001). McFadden’s pseudo R2 was 0.13, indicating that 
the model fitted the data moderately well 125. It also predicted 42% of choices correctly and the signs 
on the model coefficients were logical, offering a degree of plausibility to the underlying model (e.g. 
people preferred shorter to longer sessions). 
The analysis showed that respondents generally preferred interventions over ‘opting out’ (Table 21), 
with ‘talking’ interventions the most clearly favoured option (OR 1.45; 95%CI 1.35, 1.57 versus ‘email 
or text’). Face-to-face group sessions were generally less preferred to individual face-to-face sessions 
(OR 0.66; 95%CI: 0.57, 0.78) or to ‘one-to-one phone calls’ although the latter comparison did not 
achieve statistical significance (OR 0.87; 95%CI 0.73, 1.02). Respondents generally preferred fewer 
sessions to more sessions, and shorter sessions were more highly valued than longer sessions. 
Respondents indicated a strong preference for sessions to be facilitated by healthcare providers 
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than peers (OR 0.53; 95%CI 0.46, 0.60), but they did not express a clear preference on the type of 
health care professional. 
Table 20: Actual versus predicted results 
Choices Actual N (%) 
Predicted N (%) 
CLOGIT LCM 
Talking 1,740 (40.5) 3,225 (75.0) 2,071 (62.5) 
Online 1:1 547 (12.7) 0 179 (5.4) 
Online group 519 (12.1) 0 35 (1.0) 
Email or text 1,148 (26.7) 1,074 (25.0) 856 (25.8) 
Opt out 345 (8.0) 0 171 (5.2) 
Total 4,229 4,229 3,312* 
*The latent class model (LCM) only includes responses where demographic data were complete 
 
Table 21: CLOGIT results 
 Dummy coded Effects coded 
 ORs 95% CIs p-value ORs 95% CIs p-value 
Online Group* - - - 0.42 0.38, 0.47 <0.001 
Online 1:1* - - - 0.44 0.40, 0.49 <0.001 
Talking* - - - 1.45 1.35, 1.57 <0.001 
None* - - - 0.30 0.26, 1.34 <0.001 
F2F Group - - - 0.66 0.57, 0.78 <0.001 
1:1 Phone 0.87 0.74, 1.02 0.08 - - - 
Sessions 2 to 3 0.76 0.68, 0.84 <0.001 - - - 
Sessions 4 to 6 0.60 0.54, 0.66 <0.001 - - - 
15 to 30 mins 0.85 0.77, 0.93 0.001 - - - 
30 to 60 mins 0.59 0.53, 0.66 <0.001 - - - 
Nurse 1.01 0.90, 1.15 0.76 - - - 
Peer 0.53 0.46, 0.60 <0.001 - - - 
*Alternative specific constants indicating the strength of preference for individual labels relative to ‘emails / 
texts’ 
Latent class model (LCM) 
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Three classes were identified for the LCM. It predicted a higher proportion of correct choices than 
the CLOGIT analysis, 73% (2,419/3,312) and was more flexible in terms of the options it predicted. 
None of the sociodemographic variables were predictive of class membership, and were therefore 
omitted from the final model.  
Participants in the classes were similar in how they valued the number and length of sessions, the 
choice of facilitator and whether or not meetings were one-to-one or group based. However, they 
differed in terms of their preferred intervention method ( 
Figure 5). Participants who were more likely to be in class 1 (60%) favoured ‘talking’ interventions, 
although all other options were preferred to ‘nothing’. Those who were more likely to be in class 
2 (14%) had a general preference for ‘opting out’, although their next strongest preference was also 
for ‘talking’ interventions. Respondents who were more likely to be in class 3 (26%) demonstrated a 
preference for ‘email or text’ based interventions compared to all other options.  
 
Figure 5: Latent class model results 
 
 
*Indicates ORs are effects coded, otherwise they are dummy coded; label percentages indicate the proportion of 
respondents likely to be in each class; log likelihood -3,547; McFadden’s pseudo R2 = 0.33 
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4.5 Discussion 
We conducted a mixed method assessment of current triage and sexual risk reduction interventions 
offered through sexual health clinics and the acceptability and feasibility of the brief interventions 
identified in the literature review. We found agreement between healthcare providers and service 
users in terms of intervention acceptability and preferences, and identified key barriers and 
potential opportunities related to the delivery of brief behavioural interventions in SH clinics.  
 
4.5.1 Current practice 
We found that most services at the time of interview and the web-survey (September 2015 – June 
2016) reported to offer some form of sexual risk reduction interventions. Most of these took the 
form of brief one-to-one sessions conducted in clinics, delivered by health advisors in GUM clinics 
and nurses in Brook clinics. The smaller level-2 service staff, such as in enhanced GP services, 
reported seeing mostly uncomplicated and low-risk patients and referral to GUM services was the 
primary approach to intervention. In addition, clinics who did not currently report offering brief one-
to-one sessions viewed them as a desirable intervention, with the main barriers being resourcing 
(trained staff, and staff time).This is in-line with NICE recommendations that high risk patients 
should be offered brief sessions.117 Brief one-to-ones were seen by HCPs as being effective, 
acceptable to patients and allowed for tailoring of interventions; notably, patients concurred that 
the ‘human factor’ and tailoring of a one-to-one was important.  
Similarly, three quarters of clinics in the web-survey reported conducting some form of triaging of 
patients based on sexual risk. However, no service reported using a standardised triage based on risk 
modelling, as we proposed in this study, and triaging embedded into EPR systems was again not 
common. As triaging is already routine practice, this resulted in many HCPs seeing it as acceptable; 
this also meant that many HCPs commented that they did not see the point of a model based triage. 
While clinical risk scores, based on predictive modelling of population data, has been implemented 
in some specialties (e.g. cardiology,126 intensive care medicine127), it has not be rolled-out in sexual 
health previously. In order to change sexual health clinic pathways to triage based on models rather 
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than clinical experience or expert opinion, would likely require strong evidence and HCP 
engagement.  
 
4.5.2 Opportunities 
Several opportunities for risk reduction interventions were raised by both HCPs and service users. 
Firstly, service users showed a preference for having any intervention over having no intervention, 
with <10% of patients in the DCE opting for no intervention. Similarly, healthcare providers saw the 
role of sexual health services as prevention, and not just treatment. This supports risk reduction 
interventions are being acceptable in general.  
There was agreement between HCPs and service users around brief one-to-one sessions being 
generally preferred. During interviews with health advisors, many felt that one-to-one sessions were 
beneficial to patients, although acknowledged that patient motivation was important, and that they 
were part of a health advisors role. These ‘talking’ interventions were the most preferred by service 
users, based on the DCE, with fewer sessions, shorter sessions and healthcare provider facilitation 
being preferred. As clinic resources were raised as a potential challenge to delivery of interventions, 
conducting a single brief session would suit both service providers and users.  
Again, digital interventions were seen as favourable by both service providers and users, although 
reasoning for finding this intervention type acceptable differed. HCPs highlighted the benefits of 
digital interventions as not being resource intensive and perceived patient preference. Service users 
highlighted the convenience of online interventions, and many reported having gone online to find 
information before attending the clinic.  
 
4.5.3 Barriers 
The main barriers raised by HCPs revolved around resourcing and patient motivation, while the key 
concerns of service users related to privacy and the need or usefulness of an intervention. During 
the course of this study, changes to commissioning of sexual health services were on-going, with an 
overall decrease in sexual health service funding nationally. These decreases were not consistent 
across local authorities, with some reductions in services as high as 20%, alongside an overall 
increase in GUM attendances.128, 129 One area which was highlighted as suffering from these cuts to 
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funding is a reduction in the number of health advisor positions within GUM clinics. The role of 
health advisors includes partner notification as well as delivering sexual risk reduction interventions. 
At the time of data collection, services highlighted a lack of staff time and a lack of trained staff in 
motivational interviewing (MI) as key barriers to delivering risk reduction interventions. With on-
going cuts to funds and services, it could be anticipated that these resource constraints persist and 
even increase, making a currently feasible intervention unfeasible.  
The need for privacy was crucial for service users, and this was reflected in the preferences for 
intervention types (i.e. group, social media and peer led interventions being less favourable). Also 
important to service users was trust in healthcare providers, and the need for any interventions, 
especially digital interventions, to be seen as NHS supported or endorsed.  This is similar to other 
studies, who have found that trust of online resources is important to patients,130, 131 and therefore 
any digital intervention would need to be seen as trust-worthy. Based on the literature review in 
WP1 (Chapter 2), none of the digital interventions were developed in the UK or within the NHS. This 
may prove a barrier to service user engagement if they deem these digital interventions as 
untrustworthy.  
Many clinics reported having EPR systems (86%); however types of system was not universal which 
may prove a challenge for implementing a standardised, model-based triage approach. EPR 
providers were diverse, and there were different clinic experiences in adapting these systems. In 
order to trial an EPR based triage adaptations would need to be made to multiple systems and 
would be limited to clinics with functioning systems – a potential bias.  
Based on the clinic staff interviewed and web-survey responses, we observed a lot of heterogeneity 
in current services offered, triaging pathways and resourcing. The aim of this project was to 
determine feasibility of delivering a package of brief behavioural interventions within existing 
resources in a sexual health clinic setting. Therefore, a key barrier that we can anticipate in 
determining feasibility is whether different types of services (e.g. level-3 and level-2) and services 
commissioned by different local authorities, which have different funding structures, will be able to 
deliver these types of interventions. This would be both a challenge to intervention delivery, as well 
as intervention evaluation.  
 
4.5.4 Strengths and Limitations 
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In both service user and service provider interviews, we reached data saturation regarding 
intervention opportunities and barriers, despite not reaching the targeted sample of 30 interviews 
with providers. We were unable to recruit the pre-determined number of level-2 providers, and 
therefore this service type had less representation that we had planned. The interviews with 
providers and service users were conducted by three female researchers, which may have 
influenced the responses, especially amongst MSM or young men. However, we saw agreement 
between reasons for preferences between young women, men and MSM, and also with service 
providers. We also saw agreement between the qualitative interviews and the quantitative surveys 
conducted (triangulation), adding strength to our conclusions.   
The response rate for the web-survey was poor, and therefor the results may not representative of 
sexual health services nationally. We attempted several methods to improve the response rate to 
the survey, including personalised emails and dissemination at a national sexual health conference. 
Neither of these approaches resulted in significantly increased responses. We contacted clinics 
directly by email, using a list of contacts provided by PHE and supplemented by a list compiled 
during a PhD project. We found that many of the email addresses were no longer in use as staff had 
moved on, that the person indicated was not an appropriate primary contact for the clinic or there 
was no contact email available. Particular examples of no contact being possible were services which 
had been tendered by local authorities to private companies or charities (e.g. all services run by 
Virgin Care). Therefore, several clinical services were unlikely to have been reached, and these may 
not be representative of other services (e.g. tendered to a private provider or with high staff 
turnover).  
A limitation of the DCE was the ASC odds ratios were generally large in comparison to the attribute 
levels. This suggests either the intervention characteristics are generally less important to people 
than the overall format or important attributes and levels were omitted from the design. The 
attributes and levels were selected on the basis of the qualitative interviews, and therefore based on 
evidence. We chose not to estimate whether people were more willing to, for example, spend 
30 minutes talking with someone than answering questions online when all other factors were held 
constant (so called alternative specific parameters). This meant that the estimated parameters, such 
as the duration of each session, were common across the intervention options. However, it is 
possible that people would value their time differently depending on the intervention type that they 
are considering. Third, a number of options, such as having videos in clinics and distributing leaflets 
containing health advice, were excluded from the final DCE design, despite being in the literature 
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review. Videos were omitted based on the interviews and therefore the results of the DCE are driven 
by the validity of the findings from the service user interviews.  
 
4.6 Conclusion 
Clinics across England, at the time of data collection, offered a range of risk reduction interventions, 
with one-to-one motivational interviewing being the most common and most desired service on 
offer. However, contrary to guidelines, high risk individuals were not being provided with additional 
risk reduction interventions uniformly, and we found a high level of heterogeneity between services. 
We found similar preferences and concerns raised by providers and service users about different 
intervention formats. One-to-one sessions were viewed favourably as an intervention format, with 
the ability for tailoring being very important. This was followed by digital intervention approaches, 
which were seen as convenient. Videos, which were found to be effective in reducing STIs and risky 
behaviours and increasing testing in the systematic review, were viewed with mixed feelings by both 
providers and service users. Finally, peer-based interventions were not popular, both for logistical 
reasons by providers and privacy concerns by service users.  
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Chapter 5: Work Package 4 – Choosing and adapting the components of the intervention 
5.1 Background 
As anticipated in the methodological plan (Figure 6), at this stage in the project the following had 
been completed:  obtaining the views of stakeholders, including service users and staff who deliver 
interventions; conducting a review of available interventions. We had information as to what 
interventions were potentially acceptable, practically feasible and sustainable over time.34  
Having completed work packages 1, 2 and 3 we had the basis for the next step in the IM process, to 
complete the intervention selection. This would allow the manualisation of the one-to-one 
component of the intervention package, although as discussed above the digital intervention was 
not immediately available.  
 
              
  
WP1: 33 RCTs of 
brief behavioural 
interventions 
identified 
 
WP2: Routine 
demographic and 
behavioural data 
can be used to 
triage STI risk 
 
WP3: HCP and 
patient 
preferences for 
interventions seen 
  
  
 
      
 
  
  
WP4: Intervention adaptation 
  
  
          
  
  
WP5: Pilot and assess interventions 
  
  
       
  
  
WP6: Refine and design of RCT 
  
              
Figure 6: Summary of the work packages contributing to the Intervention Mapping process 
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5.2 Aim 
The aim of this work package was to select, adapt, if required, and manualise an evidence-based 
suite of interventions that could be combined and delivered as intervention packages to meet 
individual needs.  
 
5.3 Method 
5.3.1 Intervention mapping 
This work package brought together the three central steps in the IM, as set out below: 
1. Mapping of intervention objectives (i.e. main outcomes) onto psychological, behavioural and 
environmental determinants or change processes 
2. Selecting techniques and strategies to modify the determinants of behaviour based on an 
understanding of change processes 
3. Selection and construction of intervention components and materials 
 
The process had begun with the systematic review (Chapter 2 - WP1), which was used to identify 
potentially effective intervention components and change mechanisms that may be critical to 
intervention effectiveness. We identified pre-existing intervention materials which appeared to be 
effective in reducing STIs and risky sexual behaviour that would be appropriate for UK clinic settings 
in order to identify ‘best bet’ techniques and strategies. Findings from WP3 (Chapter 4), from both 
service providers and users, were used to prioritise intervention approaches and components 
according to preference, likely engagement and pragmatic resource constraints. 
 Decisions on the intervention package design and components were made through a series of face-
to-face group discussions with the intervention development team (CL, CA, AR, MS, CK, LC, JB, SA 
and AP), and feedback sought from the PPI group. Three meetings were held as part of this iterative 
adaptation process, supported by on-going broader discussion with the PSC and PMG.  
 
5.3.2 Service user input 
Focus group discussions and semi-structured interviews were conducted with service users, to 
present candidate interventions and stimulate discussions about: how best to adapt to each group; 
103 
 
feasibility of delivery; likely uptake - and therefore inform the on-going IM process. Candidate 
interventions for discussion were shortlisted by the intervention development team and shared with 
the PPI group prior to seeking service user input.  
Participant selection: We used a sampling framework, with quota sampling based on sexual 
orientation, age and gender (including MSM and young people) to gain a broad range of opinions. 
Four groups were defined: MSM <25 years, MSM > 25years, young heterosexual women, young 
heterosexual men. Approximately 6-8 participants (n=24-32 in total) were invited to attend for each 
group.  
Recruitment: Participants were recruited from the sexual health service and community settings 
through posters and leaflets for group discussions. Young heterosexual men were purposefully 
approached and recruited from SH clinics for individual interviews due to lack of uptake for group 
discussions. All participants were recruited in Brighton for pragmatic reasons.  
Data Collection: Written consent was taken prior to the focus group discussions or interviews 
starting, and all discussions were anonymous. Each FGD was planned to last 45-60 minutes. 
Discussions were facilitated by two researchers trained in focus group methodology and were 
transcribed verbatim. Interviews were planned to be 30 minutes, and were conducted by a single 
researcher. Patient participants received £20 as recompense in line with current practice. 
Analysis: We used the same analysis approach as described in Chapter 4 (content analysis, using a 
framework approach).  
 
5.3.3 Manualisation 
The intervention package was manualised to define specific and replicable modes of delivery with 
underlying behaviour change mechanisms. As there is a need to translate effective behaviour change 
interventions from research settings to clinical practice, the manual provides recommendations for 
implementation in a clinical context, such as role play examples. A training plan was developed as 
part of the intervention manual in collaboration with clinical staff.  
The manual was shared with the management team, PPI and steering committee for feedback, and 
shared with clinical staff from MMC, Archway, Claude Nicol and Brook services for feedback.  
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5.4 Results 
5.4.1 Selecting intervention components 
Intervention types were selected, using both the preferences of service providers and users 
presented in WP3 (Chapter 4), and prioritising behaviour change needs according to the overall 
objective of adapting a package of interventions that would lead to a reduction in STIs. The 
conclusions of the prior work, that set the scene for this stage in the project were summarised as 
follows: 
 There is evidence that a range of intervention formats, including brief motivational 
interviewing sessions, digital interventions, educational videos and home testing kits, can 
lead to moderate reductions in STIs and risky sexual behaviours. 
 Delivery of sexual health promotion tailored to risk was mostly acceptable to providers and 
patients, and model-based triage algorithms showed moderate discrimination. 
 One-to-one talking and online interventions were acceptable to service users and seen as 
feasible by HCPs, however resource limitations favoured fewer and shorter sessions (brief 
behaviour change interventions [BBCI]). 
 Waiting room videos, group sessions and peer-led interventions were undesirable and posed 
resource and pragmatic challenges. 
Based on these broad conclusions this part of the IM process focussed on one-to-one brief sessions 
only for patients considered to be at higher risk, as this would be resource intensive; and a digital 
intervention for all patients regardless of risk, as a low-resource intervention. Evidence generated to 
this point suggested this approach would be both acceptable and feasible within the current NHS 
sexual health environment. Further refinement and adaptation of existing interventions is presented 
below.  
 
 
 
Brief one-to-one consultation 
Reasons for choosing this intervention included:  
 One of the effective approaches identified in the WP1 systematic review  
 Clear front runner from the process of WP3  
 Already in place with most of the clinics interviewed currently offering these 
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 Most participants had favourable opinions about it 
 Needed to be conducted in a personal and private space 
For MSM, there were three effective trials which used a one-to-one approach, with counselling, 
motivational interviewing (MI) and personalised cognitive counselling.52, 72, 73 For young people, two 
effective interventions used this approach, and one trial included both young people and MSM.54, 55 
Of these five effective trials, the intervention manuals were available for three. Through round table 
discussion, the conclusions from WP3 were used to refine and select the intervention components 
from these trials to make decisions about the format and content of sessions. For example, 
personalisation was considered important to patients and therefore this influenced the decision as 
to how the session would be structured. We decided the one-to-one approach would use the most 
appropriate components of all the available manuals for both MSM and young people, and apply 
these to the needs of both groups. This was based on the finding that generally the needs, risk 
perception motivations and preferences for delivery were similar between young people and MSM. 
It also supports the flexible nature of the one-to-one approach.  
In the interests of equitable delivery, the intervention was designed to be offered to all service users 
at high risk, regardless of their motivational assessment, a key barrier to delivery raised by providers 
and service users. The focus of the sessions would then initially be on identifying ‘what aims need to 
be achieved in this session and how to do it’, including a checklist of conversation topics and their 
level of motivation. Consultation tasks might include risk assessment (e.g. patients’ individual risk 
level, the kind of problems they encounter) and provide normative or attitudinal information based 
on their risks. If the person is already motivated, i.e. understands their risks and wants to change, 
then this process could be skipped and refocussed on ‘what can you do’, e.g. condom use. The 
sessions will draw on motivational interviewing principles but not attempt to deliver motivational 
interviewing per se. The lack of trained staff time was a key barrier to delivering interventions. It was 
therefore concluded that the intervention should be consistent with MI principles, but without 
requiring intensive MI skills training. This would make it more likely to be feasible.   
We sought service user input on the duration and proposed that the intervention would be a single 
session, designed to last 20-45 minutes, dependent on need and motivation. The decision to have a 
single session was based on the need for the intervention to be pragmatic, able to be delivered 
within existing resources. Service-user also suggested that multiple sessions would be a barrier to 
patient attendance and engagement. We acknowledge that service users may be referred for health 
promotion or partner notification on future clinic visits; even though we decided on a single session, 
we planned for these to be adaptable and that additional booster sessions could be offered through 
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the use of action plans to be included in patients’ records on an EPR system. These decisions and the 
overall design attempt to standardise what many HCPs reported they were already doing and adds 
evidence-based structured elements to enhance this. 
Motivational Interviewing is a collaborative, goal-oriented style of communication with particular 
attention to the language of change. It is designed to strengthen personal motivation for and 
commitment to a specific goal by eliciting and exploring the person’s own reasons for change within 
an atmosphere of acceptance and compassion. We prioritised a focus on listening for Change Talk 
within Motivational Interviewing (DARN-C).132 Identifying and working with patients’ change talk is 
essential for moving from exploration and motivation to directional change. The consultation was 
not intended to add additional consultations to the clinic service, but rather to provide a way of 
structuring usual discussions with high-risk clinic attendees as identified in a standardised way by the 
triage algorithm.  
 
Brief one-to-one manualisation 
In order to provide a pragmatic, effective and time-efficient intervention, the one-to-one 
consultation was structured to suit HAs existing experience with MI by providing a sequence of five 
linked key steps (Figure 7) that target specific needs and provides a menu of effective intervention 
strategies (Box 2).  The five steps are:  
 Step 1: Eliciting and identifying patient’s current needs  
 Step 2: Matching needs to any of the motivational intervention strategies we have provided; 
for example, using supplemented MI techniques to: provide information; talk about the 
patients attitudes; talk about risks and consequences; and /or talk about what others do and 
approve of.  
 Step 3: Collaborating with the patient to set specific goals 
 Step 4: Engaging the patient in barrier identification and problem solving in relation to their 
goals (overcoming barriers) 
 Step 5:  Setting specific action plans and discussing self-management approaches helpful to 
goal enactment and further skills development such as: Increasing self-efficacy/ ability; 
enhancing condom use skills and/or increasing self-management using If-Then planning. 
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Figure 7: Santé Task List - Leading the patient through change - The 5 step pathway for Young People and MSM (based on strategies described in Box 2) 
Behavioural 
Goal 
Outcome 
Intervention 
steps 
Step 1 Step 2 Step 3 Step 5 Steps beyond feasibility trial 
Motivational 
interventional 
strategies  
Providing wanted 
information  
Talking about patients 
attitudes  
Elicit and identify 
patient needs 
Talking about risks and 
consequences  
Talking about what 
others do and approve 
of 
Problem 
Solving in 
relation to 
goals 
Further skills 
development 
e.g. self-
management, 
interpersonal 
or 
behavioural 
skills  
Collaborate to 
set goals  
Action 
Planning 
Correct use of 
condoms 
Reduction 
in STIs 
Consistent use 
of condoms 
Reduction in 
partner no. 
Step 4 
Remember: Use 
your MI skills to 
elicit and deliver 
interventional 
strategies 
Post-motivational Interventional 
strategies  
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Digital online intervention:  
Reasons for choosing this intervention type included:  
 One of the effective intervention types identified in the systematic review  
 Favourable to service providers due to the limited demand on available resources  
 Favourable to service users due to the convenience, however participants were worried 
about discretion of an app on their phone and therefore generally preferred websites 
 Some clinics already refer participants to websites and/or are in the process of developing 
digital services.  
Intervention Mapping identified effective trials that used some form of digital intervention: three 
trials that were effective in young people, and five that were effective in MSM. However, of these 8 
trials only two had any intervention materials available (Figure 8). None of the effective 
interventions identified in WP1 are currently available online.  Downs et al. was developed in the US 
and used videos to present relationships and sexual health education, but at the time of our study 
this webpage was being updated and required individual user-fees for access 57. The need to adapt 
to a UK NHS setting, individual user-fees, and cultural differences in the content were barriers for 
use. The second intervention with available content was Mevissen et al. which consisted of a virtual 
clinic consultation 69. However, the virtual clinic was developed in the Netherlands; adaptation 
would have required considerable resources to translate into English and the NHS setting, and was 
not available free for research use.  
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Figure 8: Summary of RCTs available for adaptation in the intervention mapping process 
 
Therefore, there were no evidence-based digital interventions which could be used ‘off the shelf’. 
We consequently decided to develop a webpage that could function as a portal to selected web-
resources, and be piloted to measure acceptability and engagement. But this would not be an 
evidence-based risk reduction intervention. We decided this would include customised links to 
trusted web resources, which would tailor content to users via brief demographic screening 
questions, as the personal aspect was important to service users. Place-holders from legitimate 
bodies (e.g. NHS Choices) were discussed for inclusion, and we sought recommendations from 
healthcare providers and our PPI group. Figure 9 shows the stand-in screening page which directed 
patients to the targeted webpages.   
 
33 RCTs identified
24 effective trials
14 trials with some 
material available
5 brief 1:1 0 MSM online2 YP online
3 trials have no intervention materials 
(e.g. self-testing intervention)
13 showed no statistically significant outcomes
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Figure 9: Screening page of the Santé Project custom-built webpage 
 
5.4.2 Intervention refinement and service user feedback 
All three aspects of the suite of interventions (triage process, one-to-one intervention, on-line 
intervention) were detailed in a manual, which presented technical behavioural language in user 
friendly terms suitable for clinical staff to use with their patients. This was then taken to service user 
focus groups, health advisors and the PMG for their input. Three focus groups were successfully 
completed with MSM of all ages and young women, in community settings. We were unable to 
recruit young heterosexual men to a focus group discussion, therefore we recruited them to semi-
structured interviews within the clinic, successfully completing four interviews (Table 22).  
Table 22: Summary of service user focus group discussion and interview participants 
Group Number Age (range) Sexual orientation Ethnicity 
MSM >25 5 26 – 46 
Gay (4) 
Bisexual (1) 
White British (5) 
MSM <25 4 18 – 21 
Gay (3) 
Bisexual (1) 
White British (4) 
Young men 4 16 – 22 Heterosexual (4) 
White British (3) 
Asian (1) 
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The process of being triaged, one-to-one MI, and on-line intervention strategies were presented for 
discussion. Due to the lack of availability of trialled online intervention materials we presented print-
outs of website home pages from a range of health promotion web services, which were either of 
known repute, those recommended by our PPI group, or which had relevant intervention 
components, alongside those identified from the systematic review. The following webpages were 
presented to young people: 17 days;57 Family Planning Association (FPA); the Mix; Brook; NHS 
Choices. The following were presented to MSM: Terence Higgins Trust (THT); Gay Men Fighting AIDS 
(GMFA); MenSS;133 NHS Choices. 
 
Triage process 
Most participants felt the offer of a one-to-one intervention could be appropriate and acceptable 
(especially to ‘others’ and ‘the younger ones’), but was contextualised with significant considerations 
when participants spoke of their own perspectives.  At least two participants, both young males, 
were anxious that the offer of an intervention by an HCP would be ‘scary’ and make them feel 
‘stressed’.   However, such an offer was felt to be more acceptable where a diagnosis underlined the 
relevance and value of the offer. Where offering an intervention was seen to be normal practice, 
and was conducted confidentially, this was seen to reduce the anxiety of being specified.   
“It depends if you’re being singled out or if it’s the same for everyone […] If they say, because of X, Y 
and Z, we think this and it’s done in a normal, generic way - that will be more relevant”. (MSM, > 25 
years group) 
The most frequent factor cited as a positive influence on the acceptability of an offer was patients’ 
perception of the value or need for an intervention. Motivating factors were identified or articulated 
as: perception of risk (and potential impact of infection); an STI diagnosis; and recognition of the 
clinic’s supportive and person-centred approach (‘not just tick a few boxes’). Across MSM and young 
people there were repeated expressions of the desire for services that addressed them as individuals 
with specific and distinct needs. Participants also speculated that the refusal by some patients to 
engage with personal risks would be a key factor in their response to the offer of an intervention, 
and this was considered to be a greater concern for younger patients, particularly according to older 
MSM.   
One-to-one consultation: 
Young women 5 18 – 21 Heterosexual (5) White British (5) 
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The offer of a health advisor appointment was considered acceptable by participants, but was only 
seen to be viable where the patient recognised there was sufficient need or value and that the 
content would be relevant. Participants expressed little appreciation of the value or purpose of 
speaking to an HA in the absence of an immediate and explicit need, such as an STI diagnosis.  
Younger participants in particular discussed the value and preferences for the timing of an HA 
intervention. There were diverse and divided opinions across and within groups, but most preferred 
an intervention to happen straight away, primarily due to other demands on their time. Younger 
participants also acknowledged the risks of forgetting and not coming back, and not wanting to 
provide phone numbers to clinics.  
Opinions on the ideal length of an HA consultation varied between 20mins and 1 hour, with most 
participants suggesting ~30mins was appropriate and acceptable. Web-based interaction with health 
advisors, such as private web-chat or telephone interactions as an alternative to face-to-face 
appointments was popular with all groups. However, the older MSM group specifically valued 
speaking one-to-one on the phone, while the younger groups tended to prefer web-chat 
interactions.  
There were mixed responses to the provision of written ‘Action Plans’ cards as part of an 
intervention. While the value of clarification and a reminder of key points was identified, some 
found them ‘nannyish’ and several participants suggested that paper versions (even at credit-card 
size) would be easily lost or discarded due to confidentiality concerns. The provision of the same 
information via text was recognised as a more effective and preferred method.  
Digital online intervention 
Participants across all demographics valued the internet as a source of immediate, accessible 
information, but it was not typically identified as an arena for exploring sexual behaviour.  However, 
participants clearly expressed a desire for interactive content over static information, which would 
enable them to ask questions specific to their individual needs.  The screening page (Figure 9) 
offered as an example (which asked for age, sex, and sexual orientation) was acceptable and valued 
by to all groups and interviews. However, any use of log-in details was seen as frustrating and off-
putting. 
There was a high level of respect for NHS web content across all groups, which was considered 
reliable and factual.  This however went hand-in-hand with a prevalent perception that NHS 
websites would also be wordy, static and unengaging: “…the NHS is gloriously boring and matter of 
fact” (MSM, >25 years). There was widespread recognition that a risky degree of unreliable 
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information existed on the Internet; however, the availability of interactive content (‘The Mix’ and 
Brook’s ‘text/web chat’) appeared to override concerns about the reliability of information on these 
(mostly) unfamiliar sites.  Younger participants expressed enthusiasm for the youth-focussed 
presentation of these sites, and the opportunity to ask questions via text/web-chat appeared to 
override or displace previously expressed caution about reliability.   
The MSM focus groups were shown the following webpages: Terrance Higgins Trust (THT), Gay Men 
Fighting AIDS (GMFA), NHS Choices (‘Sexual health for gay and bisexual men’), Men’s Safer Sex 
(MenSS 133). Familiarity with some of these sites may have influenced responses, but a key issue of 
participants being able to personally identify with sites repeatedly appeared.  The site for men of any 
sexual orientation (‘MenSS’) was largely dismissed due to the prominent image of a woman’s lips, 
but was thought potentially useful to younger bisexual men or men not fully embracing a gay 
identity: “This definitely looks predominantly targeted to straight people” (MSM, >25 years). 
Participants appeared less engaged with sites that primarily offered static information, and 
advocated more dynamic content.  The expression of risks as ‘slip-ups’ in the MenSS website was 
appreciated as an alternative to ‘risk’ when discussing future experience, and the use of narrative to 
engage readers was briefly raised in the older MSM group.  But even in this group there was little 
understanding or interest in behaviour-change interventions and most discussion centred on 
websites as sources of information. 
“…that is, for most people, what happens.  They slip up.  And they may get a reminder to plan, so I 
go, all right, yes.  Because, again, it’s for that person to kind of go, ‘All right, yes, I’ve got to plan 
this’.”  (MSM, >25 years) 
The THT page was largely dismissed and disregarded by MSM participants as being visually too busy 
and oriented to the charity’s fundraising needs: “THT is clearly about health fundraising.  That first 
page is just saying to me, ‘We’re a charity’, and I wouldn’t have even thought about going to there 
for social advice” (MSM, >25 years). The GMFA page was acceptable to some, but others (especially 
younger participants) considered the presentation of a man in underpants too sexual: “…going back 
to the idea again, of wanting to be represented; I am put off by the whole beautiful people thing and 
to me, it just seems too sexy to be educational” (MSM, >25 years). 
The young people were shown the following webpages: Family Planning Association (FPA), Brook, 
NHS Choices (‘Live Well: Sexual health’ page), The Mix; and Seventeen Days (women only). 
Preferences did not differ greatly between male and female participants. The FPA site was dismissed 
in the female group with little comment and the male one-to-one interviews took little notice of this 
page, referring only to its potential for factual information, and its off-putting status as a charity: 
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“Like maybe, people will get the wrong idea of, ‘Oh I have to donate something to the cause’, or 
something. For me personally if I see something, ‘oh charity, oh no, I need to avoid it’” (Young 
person, male). 
Interactive opportunities were more popular than static information pages, and the option of a web-
chat facility on the Brook home page was enthusiastically focused on by both men and women, for 
two key reasons: the flexibility to contact someone at the patient’s convenience, and the arms-
length method of engagement, which was frequently cited as preferable to meeting an HA:  
“I personally think the web chat would be like the best. Being able to just go straight on it and just 
have a professional writing back to you, like with an answer because, obviously, you can search all 
day and still not have an answer for something. So I think that is the best” (Young people, female).  
‘The Mix’ page was popular with the young female group and most male interviewees.  It was seen 
as being addressed specifically to younger people, and this targeted relationship was a significant 
motivator of interest. One young male participant was familiar with this site since it was promoted in 
his school. Positive discussion focussed on key aspects, including its varied content addressing 
diverse aspects of younger peoples’ lives (mental health, STIs, contraception, porn).  The homepage 
tabs: ‘Your Voices’ and ‘Mental Health’ were each mentioned as a valuable feature, despite their 
content not being visible in the single page presented to the focus group: “It’s got everything on it. 
It’s not just banging one thing. It’s got drugs and alcohol and everything” (Young people, male). 
The home-page of the ‘17 Days’ website, which was shown only to the women’s groups, where its 
narrative format and content was swiftly dismissed for its lack of apparent interaction and 
immediacy, and the discussion moved on to the value of getting quick answers to STI-related issues.  
RE2: “Yes, and they [’17 Days’] could be talking about all stuff that you didn't want to even discuss.” 
RE1: “Yes, you just wanted to know one thing and that could be at the end. Maybe too much to go 
through” (Young people, female). 
 
5.4.3 Manual refinement 
Feedback from service users was combined with feedback from the PPI and the PMG, and the 
opinions were used to inform the intervention manual, to produce the final version of a manualised 
intervention package for piloting (Intervention Manual – supplementary material). 
Triage 
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The first step of the intervention package is the application of the triage algorithm presented in WP2 
(Chapter 3). To balance clinic resources with sensitivity and specificity, the risk threshold was set to 
refer approximately 15% of MSM and 5% of young people. The triage was designed to be conducted 
through the clinic EPR system by any member of clinical staff seeing a patient.    
On-line material 
Feedback from service users indicated that a screening page used to direct users to more tailored 
on-line material was acceptable and addressed the desire for services to feel personalised. The 
proposed links received mixed opinions, so we reviewed the links with further input from the PPI 
group. The final lists of links included were: (for young people) ‘The Mix’, ‘MenSS’ and ‘BISH’; and 
(for MSM) THT, GMFA and NHS Choices. Multiple approaches were proposed for advertising and 
referring service users to the webpage, which we recommended: sending a link to patients as part of 
appointment reminder text messages; posters in clinic waiting rooms with the web link up; and 
encouraging healthcare providers to direct patients to the webpage during appointments. All of 
these methods were included in the intervention manual. 
One-to-one consultation: 
The approach proposed to service users during this phase was deemed acceptable in discussions 
across the wider project team and was not amended based on feedback.  
 
5.5 Discussion 
Through an iterative process we summarised and synthesised the evidence from WP1, 2 and 3 and 
consulted with service users and providers to develop the early stages of an intervention manual. 
The underlying ethos of the Santé consultation was based on the collaborative, well-researched 
motivational interviewing approach recommended for use in sexual behaviour change by the NICE, 
and the Society of Sexual Health Advisers (SSHA).  The approach of using an intervention package, 
where a more resource intensive consultation is focussed on those at higher risk of an STI diagnosis, 
was designed to be deliverable within existing resources and current clinic structures.  
 
5.5.1 Acceptability of one-to-one 
There were two overarching contextual factors that came from the qualitative feedback with service 
users: that services are private and non-judgemental, and that content was something participants 
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felt they could identify with. The one-to-one consultation was designed to be adaptable to differing 
patient needs and motivations, therefore addressing the desire for services to feel personalised and 
tailored. However, a contradiction was identified with the offer of a health promotion appointment 
with a health advisor sometimes being off-putting if it was seen to specify the individual patient. 
Systematic triaging, which could be viewed as ‘box-ticking’ was off-putting where it was seen as 
impersonal, and so this raises questions around how triaging could be conducted in a way that 
indicates the value of a personalised intervention, while also avoiding the anxiety that being 
specifically targeted could provoke.  
 
5.5.2 Challenges of digital 
Despite several digital interventions being included in the systematic review, and both service users 
and providers showing some preferences for this intervention format, we could not locate any 
materials that could be used for piloting. Of the two studies trialled with young people that had 
some materials available, one required individual user-licenses with significant cost implications,57 
and the other had a considerable number of components in Dutch only.69 Extensive effort was put 
into contacting authors of other studies that reported effective digital interventions, with the 
intention of adapting any potential resources to the needs of this study. If the Santé intervention 
package were to go to a full trial, a digital intervention would need to be developed or currently 
available options re-visited. A scoping review had found 19 digital interventions for young people 
that had been tested for effectiveness, raising questions about how to access, evaluate, regulate and 
sustain such interventions which quickly become obsolete.28, 134 With digital formats requiring on-
going maintenance, software updates and site management, the potential for off-the-shelf 
approaches to interventions is limited without wider investment and infrastructure.  
The feedback from service users about the various examples of online sexual health information and 
interventions revealed preferences for certain formats, which would be important in the 
development of future online interventions. Notably, from WP3 service users demonstrated a 
preference for websites rather than mobile ‘apps’. Magazine-style websites that featured sexual 
health amongst a range of other youth-oriented content (e.g. abortion, family life, friendship, 
pregnancy, drug/alcohol, parenthood, safe sex) was valued by young male and female participants 
as appropriate and engaging. It may be that this magazine-style of website was the only format in 
which younger participants moved beyond a focus on information-finding and considered the 
potential for explorations of experience and behaviour. Interactive formats, such as webchat (as 
offered by the Brook website), were preferred by younger groups as they enabled engagement with 
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services at their convenience, with the additional advantages of personal distance and anonymity 
provided by the web interface. Charity sexual health websites (THT, FPA) were considered off-
putting due to assumptions that these sites were focussed on, or risked, requests for money, and 
were unlikely to meet their needs.  MSM groups stated that over-sexualised presentation of web 
content (e.g. GMFA) diluted confidence in the content and diminished participants’ engagement 
with the website. Therefore, an interactive resource that contains both information and behaviour 
change approaches, and has varied but relevant non-sexualised content could be most acceptable to 
service users.   
 
5.5.3 Limitations 
In addition to the limitations discussed with the digital intervention, we were unable to recruit 
young male heterosexual participants to take part in a focus group discussion. This was especially 
challenging in the face of cuts to youth services, and after several attempts to recruit individuals and 
access existing youth groups, this method was replaced with one-to-one interviews, recruited and 
conducted in STI clinics. In addition, all participants for group discussions and interviews were 
recruited from Brighton, and therefore their feedback may not be relevant to young people or MSM 
in London or other parts of England. The decision to recruit from Brighton only was a pragmatic one, 
with the aim to gain rapid feedback rather than comprehensive feedback on the intervention 
package. Further service user input on the acceptability of the intervention package was planned for 
the pilot study (Chapter 6).        
 
5.6 Conclusion 
Despite there being multiple trialled interventions with evidence of effectiveness, there were 
challenges in accessing the required materials to adapt them for piloting. This was particularly 
notable for online digital interventions, with only two of the digital interventions identified in the 
review being accessible, and therefore we used stand-in digital content in our pilot study. Both one-
to-one consultations and online interventions were in principle acceptable to service-users as 
approaches to sexual risk reduction. A key feature for MSM and young people was the need for any 
intervention to be appropriately tailored to their specific needs.   
Chapter 6: Work Package 5 – Pilot feasibility trial 
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6.1 Background 
Work packages 1 to 4 aimed to establish whether there are evidence-based brief interventions that 
could feasibly be adapted for use in sexual health settings in England, and delivered within existing 
resources. And having done so, that they could be shown to have an impact on high risk behaviour 
and STI diagnoses (Figure 10). We found that both ‘talking’ interventions, such as brief motivational 
interviewing sessions, and digital interventions were acceptable to service users, and desirable for 
healthcare providers, and therefore this was the focus of our intervention mapping process. We 
developed an intervention manual for the pilot, using co-creation with service users, providers and 
the project management team.  
              
  
WP1: 33 RCTs of 
brief behavioural 
interventions 
identified 
 
WP2: Routine 
demographic and 
behavioural data 
can be used to 
triage STI risk 
 
WP3: HCP and 
patient 
preferences for 
interventions seen 
  
  
 
      
 
  
  
WP4: : Intervention manual developed, including triage, one-to-one 
and place-holder webpage 
  
  
          
  
  
WP5: Pilot and assess interventions 
  
  
       
  
  
WP6: Refine and design of RCT 
  
              
Figure 10: Summary of work packages 1 - 4 
A pilot study was used to gather information about the feasibility and acceptability of conducting an 
RCT, in order to provide information on recruitment, implementation and potential effect sizes.135, 136 
In this case, the pilot was used to investigate whether the adapted one-to-one intervention can be 
implemented as planned in a routine SH setting and if service users are likely to engage with the 
intervention package. The proposed methodology of a cluster RCT also needed to be piloted, as this 
requires both clinic and service user engagement.  
6.2 Aim and Objectives 
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To pilot the intervention package within existing clinic resources, and assess the acceptability and 
feasibility to both HCPs and service users. Specifically, we aimed to address the following objectives 
regarding trial and intervention feasibility and acceptability: 
Acceptability of the intervention to users and HCP  
1. Proportion of eligible service users who attend the clinic that were assigned a score by the 
triage tool  
2. Proportion of those who were classified as high risk who are offered the intervention 
3. Proportion of those who were offered the intervention who took up the intervention 
4. Proportion who took up the intervention who completed the intervention 
5. Reasons for not completing the intervention from the qualitative study of participants  
6. Acceptability of the intervention from the qualitative study of the staff  
Feasibility of delivering the interventions:  
1. The total time spent by service users within the clinical service compared to normal 
2. Total number of service users seen and STIs diagnosed, compared to normal  
3. Average consultation time compared to normal  
4. Number of patients seen by health advisors compared to normal  
5. Extra HCP time required for the intervention  
Feasibility of obtaining follow-up outcome data  
1. Proportion of eligible service users who consented to the follow-up 
2. Proportion of eligible service users who were contactable at 6 weeks and complete a 
questionnaire  
3. Proportion who complete follow-up tests  
 
6.3 Method 
We conducted a prospective pilot of a cluster RCT (cRCT) across multiple sexual health clinics in 
England, from March – May 2017 (Figure 11). The pilot included implementing the intervention 
package, follow-up of service users to obtain biological outcome data, and qualitative feedback from 
service providers and users.    
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Figure 11: Overview of the pilot trial protocol 
 
6.3.1 Intervention Pilot 
We planned to include eight clinics in the pilot, four intervention and four control sites. Clinics were 
purposefully selected to take part, and include level-2 and level-3 services located in different cities 
across England. The study was registered on the NIHR Portfolio, which allows sites to volunteer to 
take part. In a full trial, allocation to intervention or control would be randomised, but was not 
required in the pilot to determine feasibility.  
Participants 
All MSM and young people attending the clinics during the pilot period were eligible to be triaged 
and offered the appropriate intervention. Service users who lacked capacity to self-complete the 
triage were excluded (e.g. could not read English); however a member of the research team was 
present to help with any technical barriers to using the triage assessment tool.  
Intervention 
The intervention consisted of three components, as described in more detail in Chapter 5 (triage, 
online intervention, one-to-one intervention). Participants in the intervention clinics were triaged 
using a risk prediction tool, which was self-completed on a stand-alone tablet computer. Their triage 
result code was printed on a ticket and they were asked by a member of study staff to give the ticket 
to the healthcare provider they saw. Based on their risk score, participants were eligible to be 
offered one or both interventions:  
Control Clinic 
(n = 4) 
Triage tool 
(15% MSM 
5% YP)          
High risk 
intervention 
(1:1) 
6-week 
interview 
and 
testing 
follow up 
Low risk 
intervention 
(digital) 
Qualitative 
interviews  
Process 
data  
Process 
data 
n=300 
n=400 
Intervention 
Clinic 
(n = 4) 
Process 
data 
121 
 
High intensity: patients who scored highly in the triage algorithm for sexual risk were eligible 
to be offered the high intensity intervention. This was a brief 1:1 session with a trained 
member of the healthcare team (expected to be a health advisor in GUM clinics). This 
intervention was designed to be delivered in a single session, lasting up to 45 minutes, and 
on the same day as the participant’s clinic visit.  
Low intensity: this was offered to all patients, whether they scored above or below the 
threshold for referral for the high intensity intervention. This was a web-page designed 
specifically for the pilot trial, containing targeted sexual health information that could be 
accessed either during the clinic visit or at home later (www.santeproject.com – note this 
webpage is no longer active).   
Service users in control clinics received standard of care, which may have involved the offer of a 
behavioural intervention, including a consultation with a health advisor that the clinic already 
provided.  
In the intervention clinics, the healthcare provider that patients saw for their appointment could 
decide whether to refer a ‘high risk’ patient to the high intensity intervention or not. The triage tool 
was set to refer approximately 15% of MSM service users and 5% of young people. This meant that 
MSM with a predicted risk of STI diagnosis >24%, and  >22% in young people were classified as high 
risk, based on the development dataset used in Work Package 2. These thresholds were deemed to 
be feasible in terms of the numbers of service users being referred, and giving a reasonable balance 
between sensitivity and specificity.   
The project protocol and intervention package was presented to all clinical staff in intervention 
clinics during a routine staff meeting. Participating health advisors had a training session (designed 
to be 2 hours) on the intervention manual, including use of role-play. 
Data collection 
Triage data was self-completed by service users, and was collected using Android tablets, through a 
custom-built ODK Collect form. The same variables were collected as those presented in Table 6. 
Anonymised data was uploaded to a secure server. Data about the one-to-one intervention process 
was recorded in the EPR system in Brighton, and on paper forms in Archway. Engagement with the 
digital component of the intervention package was monitored using Google analytics during the pilot 
period. Process data for the number of service users attending the clinics during the pilot period, 
where available, was collected within the clinic existing EPR system.  
Sample Size 
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Based on historical clinic patient data on attendances provided as part of the GUMCAD data return, 
we estimated that a total of 5500 eligible patients would attend four clinics during the 1-month 
intervention period (Figure 12). Based on 70% of patients in the intervention period being triaged, 
an average of 10% being eligible for the high intensity intervention, and 60% then offered 
interventions, we expected 231 patients to be offered the high intensity intervention. Assuming 50% 
accepted the intervention, and then 50% completed it, we estimated 58 patients would complete 
the intervention, with an expected 95% confidence interval of the proportion as 44 to 57%. The 
assumptions for the proportions triaged, offered and accepting the intervention were purposefully 
conservative to reflect the potential for poor engagement with the trial from HCPs and service users.  
 
Figure 12: Flow chart for patient flow through the clinic 
 
 
Analysis 
We planned to describe the proportion of patients who went through each phase of the intervention 
process, comparing clinic types and patient demographics, adjusted for clustering at the clinic level. 
All analyses were conducted in Stata 14.  
 
6.3.2 Interviews and focus group discussions 
Telephone interviews with service users were conducted to explore the reasons for not accepting 
the intervention, or not engaging with the intervention process and how their triage score matched 
their perception of risk.  
Group discussions were held with service providers to explore potential challenges to intervention 
implementation and any feedback on acceptability.  
Assume 50% of those who accept it complete n5=58 
50% who are offered accept intervention n4 = 115
60% of those eligible are offered intervention n3=231
10% of those triaged eligible to receive high intensity intervention  n2=385 
70% triaged  n1= 3,850
Eligible (1 month attendance figures for the 4 intervention clinics)  N=5,500
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Participant selection: We sampled young men and women, and MSM who were attending sexual 
health services and completed the triage process. We sequentially recruited service users who 
scored ‘high risk’, aiming to recruit 24 service users across two clinics.  
HCPs were purposefully recruited from participating clinics to represent both health advisors and 
other clinical staff, with two FGDs planned for each participating site.  
Recruitment: Service user participants were recruited from participating clinics. They were 
approached in the clinic waiting room and given a study information sheet to read before deciding to 
take part. Participants were offered a £20 high-street voucher for taking part. Interviews were either 
scheduled to take place on the day of recruitment, or scheduled for a future time, by telephone.  
Healthcare providers were emailed to invite them to take part in a group discussion.  When there 
was not enough interest to form a group, individual interviews were conducted.  
Data collection: Interviews were by phone and group discussions were conducted within the clinical 
setting. Interviews were designed to last 20 minutes, and the group discussions 45 minutes. Written 
consent was taken at the point of recruitment for service users and prior to the discussion starting 
for providers. Interviews and discussions were audio-recorded and then transcribed using a 
professional service.  
Analysis: We used the same analysis methodology as described in Chapter 4.  
 
6.3.3 Follow-up 
We recruited a sub-set of patients from intervention and control clinics, to be followed 6-weeks 
after their clinic visit with a web-survey and STI screen. The STI screen was either through a postal 
self-sample kit, sent to patient’s homes, or patients returned to the clinic for a ‘quick check’ screen. 
The screen included chlamydia and gonorrhoea, with a urine sample for men and vaginal swab for 
women. The web-survey collected information about their recent clinic visit, including any 
interventions received.  
Participant selection: All young people and MSM attending the recruitment clinics during set time 
periods were eligible for recruitment. There were no sample targets in terms of demographics.  
Recruitment: Participants were approached in clinic waiting rooms and given information about the 
study by a member of the study team or clinic staff. Recruitment was conducted in specified time 
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blocks at clinics, until enough patients consented. The patient’s preference for returning to the clinic 
or being sent a postal self-sample kit was recorded and patient’s self-completed information about 
their age, ethnicity, sexual orientation and contact details. The clinic patient ID was used as an 
anonymised study ID that could be linked to clinic records for processing results. The process was 
standardised across intervention and control clinics, and information posters were displayed in all 
clinics. A total of 75 and 100 patients were targeted for recruitment from control and intervention 
clinics, respectively (Figure 13 – n2).  
Data collection: Recruitment data was collected using Android tablets, through a custom-built ODK 
Collect survey form. Encrypted data was uploaded to a secure server. The follow-up web-survey was 
created using SnapSurvey, with no identifiable information requested. Patients were emailed the 
survey link up to 3 times. The follow-up STI screen was either through a postal self-sample, 
processed by TDL laboratories, or participants returning to clinic. Results were emailed to an 
NHSMail email account, and patients were sent negative results via text message from a study 
phone number. Any positive results were sent to the study coordinator at the recruiting clinic for 
follow-up and treatment according to local protocols. All follow-up data was entered into a 
Microsoft Access database and processed using Stata 14.   
Analysis: We described the frequencies and proportions, by clinic, age group, sex and ethnicity, for 
each stage of the follow-up. Proportions were compared using chi2 and multivariable logistic 
regression.  
Figure 13: Sample size for patient follow-up at 6 weeks 
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*n2 = total for all participating clinics, therefore 400/4 = 100 in intervention clinics and 300/4 = 75 in control 
clinics. 
 
 
 
6.4 Results 
6.4.1 Clinic Participation 
We planned to include four intervention and four control clinics in the pilot (Figure 14), with all eight 
sites recruiting patients to the follow-up STI screen, and the four intervention clinics implementing 
the complete manualised intervention.  Inclusion in the pilot study was discussed with 13 potential 
sites over a six month period. Three sites agreed to be control clinics: Croydon, Durham and Chelsea 
& Westminster; and three agreed to be intervention clinics: Mortimer Market Centre (MMC, 
London), Archway (London), and Claude Nicol (Brighton). Both MMC and Claude Nicol have large 
MSM patient populations, and Archway serves a predominantly young and deprived patient 
population. At each site, a single site lead was identified to support the implementation, and this 
was either the clinical lead or a health advisor.  
Among the intervention sites, we were unable to pilot the intervention package at MMC despite 
their initial agreement, and it was only partially piloted at Archway (Figure 14). We had discussed 
the implementation with the clinic lead, health psychologist and health advisors over a six month 
Intervention clinics - all eligible participants 
(N=5,500)
Sub-sample consented for follow-up 
(n2=400)*
Offered choice of follow-up
Clinic appointment 
n3=150
Completed
n4=90
Postal sample 
n3=150
Completed
n4=90
Control clinics - all eligible participants 
(N=5,500)
Sub-sample consented for follow-up 
(n2=300)*
Offered choice of follow-up
Clinic appointment 
n3=120
Completed
n4=72
Postal sample 
n3=120
Completed 
n4=72
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period before determining that it was not feasible. Reasons given for the inability to implement the 
intervention focussed on the lack of staff resources and physical space within the clinic to see 
patients for a one-to-one session. This had not been raised initially when the sites were selected, but 
the pilot study period coincided with re-tendering of the sexual health services in London, which has 
resulted in a substantial reduction in the size of the service commissioned. At MMC, we tried to 
mitigate the issue of staff-time by offering bank shifts, overtime payments and recruiting temporary 
health advisors as research assistants. None of these approaches were successful in securing 
additional resources within the time available for the pilot. 
We were unable to include any level-2 services within the pilot. One service provider (Brook) were 
willing to participate following discussions with their clinical lead and London and South East service 
manager. We identified 3 potential sites, including both inside and outside of London. In the event, 
there were insurmountable problems that prevented both piloting the intervention and recruiting 
patients for follow-up. These included: implementation of a new EPR system; lack of clinic space for 
recruitment or intervention delivery; lack of staff capacity to deliver the intervention package; lack 
of clinic capacity to process additional test results; loss of one contract leading to closure of a clinic 
and relocation of staff. We contacted four alternative level-2 services, all of whom stated they were 
unable to take part due to concurrent re-commissioning or lack of capacity.  
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Figure 14: Clinic participation in the pilot feasibility study 
*The project was on the CRN portfolio, meaning it was visible to all services who could contact the 
study coordinator to take part. 
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Figure 15: Schematic of the pilot Santé intervention patient pathway 
 
 
 
 
 
  
Patients arrived in clinic 
and were asked to 
complete an electronic 
form before they were 
seen. The triage algorithm was run on 
tablets, and for MSM and young 
people produced a referral 
recommendation. This was printed 
for them to take to their 
consultation (similar to blood 
pressure). 
On the tablet, once the data was filled 
in, all patients were provided with the 
Santé website URL. 
During the consultation, 
the healthcare provider 
checked the patient’s print-
out, and if it indicated they 
were at HIGH RISK, offered 
them a referral to the 
health advisor.  
The triage algorithm aimed 
to refer 15% of MSM and 
5% of young people for 
these appointments. The 
HA intervention was an MI 
based talking intervention. 
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6.4.2 Intervention Pilot 
Triage: 
The original proposal aimed to embed the triage tools developed in WP2 within the EPR systems of 
clinics for the pilot trial. We discussed this proposal with two different EPR software providers 
(MillCare at Brighton, RioMed at MMC and Archway), but these companies were unable to 
implement the triage within either of these systems.  
In Brighton, the feedback from the EPR provider was that the implementation of a triage tool as we 
developed would be feasible but would take considerable coding and configuration, and a minimum 
of 6-months’ development and testing. Therefore, we did not pursue adaptation of the EPR at 
Brighton due to the time constraints. It was also noted that the EPR provider raised concerns over 
our approach, as despite the triage tool parameters already being collected within the EPR system, 
the real-time processing would be computationally intensive (e.g. deprivation quintile is derived 
from a patient’s postcode).  
 
 
At MMC and Archway, the EPR provider indicated that the implementation of the triage within the 
system was achievable and anticipated three-months to develop and pilot the system. Concerns 
regarding the coding or configuration were not raised. Over an eight month period the EPR provider 
developed three iterations of the triage, however none of these were deemed practical, with issues 
of double data entry, burdensome navigation through the patient record, and the removal of 
compulsory fields. Therefore, we were unable to pilot test the triage within the EPR system at these 
sites, and indicates that were this to be pursued then a programme of software development would 
need to be supported and funded by the NHS provider.     
For the purposes of the pilot trial, we developed a stand-alone Android tablet-based system using 
open source software (ODK Collect). This altered the patient pathway from that originally proposed 
such that patients self-completed the triage prior to their appointment, rather than the triage being 
conducted as part of the consultation with a healthcare provider. This system was in place for a 
month before the pilot began so that it could be integrated into the clinic and to allow providers to 
become familiar with the study protocol.  
The triage tool was completed 1,064 times, representing 16% of patient attendances during the pilot 
trial period. Sufficient information to complete the triage process was provided by 1,030 (97%) 
patients, and 612 (59%) were either young or MSM. As study staff asked service users to complete 
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the triage prior to their clinical appointment, we were unable to distinguish our target groups, and 
therefore aimed to have all patients take part. A higher proportion of young people were triaged 
than MSM in both settings (Table 23).  
 
Table 23: Summary of the triage process during the pilot trial 
 Brighton (n, %) 
Total = 925 
Archway (n, %) 
Total = 139 
Young people   
Clinic attendances 1,472  365 
Triage completed 306 (21%) 50 (14%) 
     High risk     50 (16%)     17 (34%) 
     Low risk     256 (84%)     33 (66%) 
Attended one-to-one 10 (20%) 3 (18%) 
MSM   
Clinic attendances 2,369 88 
Triage completed 246 (10%) 10 (11%) 
     High risk     71 (29%)     2 (20%) 
     Low risk     175 (71%)     8 (80%) 
Attended one-to-one 11 (15%) 1 (50%) 
 
The triage tool was set to a risk referral threshold that we had planned would identify 5% of YP and 
15% of MSM to be high-risk, based on the model performance from WP2. However at both sites, the 
triage identified considerably more than this (Table 23). Notably, there was a higher proportion of 
high risk young people at Archway clinic and a higher proportion (and attendance in general) of high 
risk MSM in the Brighton clinic. These risk profiles of the two clinics is not necessarily surprising, and 
likely reflects that the demographics and sexual history of the pilot trial populations differ from the 
development dataset. There was also a lower level of missing sexual history and behaviour data 
from the pilot, compared to the WP2 dataset, and this may have changed the triage tools 
performance. The threshold for defining a high-risk patient  could be adjusted for clinics according to 
the capacity to provide a high risk intervention, but this poses specific challenges for a standardised 
approach to triaging. 
Santé Webpage: 
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During the pilot period, the project webpage was advertised in four ways in both pilot clinics: on 
posters displayed in the clinic waiting rooms; the web address was printed on the triage tickets; 
HCPs in the clinics were informed about the webpage; it was printed on the action plan cards given 
during the one-to-one sessions.   
A total of 24 unique users visited the webpage during the pilot, of a potential 6,805 patients (0.4%), 
with one visitor returning. On average, visitors stayed on the webpage for 38 seconds, and stayed on 
the home page. Two users accessed the webpage using a mobile phone, and all other site visits were 
from computers. Figure 16 demonstrates the age and gender of the site visitors.   
Figure 16: Age and gender of the Santé Webpage visitors (derived from Google analytics) 
 
One-to-one 
At Archway, one HA agreed to work additional bank shifts during the piloting period, meaning we 
could deliver the intervention package two days a week during May 2017. In Brighton, the HAs 
implemented the intervention as part of their routine practice from the 2nd May – 2nd June 2017. 
Training was delivered in two brief (1-hour) sessions at Brighton with the whole HA team present, 
and in a single session at Archway (1-hour). The training included an overview of the study protocol, 
explanation of the intervention manual, and brief role-play exercises using the five steps of the one-
to-one consultation, and the use of the action plan cards.   
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In Brighton, the EPR system was adapted to include information about whether the patient had been 
triaged, the decision on whether the patient was referred for the one-to-one and if they accepted.  
Of the 552 eligible patients who completed the triage process, records for 168 (30%) were entered 
into the EPR system, and this was slightly higher for YP than MSM (31% versus 24%, respectively). A 
total of 21, 0.6% of all potential eligible patients, were recorded as having completed a one-to-one 
session; this represents an average of one patient a day. However, it is possible that more patients 
completed the one-to-one but were not recorded in the EPR. In the HA comments recorded within 
the EPR system, sessions took 5-15 minutes, but this was reported in only a few records. More 
general comments on the content of the sessions, of which examples are given below, showed that 
they covered a range of topics and that patients had a range of motivation around behaviour 
change:  
 “Has made patient realise that it is important to know potential partners well and use condoms, 
especially in early stages of a relationship.” (YP, Brighton) 
 “Triaged wrongly as high risk; one episode of UPAI for which he accessed PEP. No other UPAI. No 
[chemsex]. Consistent condom use and informed” (MSM, Brighton) 
“Discussed risk taking as part of PEP discussion. Patient acknowledges risk behaviour and it is usual 
for him to make decision of knowing partners. Due to alcohol this did not happen this time. Patient 
not choosing to make changes to this behaviour at this time” (MSM, Brighton) 
At Archway, of the 60 eligible patients who completed the triage, 19 (32%) were high risk, and 4 (7%) 
completed the intervention. The four sessions were recorded as taking approximately 30 minutes 
each, but the intervention steps and action planning was conducted in only three. The content of the 
sessions were reported as including condom use, peer pressure around risk behaviours such as drugs 
and contraception with young people, and PrEP, PEP and general STI knowledge in MSM. Amongst 
those who were triaged as high risk but did not attend the one-to-one session, reasons for non-
attendance included the patients not waiting for the appointment, issues with the referral process in 
the clinic and healthcare providers not feeling a referral was warranted.  
 
6.4.3 Service user qualitative feedback 
A total of sixteen interviews were completed, out of the 24 service users consented (Table 24; Box 
4). We were unable to complete eight of the planned interviews as participants did not answer our 
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calls or they declined to take part when we subsequently contacted them. We contacted individuals 
up to three times, by either phone call or text before deeming them lost to follow-up. Reasons for 
participants presenting to the sexual health clinic were: routine check (n=7), contraception (n=4), 
treatment (n=3), and because they were concerned about a recent contact with a sexual partner and 
their STI results (n=2).  
Table 24: Service user participants in pilot study qualitative feedback 
 Young people MSM 
Location 
London = 5 
Brighton = 4  
London = 2 
Brighton = 5   
Age 
<18 years = 2 
18-21 years = 3 
22-25 years = 4 
<25 years = 3 
25-50 years = 3 
>50 years = 1 
Ethnicity 
White = 4 
Black = 2 
Asian = 1 
Mixed = 2 
White = 5 
Asian = 1 
Other = 1 
 
Triage and referral to the one-to-one session: 
All the participants were recruited in participating clinics following their completion of the self-
triage; participants indicated that the triage process was acceptable, although many appear not to 
have understood its purpose. Overall, they felt comfortable with the questions being asked (i.e. 
demographic and recent sexual behaviours), and found that filling in the questions on the tablet 
computer was straightforward.  One of the main advantages was that the tablet was felt to be quick 
to complete and could save time. The discretion of self-completion was also mentioned but not as a 
key issue. 
Although one participant raised a concern about whether the questions took all the relevant 
information about sexual risks into account (MSM, >50 years), no one objected to being referred to a 
health adviser based on the triage tool. However, while conceptually acceptable, there was little 
evidence that the ticket-based system we piloted in lieu of an integrated EPR-based system was 
feasible. Only half the participants we interviewed gave the ticket to the HCP they saw - reasons for 
this failure were: confusion about an unfamiliar process; and forgetting, e.g. “We’re a bit distracted 
when we’re there” (MSM, >50 years). 
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There were mixed experiences amongst those participants who successfully passed their triage 
ticket to the HCP. For example, a young female participant (25 years old) came in for contraception 
and did not expect to talk about sexual risk. Some patients felt the triage ticket prompted a helpful 
discussion about new sexual partners and it could result in them agreeing to have an STI test. Others 
however reported that their HCP did not seem to want the ticket or discuss sexual risk, while others 
spoke briefly with the HCP about sexual risk: “I gave it to, like, my doctor, and she, did a little talk on 
sexual health and stuff” (Female, 22 years). Patients who did not give the tickets to their HCP 
generally reported discussing sexual risk with their HCP regardless.   
Many of the patients who had come for contraception or routine check-ups and neither expected 
nor were offered any health promotion interventions, such as leaflets or the anticipated referral to a 
health advisor. Among patients who were referred to a health adviser based on the triage tool, 
reasons for accepting a referral varied. For example, the opportunity to talk about post-exposure HIV 
prophylaxis (PEP), or to have a general discussion about sexual health and risk behaviours:  
“I found it reassuring that there are services in place that would be, looking out for potential relapses 
with people that come into that clinic” (MSM, 25-50 years) 
 “I think that was good because I feel, if I hadn’t given her the slip, I might not have been told to go to 
the health person.  I think that was good for me, just to speak to someone else as well” (Female, 18-
22 years) 
Santé website 
While there was no indication that patients found the idea of the Santé website unacceptable, only 
one of the interview participants (who had also attended the HA one-to-one), had visited the 
webpage. The young woman who visited the webpage (18 years old) said she went to the website 
for additional information and was happy to do both a one-to-one and visit a webpage.  Other 
participants reported wanting to find specific information from the internet, and a young woman (21 
years old) for example had searched to find out more about her treatment but had not visited the 
intervention website.   
A few participants indicated they might check a website on their phones while waiting for their 
appointments, but would not go back to it afterwards. However, none of the participants had visited 
the website using the link advertised on posters in the clinics or the tickets, and most had not 
noticed the information printed on the ticket. Barriers to this were poor understanding that the 
ticket contains relevant information, and not having the skills or facility to scan the QR code on their 
phone. One young woman stated that she might have been interested in checking the website but 
the HCP took the ticket from her. Participants reported not seeing the posters, among all the 
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displayed information, and being too distracted or busy reading or talking while they waited.  
Texting the web-link (e.g. with the appointment reminder) was suggested as a more effective way to 
promote a webpage. 
One-to-one session 
Very few of the participants we interviewed were referred to see the HA as intended. Participants 
who had previous reported experience of one-to-one sessions typically saw them as worthwhile 
giving them motivation to change and even resulting in behaviour change: “It was something that I 
was already thinking but it just pushed a bit more” (Female, 20 years). 
Participants were generally open to the idea of a one-to-one session with a HA.  Only one young 
woman (21 years) said she was always asked to see a health adviser about her drinking and 
consistently declined as she does not consider it to be a problem. Some participants wanted a clear 
reason for seeing the health adviser and would be motivated to ask to talk to someone if they had 
specific questions or concerns.  Others thought they would accept the opportunity to talk to a health 
adviser if it was recommended to them, although this sometimes raised anxious concerns: “I think 
I’d be a bit nervous as to why they recommended me to one, but, like, I would go. If they’re 
recommending me to go see one, then I would” Daniella (Female, 17 years). 
Other barriers to attending a HA referral included time and the gender of the HA, e.g. a young 
woman (25 years) said she would be more inclined to talk to a health adviser if it was quick, and 
wanting the HA to be the same gender.  
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6.4.4 Healthcare provider qualitative feedback  
We had planned to conduct FGDs with both HAs and other clinical staff from Archway and Brighton 
to get feedback on how the intervention was implemented and experience from service 
perspectives. Two group sessions were held in Brighton, including three health advisors and four 
Box 4: Case Studies 
‘Jeff’ 
Jeff (MSM, 21 years) had come in for his regular three-monthly HIV test and was referred to the 
health adviser to talk about post-exposure HIV prophylaxis (PEP).  He had never seen a health 
adviser before and was curious and, although he had to wait some time, he wanted to do it then 
and there.  Their conversation covered STIs other than HIV and he decided to have a full STI 
screen after their discussion.  Jeff explained how this clinic visit was very different from usual: 
“Because to start with there was the tablet experience, filling in and then getting a ticket and 
then being informed about the health adviser and then actually talking to that health advisor.  
Yes, it was really different because usually it would just be going to the room with the doctor and 
then getting a finger prick done and that's it, yes”. His action plan had included doing some 
research around STIs and PEP, and he had followed through on this and intended to have regular 
full screening in future. 
‘Kelly’ 
Kelly (female, 18 years) had just been diagnosed with an STI and valued the opportunity to talk to 
someone, although the health adviser did not feel it was appropriate to do an intervention with 
her because her anxiety was high: “So, I was quite happy just to talk to someone and just ask 
questions about it, because I wasn’t really sure.  And I had seen a health advisor before, and it 
was quite helpful”. She had seen a health adviser before to discuss changes she might like to 
make, although she felt a bit judged, she felt it had changed her mind about what she was doing.  
On this occasion, speaking to the health adviser helped calm her down and made her realise that 
everything was okay. 
‘Emma’ 
Emma (female, 17 years) had come in for treatment and welcomed the opportunity to see the 
health adviser and get more information.  She had kept her action plan and thought it was a 
good idea.  She thought the discussion was useful and had also visited the website. 
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other clinical staff. Recruitment from the London clinics was more difficult, with two doctors and one 
psychologist who had not been directly involved in the triage or the intervention taking part. Their 
comments remain speculative. An individual interview was conducted with the HA from Archway 
who had taken part in the pilot.  
Triage 
The value and effectiveness of the triage algorithm was questioned by most participants, who 
generally considered this to be a ‘blunt’ and diluted alternative to the more sensitive interpersonal, 
face-to-face risk assessment. Among HAs there was suspicion and lack of confidence in the capacity 
of the triage tool to accurately predict risk or need.   
“As a system, I don't think it works and it's not the same as having someone in front of you with it 
and then, kind of, ascertaining the best way for using instincts” (Brighton, Doctor)    
I think it's a completely different kind of experience and I think it depends what your measures or 
outcomes are, because I think sometime we'll see a person in clinic, they'll have a really good 
experience with us, it will be a really human experience and actually they might then come back a 
month later and tell us about something completely different that they hadn’t mentioned at the first 
visit because they feel safe, they've had a good experience. Whereas that is quite a, sort of, 
impersonal…” (London, HA) 
HAs’ experience of the pilot led them to feel that the tool had sometimes over-referred patients who 
were subsequently assessed to have not needed referral, and also to have under-referred patients 
who they subsequently identified as high-risk. Conversely, the Brighton HA group also stated that 
many of the patients referred via the triage tool were patients from the waiting room who had 
already been booked-in to see the HAs.  This was seen to both assert the effectiveness of the triage 
tool in identifying appropriate patients, but also to undermine the purpose and value of the tool:  
“And I think we're picking up the ones anyway that would engage, so they're the ones that, kind of, 
tend to be known to us and they engage and they're getting through to us in other ways.  And the 
people that won't engage are the people that won't engage, no matter what triage system you're 
using” (Brighton, HA).          
There was a further challenge to this method in the routine practice in Brighton, where all <18 year 
olds are routinely screened and receive a thorough assessment. This raised questions regarding the 
context of the pilot, as the role of an additional triage assessment was not clear:  
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“And with the young people they have an assessment anyway, really thorough from a safeguarding 
perspective, so all under 18s and that bring up anything and everything to do with risk. So that's 
going to happen anyway, when they're in the room.  So, I don't think you need something on top of 
that, with regards to young people, do you?” (Brighton, HA)   
Several advantages, or opportunities, offered by the triage tool were also discussed, including the 
potential for the triage tool to enable patients to highlight a risk profile or other issues that they 
might not feel able to raise face-to-face. This private disclosure was seen as avoiding a potentially 
embarrassing discussion with a member of staff:  
“So, what I'm saying is they may say something different to the consultant, nurse, whoever they see, 
and they may be saying what they really feel [overtalking]. If you see what I mean? Because 
sometimes it's easier to do this than it is to talk to someone face to face. So, it's tricky, yes, you're 
going to get that I think” (London, HA).  
The Brighton HA group also reflected that the piloted triage tool was potentially more effective than 
the current process of asking patients to tick key risk assessment questions on a form at reception.  
Another potential advantage of a systematised triaging which the London group proposed was the 
process and structure that it could provide to new members of staff that might lack confidence and 
skills. The systematised triage was thought to both prompt staff to identify and refer patients that 
come in for non-STI issues but who have risk profiles that would otherwise go un-assessed. 
“I suppose a good thing is that it might make a clinician think more about a patient, particularly if 
they're repeat attenders for something, and they think that they're really settled and stable and don’t 
need any intervention, this might actually pick it up. So, it might make people explore things more as 
opposed to thinking; ‘Oh, this person's a repeat attender for something’; it might make them look 
into it more.” (London, HA)  
“I rarely see the contraception service patients even though we're supposed to be integrated service. 
So, I would say it really helped clinicians to identify that. But the whole assessment was still down to 
them: do they feel this person would need to be referred?”  (London, HA) 
 
Santé website: 
We had limited feedback on the Santé webpage as consenting participants were either not aware of 
it or had not used it. At least two of the Brighton HAs were not aware that a Santé website existed, 
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and none of the others made reference to having used the Santé website. There was some brief 
discussion about the potential value of referral to websites.    
 “…there are some aspects or some topics maybe that people feel okay to do online, but I think in the 
area that we're in, in sexual health it's such a sensitive issue… it's quite a vulnerable position to be in 
to start talking about... So, when it comes to online, I'm not sure how that will translate, but for some 
people that might be just what they want, because for them, maybe talking doesn’t help them or 
they don’t feel it benefits them, and it might be a starting point for some people online” (London, 
HA).   
 
One-to-one session 
This feedback focusses on the health advisor experience, as the non-HA staff had little experience of 
the intervention. HAs from Brighton and the London HA interview each made conflicting comments 
about their use of the one-to-one sessions – stating that ‘It’s what we do anyway’, but also 
commenting that the manual provided useful structure and format for these interventions.   HAs in 
Brighton also discussed their existing use of MI as part of their routine work, although they 
acknowledged the limited amount of MI training that the HA staff had received. Much of the training 
had taken place many years ago, and they subsequently asked the study team for additional training 
in MI.   
Two of the Brighton HAs stated that they were concerned about the limitations of the intervention 
manual and felt that it repeated what was already part of their routine practice. They had therefore 
ignored it (“I must admit I didn’t really use it”). While another Brighton HA participant referred to 
the value of the manualised MI approach for the structure it provided:  
“I like the part when it gets to the work, I like the MI, I like just being able to, kind of, code or prove 
what you're doing or, I'm not saying that very well, but measuring what we do somehow” (Brighton, 
HA).  
The London HA interview in particular valued the manual for its structure and the focus on goal 
setting, which they felt guided their approach and focussed attention on action planning. They also 
suggested the focus on action plans provided structure for patients too. 
“…just having to do it 100%, thinking about it 100% and doing it 100% was more how it, kind of, 
focussed the consultations, so that it helped  to elicit three goals that the person wants, so, it really 
made the consultation more structured actually... I think in the normal run of the clinic that wouldn't 
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be the same way which we would deal with it. So, it, made it more structured for me personally” 
(London, HA).  
 
Although the London HA welcomed the use of the credit-card-sized Action Plans, none of the 
Brighton HAs had used the cards, or appeared to be aware of them. As with attitudes towards the 
Manual, the Brighton HAs described a tension between routine practice already being similar to the 
intervention process, and the Action Plans not being acted on.  “It's what we would do anyway.  The 
couple of times that I have done it I've forgotten to do an actual action plan, because I wouldn't 
necessarily do that” (Brighton, HA). Here again, the London HA interview identified advantages in 
the structure that the intervention and action plans provided, and related these to both the HAs and 
the patients:  
“I thought it was a very comprehensive tool, I really did, and a very comprehensive tool, it just, 
highlighted the bits that you needed to do; and, as I say, the action plan I think was really for me the 
best part of it” (London, HA).   
 
Implementation barriers:  
A number of implementation barriers were raised during discussions, including the ticketed triage 
process, and limited staff training. The use of tickets was seen to be a key ‘leakage’ point at which 
both patients and staff lost potential referrals. The tickets, which were a work-around in place of the 
integrated EPR system initially planned, were seen as confusing to patients, and they were lost, 
abandoned or ignored by patients, and were lost or forgotten by staff. The use of these tickets was 
introduced as a work-around due to the delays and technical barriers of adapting EPR systems, and 
this was seen to have introduced several significant barriers to the pilot trial implementation. 
Integration into the EPR system was identified as a valuable solution that would have avoided many 
of these ‘leakage’ points.  
“I found them screwed up on the lab floor, stuffed in between peoples' notes, sometimes in the 
wrong place. Or people just randomly putting notes on my desk, you know, ‘Do I give this to you, 
what do I do with it?’ (Brighton, HA) 
I think, yes, people who would've been referred to me… basically, because there were few issues with 
just getting everybody understanding what to do with that bit of paper. (London, HA)                      
The engagement of doctors, nursing staff and HAs in briefings and training about the conduct of the 
trial appears to have been inconsistent, fractured and of limited impact.  Although all participants 
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said they found ways to make things work, patients were lost to the study due to confusion about 
the triage tickets, and the intervention manual was not always read or properly applied by HAs. 
Among the HAs there was considerable variation in the engagement with the trial, and questionable 
skills/capacity of HAs to administer an MI intervention.  The capacity of many HAs to deliver MI was 
questioned by some HAs themselves and by participants in the London group.  
“I think MI is often talked about as something that everyone does, and I think everyone can do it but 
equally it can be a very filtered, watered down version of what could be most useful. So I think it's 
good to make sure if you are offering it, that it's being done by somebody that’s really experienced in 
doing it” (London, Psychologist)  
Although most staff in the two pilot clinics had been informed about the pilot’s aims and objectives, 
and all HAs had been through some training on the intervention manual, concerns were raised about 
the effectiveness of the briefings and training. In the Brighton discussions, a senior nurse had joined 
the clinic after the pilot had begun and highlighted the necessity of effective, on-going introductions 
for new staff.  This was also recognised to be an issue for junior doctors who may arrive after initial 
briefings. 
“I think if the staff that are seeing them [patients] have a grip of the basic principles of the study, 
that’s more persuasive than them just going, ‘Oh, I'm not really sure it's something to do with 
offering you an intervention if you're a high risk’.  There's consistency, isn’t there? Everyone saying 
the same thing, in the same sort of way.” (Brighton, Doctor)              
The triage and intervention were generally accepted as viable in these busy clinic environments, and 
the trial appeared to have had only a very limited impact on the day-to-day clinic work. Even HAs 
appear to have found the trial and intervention to have been acceptable within their workload – 
although this may be related to their opinion that most referrals were of patients they would already 
have expected to see, and the limited numbers of triaged patients who actually made it through to 
HA appointments. The Brighton HA group suggested that the ‘Brighton Express’ clinic for <18s, which 
provides routine and thorough face-to-face assessment of the needs of younger patients, would 
have been negatively impacted by the trial however. 
 
6.4.5 Follow-up study 
In both intervention and control clinics, service users were recruited for a follow-up survey and 
screening at 6-weeks. The follow-up involved a short web-questionnaire and either a postal self-
sample kit or returning to the clinic for a routine STI screening. The initial target was 700 patients 
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from 8 clinics; as only 6 clinics took part, the target recruitment was revised down to 525 patients. 
We had originally projected that 180/400 patients from intervention, and 144/300 patients from 
control clinics would complete follow-up (Figure 13). A total of 406 patients consented to follow-up; 
recruitment was not achieved at three clinics due to a lack of eligible patients and low consenting 
rates (Figure 17).  
 
Figure 17: Recruitment and follow-up summary 
 
 
 
 
Of the 406 who consented, 273 (67%) were young and 133 (33%) were MSM (33%). Overall 228 
(56%) participants did not participate in the web-survey or return a self-sample kit and 64 (16%) 
completed both follow-up activities. MSM were more likely than young people to participate in the 
web-survey, to return a self-sample or complete both part of the follow-up (29% versus 10%).  
The patients recruited for follow-up represented 2% of all eligible attendees attending the clinics 
during the study period (Table 25). Young people we recruited were generally representative in 
terms of age, gender and sexual orientation, however our sample had a larger number of young 
people of black ethnicity. The MSM population we recruited was generally younger than the overall 
Approached = 589  
Reasons for no consent: 
- Wasn’t interested 
- Living situation was a barrier 
- Leaving the country 
Consented = 406 (69%)  
Self-sample returned: 108 (28%) 
 
YP = 57 (22%) 
MSM = 51 (39%) 
Reasons for no follow-up: 
- No email provided =17 
- No address provided = 21 
Web-survey complete: 133 (35%) 
 
YP = 69 (28%) 
MSM = 64 (50%) 
Self-sample sent: 385 (96%) Web-survey sent: 389 (96%) 
Email bounced: 13 (3%) 
Returned without sample: 1 
(0%) 
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MSM patient population, and had a higher proportion of bisexual men. We under recruited from 
MMC compared to the other clinics.  
Table 25: Summary of participants recruited for follow-up and the general clinic populations 
 
 Young people  MSM  
Total (N, %) 
n = 6,216* 
Recruits (N, 
%) 
n = 273 
Total (N, %) 
n = 5,738* 
Recruits (N, 
%) 
n = 133 
Gender Male 1,444  (23%) 67 (25%)     
Female 4,772 (77%) 206 (75%)     
Age 16-20 years 1,890 (30%) 86 (32%) 149 (3%) 9 (7%) 
21-25 years 4,326 (70%) 69 (68%) 610 (11%) 25 (19%) 
26-35 years     1,639 (29%) 43 (32%) 
36-45 years     1,504 (26%) 29 (22%) 
>45 years     1,836 (32%) 27 (20%) 
Ethnicity White 4,296 (69%) 179 (66%) 4,485 (78%) 102 (77%) 
Mixed 455 (7%) 25 (9%) 228 (4%) 11 (8%) 
Asian 331 (5%) 11 (4%) 350 (6%) 7 (5%) 
Black 568 (9%) 52 (19%) 192 (3%) 6 (5%) 
Other 566 (9%) 6 (2%) 483 (8%) 7 (5%) 
Sexual 
orientation 
Heterosexual 5,759 (93%) 245 (90%)     
Homosexual 25 (0%) 2 (1%) 5,286 (92%) 113 (85%) 
Bisexual 404 (7%) 25 (9%) 452 (8%) 20 (15%) 
Clinic Archway 1,667 (27%) 64 (24%) 386 (7%) 11 (8%) 
Brighton 2,134 (34%) 50 (18%) 1,952 (34%) 49 (37%) 
Chelsea 968 (16%) 38 (14%) 1,532 (27%) 36 (27%) 
Croydon*   64 (24%)   12 (9%) 
Darlington 292 (5%) 31 (11%) 37 (1%) 3 (2%) 
MMC 1,155 (19%) 25 (9%) 1,831 (32%) 22 (17%) 
* Note: Croydon data was not available at the time of writing the report, the table will be updated 
once this data is received.  
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Web-survey: 
A total of 990 emails were sent, to 389 service users. 13 (3%) emails bounced as the email address 
provided by the service user was incorrect (Figure 17). Of the 376 service users who received the 
link, 133 (35%) completed the survey, and an additional 17 (5%) participants started but did not 
complete the survey. On average, participants responded to the third email reminder and took a 
median of 2 minutes to complete the survey.  
Young people were significantly less likely to complete the web-survey than MSM (OR: 0.39, 95% CI: 
0.25, 0.61), and the completion rate ranged between clinics from 47% in Darlington to 19% at 
Croydon. Table 26 presents factors associated with survey completion in MSM and young people.  
Table 26: Multivariate analysis of demographic predictors of web-survey completion in MSM and 
young people 
 Young people (N = 273) MSM (N = 133) 
Completed (n, %) aOR* (95% CI) Completed (n, %) aOR** (95% CI) 
Gender Male 7 (12%) 1.00      
Female 62 (33%) 4.35 (1.59, 11.88)     
Age 16-20 years 27 (36%) 1.00  3 (38%) 1.00  
21-25 years 42 (24%) 0.57 (0.29, 1.11) 12 (50%) 2.54 (0.33, 19.62) 
26-35 years     9 (21%) 0.56 (0.08, 4.01) 
36-45 years     19 (68%) 6.34 (0.77, 52.27) 
>45 years     21 (78%) 5.40 (0.67, 43.26) 
Ethnicity White 47 (30%) 1.00  58 (59%) 1.00  
Mixed 3 (14%) 0.34 (0.08, 1.44) 0 (0%)   
Asian 1 (10%) 0.27 (0.03, 2.41) 1 (14%) 0.13 (0.01, 1.39) 
Black 14 (27%) 2.13 (0.82, 5.52) 2 (33%) 0.37 (0.04, 3.68) 
Other 4 (67%) 9.42 (1.34, 66.41) 3 (43%) 0.70 (0.12, 4.01) 
Sexual 
orientation 
Heterosexual 57 (26%) 1.00      
Homosexual 1 (50%) 3.09 (0.18, 52.65) 53 (48%) 1.00  
Bisexual 11 (50%) 2.92 (1.08, 7.93) 11 (58%) 3.10 (0.74, 12.98) 
Clinic Archway 22 (37%) 1.00  5 (45%) 1.00  
Brighton 16 (32%) 0.73 (0.29, 1.82) 25 (53%) 0.82 (0.14, 4.92) 
Chelsea 11 (30%) 1.13 (0.43, 2.96) 15 (42%) 0.45 (0.08, 2.66) 
Croydon 7 (12%) 0.22 (0.07, 0.66) 7 (58%) 2.93 (0.30, 28.72) 
145 
 
Darlington 7 (47%) 0.24 (0.68, 8.71) 1 (50%) 1.13 (0.04, 34.11) 
MMC 6 (25%) 1.33 (0.41, 4.40) 11 (52%) 0.76 (0.11, 5.16) 
*Adjusted for: gender, age, ethnicity, sexual orientation, clinic; **Adjusted for: age, ethnicity, sexual orientation, 
clinic.  
 
Amongst young people, women were more likely to respond to the web-survey (aOR: 4.35, 95%CI: 
1.59, 11.88). Participants recruited from Croydon were significantly less likely to respond, even when 
the age, gender and ethnicity of the participant was taken into account (aOR: 0.22, 95% CI: 0.07, 
0.66). In MSM, no demographic factors were identified that predicted whether participants were 
more of less likely to respond to the web-survey, although there were trends towards older and 
white MSM responding. Interestingly, the MSM from Croydon had the highest response rate.   
 
 
STI screen: 
We offered two options for the 6-week follow-up: returning to clinic for a ‘quick check’ or being 
posted a self-sample kit. Typically, ‘quick check’ STI screening appointments involved completion of 
a very short questionnaire, self-collection of samples, and minimal interaction with clinic staff. In 
some of the clinics we were unable to offer a ‘quick-check’ appointment due to limitations with the 
booking system. Of the 406 participants recruited, 385 opted for the postal self-sample kits and 
provided address details. The return rate was higher in those who were sent kits (27%) than those 
who opted to return to clinic (3/21, 14%). Amongst the 108 participants who were successfully 
screened, there were two chlamydia positive tests and no gonorrhoea diagnosed. We aimed to send 
the self-sample kits at 6-weeks following recruitment into the study; on average samples were 
returned at a median of 9 weeks (IQR: 8 – 11).  
Young people were significantly less likely to return the self-sample kit than MSM (OR: 0.45, 95% CI: 
0.29, 0.72), and the completion rate ranged between clinics from 47% in Darlington to 19% in 
Croydon. Table 27 presents factors associated with survey completion in MSM and young people.  
Amongst young people, the only factor significantly associated with completing an STI screen was 
being female (aOR: 3.32; 95% CI: 1.32, 8.38); being older was borderline associated. In MSM, while 
nothing was statistically significant, there was again a trend towards older men completing the 
screen compared to younger MSM (63% in >45 year olds versus 0% in 16-20 year olds). 
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Table 27: Multivariate analysis of demographic predictors of STI screen completion in MSM and 
young people 
 Young people (N = 273) MSM (N = 133) 
Completed (n, %) aOR* (95% CI) Completed (n, %) aOR** (95% CI) 
Gender Male 7 (12%) 1.00      
Female 50 (26%) 3.32 (1.32, 8.38)     
Age 16-20 years 13 (16%) 1.00  0 (0%)   
21-25 years 44 (25%) 2.04 (0.97, 4.28) 8 (33%) 1.00  
26-35 years     13 (30%) 0.73 (0.23, 2.37) 
36-45 years     13 (45%) 1.21 (0.35, 4.12) 
>45 years     17 (63%) 2.03 (0.58, 7.16) 
Ethnicity White 39 (23%) 1.00  45 (44%) 1.00  
Mixed 6 (24%) 1.11 (0.37, 3.30) 3 (27%) 0.68 (0.14, 3.20) 
Asian 1 (10%) 0.27 (0.03, 2.40) 0 (0%)   
Black 10 (20%) 1.11 (0.43, 2.84) 0 (0%)   
Other 1 (20%) 1.55 (0.14, 16.81) 3 (43%) 0.95 (0.19, 4.78) 
Sexual 
orientation 
Heterosexual 49 (21%) 1.00      
Homosexual 1 (50%) 4.11 (0.23, 73.35) 45 (40%) 1.00  
Bisexual 7 (30%) 1.83 (0.65, 5.12) 6 (30%) 0.71 (0.21, 2.34) 
Clinic Archway 10 (19%) 1.00  3 (30%) 1.00  
Brighton 11 (23%) 1.21 (0.42, 3.48) 22 (45%) 1.40 (0.29, 6.83) 
Chelsea 12 (32%) 2.48 (0.88, 6.99) 13 (36%) 1.06 (0.21, 5.40) 
Croydon 11 (17%) 1.06 (0.38, 3.00) 5 (42%) 3.90 (0.41, 37.47) 
Darlington 5 (17%) 1.23 (0.34, 4,44) 0 (0%)   
MMC 8 (32%) 3.10 (0.94, 10.25) 8 (36%) 1.18 (0.21, 6.70) 
*Adjusted for: gender, age, ethnicity, sexual orientation, clinic; **Adjusted for: age, ethnicity, sexual orientation, 
clinic. 
 
6.5 Discussion 
We conducted a pilot feasibility study to determine the acceptability of our intervention package, 
the feasibility of implementing the package and the feasibility of conducting a subsequent cluster 
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RCT. We encountered multiple challenges in both trial and intervention feasibility, but found some 
evidence to support acceptability; however we also faced challenges in collecting all the data we 
planned to assess acceptability and feasibility. Table 28 summarises the pilot trial objectives and 
specific outcomes that we intended to collect, and those which we actually managed to collect.  
Table 28: Summary of pilot trial outcomes planned and measured  
Planned objective and measure Measurement status Comments 
Acceptability of the intervention to users and HCP  
1. Proportion of eligible service users who 
attend the clinic that were assigned a 
score by the triage tool  
Collected as planned 
(Table 23) 
This data was collected through the 
tablet triage, and compared to the 
total attendances recorded in the 
clinic EPR system.  
2. Proportion of those who were classified 
as high risk who are offered the 
intervention 
Partially collected 
(Table 23) 
 
This data was collected through the 
table triage system and then linked 
to the clinic EPR system in Brighton, 
and to paper forms in Archway. This 
linkage relied on HCPs asking for the 
triage ticket and then filling 
information during the consultation, 
and this was incomplete for a 
proportion of service users, limiting 
our conclusions.  
3. Proportion of those who were offered 
the intervention who took up the 
intervention 
4. Proportion who took up the 
intervention who completed the 
intervention 
5. Reasons for not completing the 
intervention from the qualitative study 
of participants  
Collected as planned 
(Section 6.4.3) 
We conducted 16 interviews with 
service users, identifying barriers to 
attending the 1:1 and accessing the 
webpage.  
6. Acceptability of the intervention from 
the qualitative study of the staff  
Partially completed 
(Section 6.4.4) 
We conducted FGDs and interviews 
with HCPs from Archway and 
Brighton, and identified barriers and 
opportunities for the intervention in 
these two settings. 
Feasibility of delivering the interventions 
1. The total time spent by service users 
within the clinical service compared to 
normal 
Data not collected We did not collect any baseline data 
from the clinics on attendances, or 
duration of consultations. Therefore, 
we did not have anything to compare 
the pilot period to. We were also 
unable to collect data on 
consultation durations from the EPR 
system.  
2. Total number of service users seen and 
STIs diagnosed, compared to normal  
Data not collected 
3. Average consultation time compared to 
normal  
Data not collected 
4. Number of patients seen by health 
advisors compared to normal  
Partially collected 
(Table 23) 
5. Extra HCP time required for the 
intervention  
Partially collected 
(Section 6.4.2) 
Health advisors were asked to record 
how long the 1:1 session lasted in the 
EPR system. This data was 
incomplete.  
Feasibility of obtaining follow-up outcome data  
1. Proportion of eligible service users who 
consented to the follow-up 
These data were collected by study 
staff and then compared to all 
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2. Proportion of eligible service users who 
were contactable at 6 weeks and 
complete a questionnaire  
Collected as planned 
(Figure 17 and Table 
25) 
attendances as recorded by the clinic 
EPR. We were unable to make this 
comparison for one clinic, who did 
not provide their EPR data.  3. Proportion who complete follow-up 
tests  
 
6.5.1 Intervention acceptability 
The intervention package consisted of three components, the triage, the webpage and the one-to-
one consultation. The first step, triage, was conducted on tablet computers with study staff asking 
patients on arrival to complete it before their appointment. This was a resource intensive approach 
to triage and we only captured 16% patients who attended during the pilot period, and could not 
capture reliably the number of patients who refused to take part. However, those patients who we 
did engage with the triage process completed the process 97% of the time – this suggests that the 
process was acceptable and that the tablet-based self-triage was usable. This was supported by the 
interviews with patients, who generally found this process to be acceptable, and the types of 
questions asked unsurprising. This is similar to the findings from other self-triage evaluations in 
sexual health which have found the process, whether using pen and paper, electronic devices or 
online, were all acceptable.89, 137 There is also evidence to suggest that self-triage could elicit more 
reliable information about sexual risk, compared to face-to-face assessments.138 However, the 
difference in completeness of data between the pilot and the triage development dataset may have 
resulted in the tool not performing as anticipated. Further work to externally validate, or refine the 
model using different clinic populations would be required before the value of standardised 
implementation could be determined.  
The acceptability was less consistent among healthcare staff. Healthcare providers expressed 
particular concern over the ability of the triage tool to accurately identify who they perceive to be 
‘high risk’. At the same time, there were questions about the value of having a tool if it was 
identifying patients who would already be flagged as ‘high risk’.  
While in principle the concept of a webpage was acceptable to patients and providers, engagement 
with the intervention webpage was extremely limited, demonstrating a disconnect between 
acceptability and uptake. This may have been because of the short period for the pilot, so that it had 
not been well embedded into the operation of the clinic. However it is a common theme in internet-
based digital interventions, with effectiveness closely linked to engagement and reach,28 and more 
methods for sharing the webpage with patients could have been employed.139  
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The one-to-one session was commented upon by both patients and providers suggesting that this 
was an acceptable approach, although this was not based on first-hand experience for most of the 
participants. Of those who should have been referred for the one-to-one intervention, only 18% 
were recorded as having completed it, which raises questions about actual acceptability. Health 
advisors, who delivered the one-to-one sessions, were not all positive about it. Some considered it 
something they already did and therefore the need for the manualised approach was questioned. 
This would likely cause challenges in terms of fidelity of delivery of the implementation across 
services and individual providers, if HAs considered the intervention only a reinforcement of their 
current practice.    
 
6.5.2 Intervention feasibility 
We were unable to collect our originally proposed metrics for intervention feasibility (Table 28); 
however we collected several different types of data about the ability and willingness of clinics to 
pilot the intervention package. Firstly, we had planned to pilot in four clinics and specifically aimed 
to engage a level-2 service. While Brook agreed to the pilot, and gave high-level support for the 
project, we encountered several practical limitations and were ultimately unable to include them. 
These barriers were mainly related to resources rather than the acceptability of the structure of the 
intervention. Similarly, the two London GUM clinics agreed to the pilot, but were unable to 
implement. They raised significant issues with staffing and clinic space. In order to conduct a trial in 
these settings, resources would need to be provided. 
On the other hand, Brighton were able to implement the intervention package, mostly within 
existing clinic resources, suggesting that not all sexual health services are experiencing the same 
level of resource constraint. In Brighton, members of clinical staff (including a HA) were part of the 
project management group, and this continued engagement may have been one of the reasons for 
engaging with the pilot. In a large cluster RCT it would be essential to engage both management and 
healthcare staff at potential sites to improve the prospects for a trial.  
While incorporating the triage tool in the EPR systems in Brighton and Archway was theoretically 
possible, we were unable to demonstrate feasibility (or therefore acceptability) of this approach 
within the timescale and resources of this study. This limited our ability to monitor process data on 
the number of patients triaged, referred and who attended. It also made the  patient pathway less 
seamless, with healthcare providers needing to be engaged enough with the intervention to ask 
patients for their triage slip, and then refer them to a HA if indicated. We had envisaged that the EPR 
systems would run the triage without prompt and then inform the healthcare provider during the 
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consultation of the result, without the provider needing to remember. We are unable to comment 
on whether this approach would have improved provider engagement with the intervention process; 
however the system piloted would not support a larger trial.  
 
6.5.3 Trial feasibility 
We worked on the premise that a full trial would be cluster randomised and powered to detect a 
reduction in STI diagnoses. In order to test the feasibility of this trial design, we recruited a sub-set of 
patients from intervention and control sites to be followed-up 6-weeks after recruitment.  We did 
not recruit the 700 planned patients, partly due to our inability to engage with all eight clinics we 
had originally planned. However, we also recruited fewer patients within clinics for a range of 
reasons. These included patients who were ineligible because they only temporarily in the country, 
or those who lived with their partner or parents and did not want to share their contact information 
in case this resulted in accidental disclosure of their clinic attendance.  
In addition, of those who we did consent to be followed-up, return rates for both the web-survey 
and STI screen were lower than we had projected. Approximately one third of participants engaged 
with the follow-up process, and there were differences in the characteristics of those who engaged. 
MSM were more likely to engage than young people. Heterosexual women were more likely to 
engage than heterosexual men, and older MSM were more likely to take part than younger MSM. In 
a trial, these differences could bias the primary outcome. Additionally, there were differences both 
in recruitment and follow-up rates between clinics, with Croydon having lower follow-up in young 
people, but higher in MSM, after adjusting for other factors. This suggests that there may other 
factors involved which we have not captured. In a cluster randomised design it would be important 
to understand how clinic features influenced both the trial implementation, as well as ascertainment 
of the primary outcome. These pilot data suggest this could be problematic.     
 
6.5.4 Strengths and limitations 
A key strength of the pilot was the inclusion of clinics from different geographical locations, with 
different patient characteristics and risk behaviours. This meant that data, while limited, was likely 
to include different perspectives and experiences from both healthcare providers and patients. We 
were only able to pilot the intervention package effectively in two clinics; this is also a limitation. As 
the clinics implemented the intervention differently, we are unable to directly compare their 
experiences or generalise to sexual health services in England, considering the diversity of standard 
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practice observed across services. In particular, we were unable to draw conclusions about trial 
feasibility and intervention acceptability in level-2 services.  
The interviews and FGDs with patients and healthcare providers included some participants who had 
not had any interaction with the intervention package, or in the case of patients they had not 
realised that they were part of an intervention. Therefore, some of the views expressed were more 
theoretical, rather than based on experience. We were aiming to understand the barriers to 
delivering the intervention, and the reasons for the intervention being acceptable, or not. While 
some participants provided concrete examples from their experience, many were only able to offer 
opinions based on a description of what was offered.   
We recruited a large number of participants to the follow-up study, albeit less than planned 
(406/700), meaning the descriptive analyses lacked power. We found very few statistically significant 
factors associated with completing follow-up. Similarly, with only two clinical services implementing 
the intervention pilot, it is not possible to understand fully the potential differences between clinic 
types. 
 
6.6 Conclusion 
We were able to pilot the intervention package and recruit patients to be followed-up for an STI 
screen 6-weeks after their visit to a SH clinic. However, we observed considerable barriers both to 
implementing the intervention and conducting the follow-up. These implementation barriers 
included the inability to recruit a level-2 service to take part in the pilot, not being able to adapt an 
EPR system to include the triage process, and a lack of trained staff time to deliver the one-to-one 
session. The 6-week follow-up suffered from lower than expected recruitment and completion, 
although differences in the types of patients who completed follow-up were noted. These 
differences could influence interpretation of the results of a trial powered for STI outcomes. In spite 
of these challenges, we found that the intervention was generally perceived as acceptable.        
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Chapter 7: Work Package 6 – Determination of the feasibility of an RCT, and further 
recommendations 
7.1 Introduction 
The systematic review (WP1) confirmed that there are several interventions which have shown 
modest, but significant, effects on sexual behaviour and STI outcomes. Both service users and 
service providers expressed a preference for one-to-one and digital interventions. Clinics indicated 
that these types of interventions have been or could be feasibly delivered within their settings. The 
specification and manualisation of one-to-one intervention, which required more development work 
than expected, was nonetheless completed, and pre-trial evaluation by service providers and users 
was positive. However, attempts to execute a pilot trial highlighted major service-level feasibility 
challenges. Implementing the triage tool, albeit not fully developed due to insufficient data being 
available to refine the model, was hampered by unresponsive and inflexible IT systems and support. 
But the biggest challenge was the inability of services to deliver. This can be summarised as being 
due to a combination of ‘bad timing’, and a service provision environment undergoing 
unprecedented upheaval, with an almost universal demand from commissioners that providers 
accommodate a reduction in funding for services. 
WP6 was designed to include the development of an outline protocol for a cluster RCT, based on the 
elements developed and tested in the Santé project to that point. However, in the light of the 
findings of the pilot, our conclusion is that the postulated cluster RCT as a whole is not feasible at 
the current time. Nonetheless there are important outputs from the project which could lead to the 
implementation and evaluation of an important public health intervention.  
 
7.2 Method 
The data from each of the work packages were reviewed and synthesized by the Project 
Management Group and a consensus arrived at regarding the feasibility of an RCT. Discussions 
focussed on the data collected related to: intervention package acceptability; intervention feasibility; 
trial feasibility. Conclusions in respect of each of these were agreed, and presented to the Project 
Steering Committee and PPI group for input and feedback.  
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7.3 Results and discussion 
7.3.1 One-to-one behavioural intervention   
Throughout the project there was support from SH service users for behavioural interventions, and 
more specifically for healthcare provider-based talking interventions. This is consistent with the 
Sexual Health Framework published by the DH, which prioritises prevention through behaviour 
change, alongside access to sexual and reproductive health services.6 Brief one-to-one sessions are 
already a recommended activity within SH services, and therefore our intervention package could 
capitalise on existing best practice, by providing an evidence-based structured intervention. 
However, despite being supported by providers and desired by patients, there was limited 
engagement with the one-to-one intervention in the small number of settings where it was trialled 
and resistance from clinics in implementing the pilot due to a lack of resources. As a result, we did 
not obtain as much evidence for the feasibility of delivery as we had hoped. Any future trial or 
implementation should include a further pilot of the acceptability and feasibility of delivery, and 
consider the costs of delivery and potential cost-benefit. 
 
7.3.2 Digital intervention 
The concept of a digital intervention was popular with service users and providers. The systematic 
review identified a number for which there was at least some evidence of efficacy, however there 
was none that could be included in the pilot. The interventions were unavailable for a variety of 
reasons including licencing issues, being offline or in non-current format, or were out of date or 
culturally or linguistically inappropriate. We used a placeholder to try to measure potential 
engagement, but other aspects of the pilot trial implementation limited the available data.  
A digital intervention places the least demand on clinic resources. We postulated that the digital 
intervention would be the best option in terms of deliverability for the majority of service users who 
are at lower risk. There is still a need to demonstrate that it could be delivered and engaged with by 
a sufficient proportion of those at risk to have a population level impact on STI rates.   
 
7.3.3 Triage tool 
The analysis of GUMCADv3 data led to a predictive model that could be implemented as an 
automated triage tool. The work in WP2 demonstrated that such a tool is feasible and, with further 
behavioural data, easily refined so as to improve its performance. Implementing the tool for the 
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pilot was not optimal, requiring alternative methods of data collection which was less robust, and 
more demanding of resources, at least in the short period available for the trial. Although there was 
scepticism from some service providers, others could see the value of a systematic evaluation of risk 
which could also be used to direct users to different STI screening pathways. It could also be easily 
adapted for use in conjunction with on-line access to STI testing. The wider application of this 
technology means that it is more likely to be supported and prioritised for implementation. 
We found this to be contradictory, as the pilot provided an opportunity to generate an evidence-
base on the value of these types of interventions, which could then be used to support their 
continued implementation and commissioning. We found that the role of HAs differed between 
clinics, and that much of these differences were the result of local commissioning decisions, rather 
than based on local patient need or staff skills. In order for our intervention package to be 
successfully delivered within SH clinics using existing resources, a commitment from commissioners 
to support these sorts of services would be required.  However, we were unable to generate the 
evidence which commissioners would likely need to make the decision to support these services. 
This is a considerable issue if research into behavioural interventions in sexual health services 
assumes a certain level of existing resources.     
 
7.3.4 RCT feasibility 
Overall, based on the experience of trying to implement the pilot, and the data collected, we 
concluded that trialling this intervention package using a cluster RCT approach is not feasible in 
existing SH services. Of the several factors identified, some could be mitigated if funding for the 
intervention delivery was met by the trial (including the HA and clinic staff time, adaptation of the 
digital intervention and implementation of the triage tool in clinic EPR systems). However, as the 
intervention effect size would still likely to be small, the cost-effectiveness may still rely on delivering 
the eventual service within existing resources. With the immediate constraints on resources for 
sexual health services nationally, the case for prioritising this prevention strategy is difficult to make, 
without the evidence for the very study that cannot be delivered.  
Other concerns with conducting a cluster RCT were highlighted. 
Firstly, we found considerable variability in services, both in terms of their current resources (which 
was particularly apparent with clinics going through re-commissioning and how this impacted their 
resourcing), patient pathways and interventions which they currently offer. This was an issue for 
multiple reasons:  
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 Standardising clinic pathways and services to the degree required for a trial would be 
challenging, meaning that local adaptations to the intervention package would likely be 
needed. The inability to ensure standardised implementation would undermine the 
evaluation.   
 The intervention may not be sufficiently different from standard care to demonstrate any 
intervention effect, as many clinics currently offer some form of one-to-one session or refer 
patients to online resources. As control sites would need to be able to offer their current 
minimum standard of care, a well-resourced control clinic with MI trained HAs may not be 
materially different from an intervention clinic.   
Secondly, there were concerns around the use a standardised triage tool, developed using national-
level data, applied to an individual clinic setting. We found a higher proportion of high-risk patients 
in the pilot sites than seen in the dataset used to develop the tool. This is not surprising as the 
proportion of MSM, for example, attending clinics varies substantially. If only a fixed, and small, 
proportion of patients can be offered the one-to-one intervention, there could be substantial 
inequality in who is offered the intervention package between services, or unfeasible numbers of 
patients requiring intervention in some clinics. This could impact on the overall effect of the 
intervention at each of the clinics, and have significant design implications.  
Thirdly, the rate of follow-up completion was much lower than would be needed for a trial, and 
there were differences in those clinic attendees who agreed to take part and those who completed 
the STI screen, compared to those that did not. This suggests that the primary outcome measure in a 
cluster RCT could suffer from material biases.  
Finally, we encountered significant research and development (R&D) barriers during the project, 
which resulted in delays to starting the pilot study, and this may have been one reason for the 
resulting poor engagement from clinics. Certainly the available time to complete the pilot was 
reduced and it was not possible to accommodate, for example, postponing implementation of the 
pilot until after a clinic moved, or a new IT system was implemented. During the period of the 
project, the process for gaining national and local ethical approvals changed, with the new system 
aiming to decrease the amount of local approvals required for multi-site projects. However our 
experience of the process did not reflect this, with each pilot site required different documentation, 
checks and time to process. These delays also affected sponsor approval. Overall, it took nine 
months to complete the R&D process for the pilot, which involved liaising with only five NHS trusts. 
A large cluster RCT would require considerably more clinics to be involved, and at present delivering 
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that represent a risk to the project.  Any delay would also incur research staff costs, and run the risk, 
as in this pilot, of a clinic no longer being able to deliver the intervention during this period.  
 
7.3.5 Alternatives designs 
We had initially planned that any large trial for the intervention package would need to be cluster 
randomised, because the intervention required a service-wide change in clinic practice and 
procedure. However, as we determined that there were significant difficulties with this design, 
several related to the clusters themselves, two alternative designs were considered, which do not 
rely on cluster-level randomisation.  
Individual randomisation: Elements of the intervention package could be well-suited to individual 
randomisation, such as the triage being randomly applied to different patients. However, there are 
still concerns about contamination between the intervention and control patients due to the service-
wide nature of the intervention. Employing study staff to deliver the intervention could mitigate this 
risk, but would have cost implications, and this implementation method would need piloting.   
Step-wedge roll-out: As the intervention package was in principle acceptable and used evidence-
based elements, the intervention package could be routinely implemented within clinics, if 
commissioners agreed to support it. A stepped-wedge trial, which did not involve randomisation or 
the need for the level of standardisation that an RCT would require, could allow for some adaptation 
of the intervention within each clinic. If this was combined with changes to GUMCAD, as currently 
being implemented for the Impact trial of HIV pre-exposure prophylaxis, then the outcome 
measures could be collected as part of routine data collection. This would allow for an evaluation of 
real world implementation. However, this approach would be unable to establish the effect size, and 
requires funding agreement from commissioners.   
We did not conclude that either of these alternative designs would be feasible for a trial within 
existing resources. Either would require additional developmental work, and piloting.  
 
7.3.6 Further developmental work and recommendations 
To realise the potential to implement the intervention package, or elements of it, there are key 
areas that require further development.  
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Digital intervention: A digital risk reduction intervention would need to be developed, or adapted 
from one of the trialled interventions, for which materials are available. Following the development 
process, additional piloting work would be needed to improve and incentivise engagement, such as 
the processes used in the pilot (e.g. specific text message promotion).  
One-to-one session: One concern with the one-to-one session, which was supported by our pilot 
work, is that due to being similar to HA’s current practice there may be issues with intervention 
fidelity. Furthermore, different SH providers, have different levels of training. Some MI training is 
required, but is not universal even among HAs. Extensive training was considered unfeasible within 
current clinics resources for the pilot. We designed the training to be pragmatic within existing clinic 
resources, assuming a baseline level of MI experience amongst staff, which was not always found. 
Additional work would be needed to evaluate how well this training module could be implemented, 
the gaps it would leave and how well those healthcare providers implemented the intervention 
session, rather than defaulting to their usual practice.  
EPR-based triage tool: While implementing the triage tool within clinic EPRs seems feasible, we were 
unable to actively demonstrate this within the pilot. A key challenge in this was communicating how 
the triage should be presented in the front-end of the system (i.e. what the HCP interacts with). 
Therefore, further work which includes the participation of clinical staff and engages with multiple 
different EPR providers would be needed. An important aspect of this would be how to standardise 
to a sufficient level, both the way in which the data is captured and processed, but also the end-user 
experience. In addition, further work on the external validation or refinement of the triage tool is 
needed using more complete data, to demonstrate whether it could be usefully rolled-out either in 
clinics or in online pathways.  
Follow-Up: Due to the relatively poor follow-up rates, further investigation and piloting of different 
methods (e.g. phone call reminders) and potential incentives (e.g. vouchers for samples returned) to 
improve follow-up rates would be needed. Specifically these would need to assess whether 
heterogeneity in follow-up increased or decreased by location and type of clinic, and the service user 
demographics.   
Economic evaluation: We had intended to estimate the cost of delivering the intervention package 
as part of the pilot trial, but were unable to collect the data we needed to do this. At the outset, it 
was envisaged that the intervention would be delivered within existing resources, by reallocation of 
staff time in particular, from existing work with patients. As such, an economic analysis might be less 
useful. However it was clear that to deliver the intervention, existing resources were not sufficient, 
and an economic evaluation is needed. One of the main barriers we faced in conducting the pilot 
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trial was delivering the one-to-one, and having a clear understanding of what resources a clinic 
would require to deliver the intervention package could have improved our ability to make 
conclusions on feasibility.  
Dissemination: Further communication between service providers, commissioners and service users 
is needed if the proposed intervention approach was to be trialled or undergo further piloting. A 
barrier we faced was the disconnect between service provider and user’s preference for risk 
reduction and what commissioners are prioritising for funding. We plan to disseminate the findings 
from this project to both service providers and commissioners, through this report, academic 
publications and conference presentations, to encourage this communication.   
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Chapter 8: Conclusion 
8.1 Summary of Main Findings 
Our key findings from this feasibility study were:  
 Evidence-based brief behavioural interventions that could be appropriate to SH clinics in the 
UK are available. But there are considerable barriers to the implementation of sustainable 
digital interventions and additional infrastructure would be needed if this approach were to 
be pursued. A more intensive, but still brief, one-to-one intervention based on the results of 
published trials was specified and could be deliverable.  
 Both HCP delivered talking interventions and online interventions were more desirable than 
other intervention formats, and were considered acceptable to providers and patients 
during piloting. However, the assessment of acceptability was limited in the project because 
of limited implementation.  
 Risk of an STI diagnosis could be predicted with reasonable accuracy using a limited number 
of routinely collected demographic and behavioural data; however this approach to triage 
was met with contradictory opposition by some HCPs and EPR software providers. The 
acceptability of conducting self-triage by patients though could provide opportunities in the 
context of online patient pathways.    
 During the course of the project, re-commissioning and reductions to sexual health clinic 
resources and staffing resulted in considerable challenges to involving clinics in the pilot. 
This was especially pronounced in level-2 services, which despite high-level support and 
interest in the project were unable to take part. Plans for future work in this area will need 
to consider the full resource implications of implementing and evaluating brief behavioural 
interventions.   
 Participant recruitment for a 6-week follow-up demonstrated biases in those who agreed to 
participate and those who completed the follow-up, raising concerns about the ability to 
conduct a large-scale trial with STI outcomes. Different approaches to incentivising 
participants should be considered going forward.  
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8.2 Overall Conclusion 
We concluded that a cluster RCT of the Santé intervention package would be very difficult to 
undertake in sexual health services in England at the present time. However, we are limited in our 
ability to draw a more definitive conclusion on feasibility, primarily due to the smaller than expected 
number of services which took part in the pilot study. In the literature review we found RCTs of 
behavioural interventions which had been successfully undertaken. However, a large scale pragmatic 
cluster RCT could only be delivered if the resources were available for the interventions. At the time 
of this study, resource limitations and major service reconfigurations meant that there were neither 
the resources nor the necessary service engagement to deliver such a trial. 
With limited resources and service re-organisation, there is a shift in focus of commissioning away 
from face-to-face consultation, to self-testing and online patient pathways. While there is 
agreement that there is a need for behavioural interventions, including one-to-one sessions for the 
highest risk groups, the heterogeneity of services means that the design and implementation of a 
large-scale national trial would be challenging. Digital interventions could be implemented in 
conjunction with new care pathways for STI testing but these have not been widely  commissioned. 
Further developmental work is required to see how behavioural interventions can be incorporated 
into the new models of service delivery. Alternative evaluation designs are likely to be required to 
provide evidence of efficacy and cost-effectiveness at that point. 
This project has wider lessons for sexual health services. We found both staff and patients valued 
the human interaction of one-to-one consultations, with patients particularly concerned that 
services should be tailored to their specific and varied needs. Reducing the flexibility of  the 
response in sexual health services, and replacing it with standardised online pathways may risk 
disengaging patients and reduce the opportunity to exploit teachable moments in the clinical 
setting. On the other hand, lower cost alternative models of service delivery for the majority of low-
risk patients may lead to resources being released for the delivery of more intensive behavioural 
interventions for those most at risk. On-line and remote testing models will provide an opportunity 
to exploit digital interventions although as we found, these will require further development. 
The re-commissioning and service reorganisation that coincided with the period of this study was a 
considerable barrier to effective piloting of the intervention package. Further development of the 
proposed intervention package, and a commitment to funding of the intervention during its 
evaluation would be required if the potential for this approach to reducing STI rates is to be realised.  
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Appendix 1: Medline search strategy (WP1) 
1. exp Health Promotion/  
2. exp Health Education/     
3. exp Sex Education/     
4. exp Preventive Health Services/     
5. exp Preventive Medicine/     
6. exp Primary Prevention/     
7. Public Health/     
8. exp Social Medicine/     
9. exp Behavior Therapy/     
10. exp Health Behavior/     
11. exp Sexual Behavior/     
12. exp risk reduction behavior/ or exp risk-taking/ or exp condoms/     
13. exp unsafe sex/     
14. exp safe sex/     
15. exp sexual abstinence/     
16. exp Sex Education/ or exp sexology/     
17. ((prevent$ or reduc$ or educat$ or promot$ or increas$ or decreas$ or facilitat$ or barrier$ or 
encourag$) adj2 (sex$ or HIV or STI or STIs or STD$)).ab,ti.   
18. Attitude to health/ or health knowledge, attitudes, practice/ 
OR 
20. exp Sexually Transmitted Diseases/     
21. exp chancroid/ or exp chlamydia infections/ or exp lymphogranuloma venereum/ or exp 
gonorrhea/ or exp granuloma inguinale/ or exp syphilis/     
22. exp HIV infections/  HIV*.ti,ab.  /acquired immuno deficiency syndrome/ Acquired 
Immunodeficiency Syndrome/     
23. Herpes Genitalis/     
24. Condylomata Acuminata/     
25. (HPV or human papilloma$).ab,ti.     
26. ((genital or venereal) adj2 wart$).ab,ti.     
27. (STI or STIs or STD or STDs).ab,ti.     
28. (Sexual$ transmit$ adj3 (infect$ or disease$)).ab,ti. 
OR 
29. exp Adolescent/     
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30. (young$ adj2 (men or man or woman or women or female$ or male$ or people or person)).ab,ti.     
31. (teenage$ or adolescen$ or youth or youths).ab,ti.     
32. exp men/     
33. ((gay adj2 man) or men).ti,ab.     
34. (men$ adj6 men).ab,ti.     
OR 
35. 19 and 32 and 39-41. randomized controlled trial.pt.     
36. controlled clinical trial.pt.     
37.  random$.ti,ab.     
38.  control$.ab,ti.     
39.  (effectiveness or trial).ti.     
40.  placebo.ab,ti.     
41.  one to one intervention$.ti,ab.     
42.  intervention$.tw.     
43.  ((control$ or experimental or compar$) adj2 (Group$ or trial$ or study or studies or evaluat$ or 
condition))  
 
